<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">76640</article-id><article-id pub-id-type="doi">10.7554/eLife.76640</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Cd59 and inflammation regulate Schwann cell development</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-265603"><name><surname>Wiltbank</surname><given-names>Ashtyn T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265604"><name><surname>Steinson</surname><given-names>Emma R</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265605"><name><surname>Criswell</surname><given-names>Stacey J</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265606"><name><surname>Piller</surname><given-names>Melanie</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-129378"><name><surname>Kucenas</surname><given-names>Sarah</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1950-751X</contrib-id><email>sk4ub@virginia.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0153tk833</institution-id><institution>Neuroscience Graduate Program, University of Virginia</institution></institution-wrap><addr-line><named-content content-type="city">Charlottesville</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0153tk833</institution-id><institution>Program in Fundamental Neuroscience, University of Virginia</institution></institution-wrap><addr-line><named-content content-type="city">Charlottesville</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0153tk833</institution-id><institution>Department of Biology, University of Virginia</institution></institution-wrap><addr-line><named-content content-type="city">Charlottesville</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0153tk833</institution-id><institution>Department of Cell Biology, University of Virginia</institution></institution-wrap><addr-line><named-content content-type="city">Charlottesville</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Feltri</surname><given-names>M Laura</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01q1z8k08</institution-id><institution>SUNY Buffalo</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Stainier</surname><given-names>Didier YR</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0165r2y73</institution-id><institution>Max Planck Institute for Heart and Lung Research</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>24</day><month>06</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e76640</elocation-id><history><date date-type="received" iso-8601-date="2021-12-23"><day>23</day><month>12</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-06-01"><day>01</day><month>06</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-01-12"><day>12</day><month>01</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.01.11.475853"/></event></pub-history><permissions><copyright-statement>© 2022, Wiltbank et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Wiltbank et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-76640-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-76640-figures-v2.pdf"/><abstract><p>Efficient neurotransmission is essential for organism survival and is enhanced by myelination. However, the genes that regulate myelin and myelinating glial cell development have not been fully characterized. Data from our lab and others demonstrates that <italic>cd59</italic>, which encodes for a small GPI-anchored glycoprotein, is highly expressed in developing zebrafish, rodent, and human oligodendrocytes (OLs) and Schwann cells (SCs), and that patients with CD59 dysfunction develop neurological dysfunction during early childhood. Yet, the function of Cd59 in the developing nervous system is currently undefined. In this study, we demonstrate that <italic>cd59</italic> is expressed in a subset of developing SCs. Using <italic>cd59</italic> mutant zebrafish, we show that developing SCs proliferate excessively and nerves may have reduced myelin volume, altered myelin ultrastructure, and perturbed node of Ranvier assembly. Finally, we demonstrate that complement activity is elevated in <italic>cd59</italic> mutants and that inhibiting inflammation restores SC proliferation, myelin volume, and nodes of Ranvier to wildtype levels. Together, this work identifies Cd59 and developmental inflammation as key players in myelinating glial cell development, highlighting the collaboration between glia and the innate immune system to ensure normal neural development.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>The nervous system of vertebrates is made of up of complex networks of nerve cells that send signals to one another. In addition to these cells, there are a number of supporting cells that help nerves carry out their role. Schwann cells, for example, help nerve cells to transmit information faster by wrapping their long extensions in a fatty membrane called myelin. When myelin is not produced properly, this can disturb the signals between nerve cells, leading to neurological defects.</p><p>Schwann cells mature simultaneously with nerve cells in the embryo. However, it was not fully understood how Schwann cells generate myelin during development. To investigate, Wiltbank et al. studied the embryos of zebrafish, which, unlike other vertebrates, are transparent and develop outside of the womb. These qualities make it easier to observe how cells in the nervous system grow in real-time using a microscope.</p><p>First, the team analyzed genetic data collected from the embryo of zebrafish and mice to search for genes that are highly abundant in Schwann cells during development. This led to the discovery of a gene called <italic>cd59,</italic> which codes for a protein that also interacts with the immune system. To find out whether Schwann cells rely on <italic>cd59</italic>, Wiltbank et al. deleted the <italic>cd59</italic> gene in zebrafish embryos. Without <italic>cd59,</italic> the Schwann cells produced too many copies of themselves and this, in turn, impaired the appropriate production of myelin.</p><p>Since the protein encoded by <italic>cd59</italic> normally balances inflammation levels, it was possible that losing this gene overactivated the immune system in the zebrafish embryos. In support of this hypothesis, when the <italic>cd59</italic> mutant embryos were treated with an anti-inflammatory drug, this corrected Schwann cell overproduction and restored myelin formation.</p><p>Taken together, these findings reveal how inflammation helps determine the number of Schwann cells produced during development, and that <italic>cd59</italic> prevents this process from getting carried away. This suggests that the nervous system and immune system may work together to build the nervous system. In the future, it will be interesting to investigate whether <italic>cd59</italic> acts in a similar way during the development of the human nervous system.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Schwann cell</kwd><kwd>myelin</kwd><kwd>node of Ranvier</kwd><kwd>CD59</kwd><kwd>complement</kwd><kwd>inflammation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01NS107525</award-id><principal-award-recipient><name><surname>Kucenas</surname><given-names>Sarah</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100018378</institution-id><institution>Owens Family Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kucenas</surname><given-names>Sarah</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Cd59 and developmental inflammation are key players in myelinating glial cell development, highlighting the collaboration between glia and the innate immune system to ensure normal neural development.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Myelin is a highly specialized, lipid-rich membrane that insulates axons in the nervous system to enhance neurotransmission (<xref ref-type="bibr" rid="bib108">Ritchie, 1982</xref>) while preserving axon health (<xref ref-type="bibr" rid="bib122">Stadelmann et al., 2019</xref>). Myelin is produced and maintained by myelinating glial cells such as motor exit point glia (<xref ref-type="bibr" rid="bib40">Fontenas and Kucenas, 2021</xref>; <xref ref-type="bibr" rid="bib39">Fontenas and Kucenas, 2018</xref>; <xref ref-type="bibr" rid="bib120">Smith et al., 2014</xref>) and myelinating Schwann cells (SCs; <xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="bibr" rid="bib1">Ackerman and Monk, 2016</xref>; <xref ref-type="bibr" rid="bib10">BEN GEREN, 1954</xref>; <xref ref-type="bibr" rid="bib59">Jessen and Mirsky, 2005</xref>) in the peripheral nervous system (PNS) as well as oligodendrocytes (OLs) in the central nervous system (CNS) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; <xref ref-type="bibr" rid="bib1">Ackerman and Monk, 2016</xref>; <xref ref-type="bibr" rid="bib84">Maturana, 1960</xref>; <xref ref-type="bibr" rid="bib96">Nave and Werner, 2014</xref>; <xref ref-type="bibr" rid="bib103">Peters, 1960a</xref>; <xref ref-type="bibr" rid="bib104">Peters, 1960b</xref>). Normal myelin and myelinating glial cell development facilitate an efficient and effective nervous system, ensuring precise motor, sensory, and cognitive function (<xref ref-type="bibr" rid="bib3">Almeida and Lyons, 2017</xref>; <xref ref-type="bibr" rid="bib11">Berger et al., 2006</xref>; <xref ref-type="bibr" rid="bib122">Stadelmann et al., 2019</xref>; <xref ref-type="bibr" rid="bib138">Wei et al., 2019</xref>). When this process is impaired, as seen with inherited disorders that cause abnormal myelination, patients present with neurological dysfunction that often leads to severe physical and intellectual disabilities (<xref ref-type="bibr" rid="bib11">Berger et al., 2006</xref>; <xref ref-type="bibr" rid="bib122">Stadelmann et al., 2019</xref>; <xref ref-type="bibr" rid="bib136">van der Knaap and Bugiani, 2017</xref>; <xref ref-type="bibr" rid="bib138">Wei et al., 2019</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>cd59</italic> is expressed in myelinating glial cells during nervous system development.</title><p>(<bold>A</bold>) Timeline of Schwann cell (SC) (orange) development (top panel). SC developmental stages for zebrafish (hours post fertilization [hpf]) and mice (embryonic day [E]) are indicated in the bottom panel. (<bold>B</bold>) Timeline of oligodendrocyte (OL) (blue) development. OL developmental stages for zebrafish (hpf) and mice (E and postnatal day) are indicated in the bottom panel. (<bold>C</bold>) Scatter plot of <italic>cd59</italic> expression (TPM) in oligodendrocyte lineage cells (OLCs), SCs, and neurons (N) at 72 hpf (left; mean ± SEM: OLC: 2145.1 ± 1215.1; SC: 40.1 ± 16.3; N: 240.5 ± 173.3; dot = replicate) as well as SCs at 36 and 72 hpf (right; mean ± SEM: 36 hpf: 0.0 ± 0.0, 72 hpf: 40.2 ± 16.3; dot = replicate). (<bold>D</bold>) Schematic of the relative <italic>cd59/Cd59a</italic> expression in developing SCs (orange) and OLs (blue) determined from RNAseq analysis in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>. Developmental stage numbers correspond with stages indicated in (<bold>A</bold>) and (<bold>B</bold>). Artwork created by Ashtyn T. Wiltbank with Illustrator (Adobe) based on previous schematics and electron micrographs published in <xref ref-type="bibr" rid="bib1">Ackerman and Monk, 2016</xref>; <xref ref-type="bibr" rid="bib26">Cunningham and Monk, 2018</xref>; <xref ref-type="bibr" rid="bib59">Jessen and Mirsky, 2005</xref>.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Source data for <italic>cd59</italic> bulk, RNAseq expression depicted in <xref ref-type="fig" rid="fig1">Figure 1C</xref>.</title><p>Data contributed to scatter plot of <italic>cd59</italic> expression (TPM) in oligodendrocyte lineage cells (OLCs), Schwann cells (SCs), and neurons (N) at 72 hours post fertilization (hpf) (left; mean ± SEM: OLC: 2145.1 ± 1215.1, SC: 40.1 ± 16.3; N: 240.5 ± 173.3; data point = replicate) as well as SCs at 36 and 72 hpf (right; mean ± SEM: 36 hpf: 0.0 ± 0.0, 72 hpf: 40.2 ± 16.3; data point = replicate).</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Myelinating glial cell <italic>cd59/Cd59a</italic> expression from bulk and scRNAseq.</title><p>(<bold>A</bold>) Uniform manifold approximation and projection (UMAP) of <italic>cd59</italic> expression in developing, zebrafish neural crest cell (NCC) lineages (48–50 hours post fertilization [hpf] and 68–70 hpf; <xref ref-type="bibr" rid="bib57">Howard et al., 2021</xref>). (<bold>B.1</bold>) t-SNE plot and (<bold>B.2</bold>) violin plot of <italic>Cd59a</italic> expression [natural log(ln)] in developing, mouse sciatic nerve cells (postnatal day 1 [P1]) (<xref ref-type="bibr" rid="bib42">Gerber et al., 2021</xref>). (<bold>B.3</bold>) Bar chart of <italic>Cd59a</italic> expression (RPKM) in developing, mouse sciatic nerve cells (P5) (<xref ref-type="bibr" rid="bib42">Gerber et al., 2021</xref>). (<bold>C.1</bold>) Violin plot and (<bold>C.2</bold>) UMAP of <italic>cd59</italic> expression in developing, zebrafish NCC lineages (5 days post fertilization [dpf]; <xref ref-type="bibr" rid="bib114">Saunders et al., 2019</xref>). (<bold>D</bold>) Bar chart of <italic>cd59a</italic> expression [log(TPM)] in zebrafish, myelinating oligodendrocyte lineage cells (OLCs) (5 dpf; <xref ref-type="bibr" rid="bib81">Marisca et al., 2020</xref>). All panels were prepared with the web applications included in the noted publications except for (<bold>C.1</bold> and <bold>C.2</bold>), which were assembled by our lab.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig1-figsupp1-v2.tif"/></fig></fig-group><p>Despite the importance of myelin, we still lack a complete understanding of myelin and myelinating glial cell development. With the recent boon of transcriptomic and proteomic analyses, many genes and proteins have been highlighted as differentially expressed during myelinating glial cell development, yet their precise functions remain unknown. For example, <italic>cd59</italic>, a gene that encodes for a small, glycosylphosphotidylinositol (GPI)-anchored glycoprotein, is a particularly interesting candidate for exploration. This gene features in several RNA sequencing (RNAseq) and proteomic analyses of zebrafish and rodent myelinating glial cells (<xref ref-type="bibr" rid="bib42">Gerber et al., 2021</xref>; <xref ref-type="bibr" rid="bib57">Howard et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Marisca et al., 2020</xref>; <xref ref-type="bibr" rid="bib83">Marques et al., 2018</xref>; <xref ref-type="bibr" rid="bib82">Marques et al., 2016</xref>; <xref ref-type="bibr" rid="bib105">Piller et al., 2021</xref>; <xref ref-type="bibr" rid="bib114">Saunders et al., 2019</xref>; <xref ref-type="bibr" rid="bib117">Siems et al., 2021</xref>; <xref ref-type="bibr" rid="bib144">Wolbert et al., 2020</xref>; <xref ref-type="bibr" rid="bib149">Zhu et al., 2019</xref>), all of which demonstrate high expression of <italic>cd59</italic> in developing oligodendrocyte lineage cells (OLCs) and SCs. <italic>cd59</italic> continues to be expressed in juvenile and adult zebrafish (<xref ref-type="bibr" rid="bib114">Saunders et al., 2019</xref>; <xref ref-type="bibr" rid="bib117">Siems et al., 2021</xref>; <xref ref-type="bibr" rid="bib125">Sun et al., 2013</xref>) and becomes the fourth most abundant CNS myelin protein in adult zebrafish (<xref ref-type="bibr" rid="bib117">Siems et al., 2021</xref>). Phylogenetic analysis demonstrates that Cd59 is conserved within vertebrate evolution (<xref ref-type="bibr" rid="bib117">Siems et al., 2021</xref>), and accordingly, CD59 protein is also found in developing and adult human myelin (<xref ref-type="bibr" rid="bib35">Erne et al., 2002</xref>; <xref ref-type="bibr" rid="bib67">Koski et al., 2002</xref>; <xref ref-type="bibr" rid="bib115">Scolding et al., 1998</xref>; <xref ref-type="bibr" rid="bib147">Zajicek et al., 1995</xref>). Collectively, these data indicate that <italic>cd59</italic> is a key component of the genetic program that orchestrates myelinating glial cell development. However, despite this knowledge of Cd59 expression, little is known about the function of Cd59 in the developing nervous system.</p><p>Outside of the nervous system, Cd59 is best known as a complement inhibitory protein. Complement is a molecular cascade within the innate immune system that aids in cell lysis of invading pathogens or aberrant cells in the body (<xref ref-type="bibr" rid="bib90">Merle et al., 2015</xref>). This process lacks specificity and requires inhibitory proteins, such as Cd59, to protect healthy cells from lytic death (<xref ref-type="bibr" rid="bib29">Davies et al., 1989</xref>). Cd59, specifically, acts at the end of the complement cascade where it binds to complement proteins 8 and 9 (C8 and C9, respectively) to prevent the polymerization of C9 and the subsequent formation of lytic pores (also known as membrane attack complexes [MACs] or terminal complement complexes [TCCs]) in healthy cell membranes (<xref ref-type="bibr" rid="bib89">Meri et al., 1990</xref>; <xref ref-type="bibr" rid="bib99">Ninomiya and Sims, 1992</xref>; <xref ref-type="bibr" rid="bib110">Rollins et al., 1991</xref>). This interaction is important throughout the adult body, including the nervous system, where CD59a is neuroprotective in models of multiple sclerosis (<xref ref-type="bibr" rid="bib88">Mead et al., 2004</xref>) and neuromyelitis optica (<xref ref-type="bibr" rid="bib145">Yao and Verkman, 2017</xref>). Beyond complement-inhibitory functions, Cd59 can also facilitate vesicle signaling in insulin-producing pancreatic cells (<xref ref-type="bibr" rid="bib44">Golec et al., 2019</xref>; <xref ref-type="bibr" rid="bib68">Krus et al., 2014</xref>), suppress cell proliferation in T cells responding to a viral infection (<xref ref-type="bibr" rid="bib76">Longhi et al., 2005</xref>) or smooth muscle cells in models of atherosclerosis (<xref ref-type="bibr" rid="bib74">Li et al., 2013</xref>), and orchestrate proximal-distal cell identity during limb regeneration (<xref ref-type="bibr" rid="bib33">Echeverri and Tanaka, 2005</xref>). Like complement inhibition, these processes are critical to normal nervous system function (<xref ref-type="bibr" rid="bib4">Almeida et al., 2021</xref>; <xref ref-type="bibr" rid="bib8">Baron and Hoekstra, 2010</xref>; <xref ref-type="bibr" rid="bib107">Reiter and Bongarzone, 2020</xref>; <xref ref-type="bibr" rid="bib139">White and Krämer-Albers, 2014</xref>). However, it is unclear exactly what role Cd59 is playing in myelinating glial cell development.</p><p>Though the precise function is unknown, it is clear that CD59 does impact human nervous system development. Patients with CD59 dysfunction, such as those with congenital CD59 deficiency (<xref ref-type="bibr" rid="bib51">Haliloglu et al., 2015</xref>; <xref ref-type="bibr" rid="bib56">Höchsmann and Schrezenmeier, 2015</xref>; <xref ref-type="bibr" rid="bib62">Karbian et al., 2018</xref>; <xref ref-type="bibr" rid="bib121">Solmaz et al., 2020</xref>) or germline paroxysmal nocturnal hemoglobinuria (<xref ref-type="bibr" rid="bib60">Johnston et al., 2012</xref>), present with polyneuropathies during infancy and continue to have nervous system dysfunction throughout their lives. Intriguingly, these neurological symptoms persist even with complement inhibition, the most common treatment for congenital CD59 deficiency (<xref ref-type="bibr" rid="bib56">Höchsmann and Schrezenmeier, 2015</xref>). Together, these observations further indicate that CD59 has an additional role in the developing nervous system and requires further investigation.</p><p>Here, utilizing the zebrafish model, we examined the role of Cd59 in the developing nervous system. In this study, we found that <italic>cd59</italic> is highly expressed in a subset of developing SCs in addition to mature OLs and myelinating and nonmyelinating SCs. We chose to focus on SCs and found that <italic>cd59</italic> mutant zebrafish have excessive SC proliferation. These mutants also have impaired myelin and node of Ranvier development. Finally, we demonstrate that complement activity increases in <italic>cd59</italic> mutants and that unregulated inflammation contributes to SC overproliferation and mutant larvae may also have aberrant myelin and node of Ranvier formation. Overall, this data demonstrates that developmental inflammation stimulates SC proliferation and that this process is balanced by Cd59 to ensure normal SC and myelinated nerve development.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>Cd59</italic> is expressed in myelinating glial cells during nervous system development</title><p>Myelinating glial cell development is a complex process (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>) orchestrated by a genetic program that is not yet fully elucidated. To identify unexplored genes that may impact myelinating glial cell or myelin development, we evaluated bulk and single-cell (sc) RNAseq datasets that assessed myelinating glial cells during nervous system development (<xref ref-type="bibr" rid="bib42">Gerber et al., 2021</xref>; <xref ref-type="bibr" rid="bib57">Howard et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Marisca et al., 2020</xref>; <xref ref-type="bibr" rid="bib83">Marques et al., 2018</xref>; <xref ref-type="bibr" rid="bib82">Marques et al., 2016</xref>; <xref ref-type="bibr" rid="bib105">Piller et al., 2021</xref>; <xref ref-type="bibr" rid="bib114">Saunders et al., 2019</xref>; <xref ref-type="bibr" rid="bib144">Wolbert et al., 2020</xref>; <xref ref-type="bibr" rid="bib149">Zhu et al., 2019</xref>). Across multiple datasets, <italic>cd59</italic> (zebrafish) or <italic>Cd59a</italic> (mouse)<italic>,</italic> which encodes for a small, GPI-anchored glycoprotein that has no known function in the developing nervous system, is expressed in SCs and OLCs (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p><p>When looking at SCs, data from developing zebrafish and mice indicated that <italic>cd59/Cd59a</italic>, respectively, is minimally expressed in neural crest cells (NCCs; the multipotent progenitors that give rise to SCs; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib57">Howard et al., 2021</xref>; <xref ref-type="bibr" rid="bib149">Zhu et al., 2019</xref>) but increases in expression in SC precursors (SCPs; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B.1,B.2</xref>; <xref ref-type="bibr" rid="bib42">Gerber et al., 2021</xref>), immature SCs (iSCs; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B.1,B.2</xref>; <xref ref-type="bibr" rid="bib42">Gerber et al., 2021</xref>), pro-myelinating SCs (pmSCs; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B.1,B.2</xref>; <xref ref-type="bibr" rid="bib42">Gerber et al., 2021</xref>), and mature myelinating SCs (MSCs) and non-myelinating SCs (MSCs and NMSCs; <xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B.3,C.1,C.2</xref>; <xref ref-type="bibr" rid="bib42">Gerber et al., 2021</xref>; <xref ref-type="bibr" rid="bib105">Piller et al., 2021</xref>; <xref ref-type="bibr" rid="bib114">Saunders et al., 2019</xref>; <xref ref-type="bibr" rid="bib144">Wolbert et al., 2020</xref>). This data indicates that Cd59 may be important during early stages of SC development as well as in mature MSCs and NMSCs (<xref ref-type="fig" rid="fig1">Figure 1D</xref>).</p><p>In contrast, bulk RNAseq of zebrafish oligodendrocyte progenitor cells (OPCs) and OLs indicated that <italic>cd59</italic> is expressed near the onset of myelination (72 hours post fertilization [hpf]; <xref ref-type="fig" rid="fig1">Figure 1C</xref>; <xref ref-type="bibr" rid="bib105">Piller et al., 2021</xref>). scRNAseq (<xref ref-type="bibr" rid="bib81">Marisca et al., 2020</xref>; <xref ref-type="bibr" rid="bib83">Marques et al., 2018</xref>; <xref ref-type="bibr" rid="bib82">Marques et al., 2016</xref>) and in situ hybridization (ISH; <xref ref-type="bibr" rid="bib117">Siems et al., 2021</xref>) of zebrafish and mouse OLCs showed that <italic>cd59/CD59a</italic> is mostly expressed in mature OLs and not OPCs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). CD59 protein is also present within newly formed human myelin sheaths as is evident in immunostaining of third trimester fetal brains (<xref ref-type="bibr" rid="bib147">Zajicek et al., 1995</xref>). Based on these findings, it is likely that Cd59 does not play a role in early stages of OLC development but could influence mature, myelinating OL function (<xref ref-type="fig" rid="fig1">Figure 1D</xref>).</p><p>Intrigued by this elevated expression of <italic>cd59</italic> in developing myelinating glial cells, we verified that <italic>cd59</italic> RNA was expressed in OLCs and SCs with chromogenic ISH (CISH) and fluorescent ISH (FISH) at 3 days post fertilization (dpf) (<xref ref-type="fig" rid="fig2">Figure 2A–C</xref>). Morphology, location, and co-expression with <italic>sox10:megfp</italic>, which is a marker for both OLCs and SCs, showed that <italic>cd59</italic> RNA is expressed in both cell types at 3 dpf (<xref ref-type="fig" rid="fig2">Figure 2A–C</xref>). Beyond expression in the heart and pancreas, <italic>cd59</italic> expression is largely confined to developing myelinating glial cells at this stage.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>cd59</italic> is expressed in Schwann cells (SCs) and oligodendrocytes (OLs).</title><p>(<bold>A</bold>) Bright-field images of whole-mount chromogenic in situ hybridization (CISH) showing <italic>cd59</italic> expression (purple) in the heart, pancreas, dorsal and ventral oligodendrocyte lineage cells (OLCs) (dOLCs and vOLCs, respectively; filled arrows), and posterior lateral line nerve (pLLN) SCs (empty arrows) at 3 days post fertilization (dpf). Schematic (right panel) indicates location of spinal cord, notochord, and pLLN in transverse section. (<bold>B</bold>) Fluorescent in situ hybridization (FISH) (RNAscope; ACD) showing <italic>cd59</italic> expression (cyan) in <italic>sox10:megfp</italic>-positive, pLLN SCs (<italic>cd59</italic>-positive orange cells indicated by empty arrows), and spinal cord OLs (<italic>cd59</italic>-positive orange cells indicated by filled arrows) at 3 dpf in transverse sections (top row). Representative image (top row) displays one SC on each pLLN (left and right empty arrows) as well as multiple OLs in the spinal cord (filled arrows). Images were acquired with confocal imaging. (<bold>C</bold>) Imaris renderings of the confocal images shown in (<bold>B</bold>), including the full image (left panel). From the full image (left panel, <bold>C</bold>), a single SC (indicated with the open magenta arrow and enlarged in the middle panel, <bold>C’</bold>) and a single OLC (indicated with the filled magenta arrow and enlarged in the right panel, <bold>C’’</bold>) illustrate the <italic>cd59</italic> puncta localized within the myelinating cells. (<bold>D</bold>) Mosaic labeling showing a <italic>cd59:tagrfp</italic>-positive OL in the spinal cord (left) and two SCs on the pLLN (right) at 3 dpf. (<bold>E</bold>) Immunofluorescence (IF) showing <italic>cd59:tagrfp</italic> expression (cyan) in Sox10-positive SCs (orange) along the pLLN at 3 and 7 dpf (left and right panels, respectively). Double-positive cells are indicated with white arrows. White dashed lines outline the pLLN. Sox10-positive pigment cells outside of the dashed lines were not included in the analysis. (<bold>F</bold>) Scatter plot of percent <italic>cd59:tagrfp</italic>-positive SCs on the pLLN from 3 to 7 dpf (mean ± SEM: 3 dpf: 9.4 ± 1.5; 4 dpf: 10.0 ± 1.0; 5 dpf: 7.8 ± 1.2; 6 dpf: 4.4 ± 0.6; 7 dpf: 5.8± 0 .6; p-values: 3 vs. 6 dpf: p=0.0126, 4 vs. 6 dpf: p=0.0095, 4 vs. 7 dpf: <italic>P</italic>p0.0477; dot = 1 fish). Data collected from somites 11–13 (~320 µm) and normalized to units per 100 µm. These data were compared with a one-way ANOVA with Tukey’s post-hoc test using GraphPad Prism. All fluorescent images were acquired with confocal imaging. Scale bars: (<bold>A</bold>) lateral view, 100 µm; transverse section, 25 µm; (<bold>B, D</bold>) 10 µm; (<bold>E</bold>) 25 µm. Artwork created by Ashtyn T. Wiltbank with Illustrator (Adobe).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source data for the quantification of percent <italic>cd59:tagrfp</italic>-positive cells per 100 µm depicted in <xref ref-type="fig" rid="fig2">Figure 2E</xref>.</title><p>Data contributed to scatter plot of percent <italic>cd59:tagrfp</italic>-positive Schwann cells (SCs) on the posterior lateral line nerve (pLLN) from 3 to 7 days post fertilization (dpf) (mean ± SEM: 3 dpf: 9.4 ± 1.5; 4 dpf: 10.0 ± 1.0; 5 dpf: 7.8 ± 1.2; 6 dpf: 4.4 ± 0.6; 7 dpf: 5.8 ± 0.6; p-values: 3 vs. 6 dpf: p=0.0126, 4 vs. 6 dpf: p=0.0095, 4 vs. 7 dpf: p=0.0477; data point = 1 fish). These data were compared with a one-way ANOVA with Tukey’s post-hoc test using GraphPad Prism. Data collected from somites 11–13 (~320 μm) and normalized to units per 100 μm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title><italic>cd59</italic> is expressed in the floorplate, hypochord, and developing Schwann cell (SCs).</title><p>(<bold>A</bold>) Bright-field images of whole-mount chromogenic in situ hybridization (CISH) showing <italic>cd59</italic> expression (purple) in the floorplate (FP) and hypochord at 24 hours post fertilization (hpf). Schematic (right panel) indicates location of <italic>cd59</italic> expression (purple) in FP, hypochord, and neural tube in transverse section. (<bold>B</bold>) Fluorescent in situ hybridization (FISH) (RNAscope; ACD) showing <italic>cd59</italic> expression (cyan) in the FP (outlined in white dashed lines) and lack of expression in <italic>sox10:megfp</italic>-positive neural crest cells (NCCs) (orange) in transverse sections (z projection of 20 µm). DAPI-positive nuclei indicated in blue. (<bold>C</bold>) FISH (RNAscope; ACD) showing <italic>cd59</italic> expression (cyan) in <italic>sox10:megfp</italic>-positive (orange) SC precursors (SCPs) at 36 hpf, immature SCs (iSCs) at 48 hpf, and SCs at 72 hpf on the posterior lateral line nerve (pLLN). Representative images each display a transverse section (z projection of 20 µm) of single SC on the pLLN. (<bold>D</bold>) Imaris renderings show <italic>cd59</italic> puncta that are localized within the SC at each stage. Two viewpoints are provided to better visualize the location of the puncta. All florescent images were acquired with confocal imaging. Scale bars: (<bold>A</bold>) lateral view, 100 µm; transverse section, 25 µm; (<bold>B</bold>) 10 µm; (<bold>C</bold>) 5 µm. Artwork created by Ashtyn T. Wiltbank with Illustrator (Adobe).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title><italic>cd59:tagrfp</italic>-positive Schwann cells (SCs) express canonical SC markers.</title><p>(<bold>A</bold>) Fluorescent in situ hybridization (FISH) (RNAscope; ACD) showing <italic>cd59</italic> expression (cyan) in <italic>cd59:tagrfp</italic>-positive SC (orange) along the posterior lateral line nerve (pLLN) at 72 hours post fertilization (hpf). Representative image displays a transverse section (z projection of 20 µm) of single SC on the pLLN. (<bold>B</bold>) Imaris renderings show <italic>cd59</italic> puncta that are localized within the SC. Two viewpoints (<bold>B, B’</bold>) are provided to better visualize the location of the puncta. (<bold>C</bold>) In vivo imaging showing <italic>cd59:tagrfp</italic>- (orange), <italic>sox10:megfp</italic>- (cyan) positive SCs on the pLLN at 72 hpf. The <italic>cd59:tagrfp</italic> line labels the cytoplasm of <italic>cd59</italic>-expressing cells with TagRFP. The <italic>sox10:megfp</italic> line labels the cell membranes of <italic>sox10</italic>-expressing cells with EGFP. (<bold>D</bold>) In vivo imaging showing <italic>cd59:tagrfp</italic>-(orange), <italic>gal4:erbb3b;uas:egfp</italic> (cyan)-positive SCs on the pLLN at 72 hpf. The <italic>gal4:erbb3b;uas:egfp</italic> line labels the cytoplasm of <italic>erbb3b</italic>-expressing cells with EGFP. (<bold>E</bold>) In vivo imaging showing that <italic>cd59:tagrfp</italic>- (orange), <italic>mbp:egfp-caax</italic> (cyan)-positive SCs on the pLLN at 7 dpf. The <italic>mbp:egfp-caax</italic> line labels the cell membranes of mbp-expressing cells with EGFP. All images were acquired with confocal imaging. Scale bars: (<bold>A</bold>) 5 µm; (<bold>C–E</bold>) 10 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig2-figsupp2-v2.tif"/></fig></fig-group><p>To study these cells in vivo, we created a transcriptional reporter zebrafish line for <italic>cd59</italic> (herein referred to as <italic>cd59:tagrfp</italic>). This line utilizes 5 kb of the <italic>cd59</italic> promoter as well as the first exon and intron, the latter containing an enhancer that is important for <italic>cd59</italic> expression (<xref ref-type="bibr" rid="bib133">Tone et al., 1999</xref>), to drive cytoplasmic expression of TagRFP in <italic>cd59</italic>-expressing cells. With in vivo, confocal imaging, mosaic labeling with our <italic>cd59:tagrfp</italic> construct revealed labeling of OLs and SCs with myelin-like processes (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), indicating that <italic>cd59</italic> is expressed in mature myelinating glial cells.</p><p>Bulk and scRNAseq data indicated that <italic>cd59</italic> is expressed during early stages of SC development whereas <italic>cd59</italic> expression was restricted to mature OLs. To verify this expression pattern, we looked at <italic>cd59</italic> RNA expression at earlier stages in the SC lineage. At 24 hpf, using CISH and FISH, we did not observe <italic>cd59</italic> expression in <italic>sox10:megfp</italic>-positive NCCs, though we did see it in the hypochord and floor plate of the spinal cord at this stage (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A and B</xref>). At 36 and 48 hpf, when NCCs begin to develop into SCPs and iSCs, we detected sporadic expression of <italic>cd59</italic> with FISH in <italic>sox10:megfp</italic>-positive cells along the posterior lateral line nerve (pLLN) in the PNS (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C and D</xref>). By 72 hpf, we observed robust <italic>cd59</italic> expression within <italic>sox10:megfp-</italic>positive SCs along the pLLN (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C and D</xref>). These data demonstrate that <italic>cd59</italic> is expressed in developing SCs, confirming the expression patterns seen in the RNAseq datasets we analyzed (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p><p>From our ISH data, we noticed that <italic>cd59</italic> was not expressed in every SC. Notably, SCs associated with spinal motor nerves did not express <italic>cd59</italic> (<xref ref-type="fig" rid="fig2">Figure 2A–C</xref>). Rather, <italic>cd59</italic> expression was largely confined to SCs along the pLLN (<xref ref-type="fig" rid="fig2">Figure 2A–C</xref>). To investigate this expression further, we utilized our stable <italic>cd59:tagrfp</italic> line. This transgenic line provides clear, in vivo labeling of c<italic>d59</italic>-expressing pLLN SCs, which we confirmed using FISH with a <italic>cd59</italic> probe in <italic>cd59:tagrfp-</italic>positive SCs (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A,B, B'</xref>). To verify that <italic>cd59:tagrfp</italic>-positive SCs expressed canonical SC markers, including <italic>SRY-box transcription factor 10</italic> (<italic>sox10</italic>), <italic>erb-b2 receptor tyrosine kinase 3b</italic> (<italic>erbb3b</italic>), and <italic>myelin basic protein a</italic> (<italic>mbpa</italic>), we examined pLLN SCs in transgenic and gene trap larvae co-expressing these markers with in vivo confocal imaging. As expected, <italic>cd59:tagrfp</italic> expression was observed in <italic>sox10, erbb3b,</italic> and <italic>mbp-</italic>positive SCs at 72 and 7 dpf (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C–E</xref>), confirming that <italic>cd59:tagrfp-</italic>positive SCs express other known SC genes.</p><p>To determine whether <italic>cd59</italic> was expressed in all pLLN SCs, we used immunofluorescence (IF) to co-label <italic>cd59:tagrfp</italic>-positive SCs with an antibody against Sox10, which labels all SCs along the pLLN. Strikingly, when looking at SCs from 3 to 7 dpf, <italic>cd59:tagrfp</italic> was only expressed in a subset of pLLN SCs (average of 4.4 ± 1.5% to 9.4 ± 3.8% of pLLN SCs; <xref ref-type="fig" rid="fig2">Figure 2E and F</xref>). We also noted that <italic>cd59</italic> expression was only expressed in a subset of OLs (<xref ref-type="fig" rid="fig2">Figure 2B, C, C''</xref>) and was completely lacking in MEP glia. Taken together, these data demonstrate that <italic>cd59</italic> expression is heterogeneous in developing myelinating glial cells.</p></sec><sec id="s2-2"><title>Generation of <italic>cd59</italic> mutant zebrafish with CRISPR/Cas9 genome editing</title><p>Our findings demonstrate that <italic>cd59</italic> is expressed in a subset of developing SCs. However, it is unclear how Cd59 influences SC development. In other cells, Cd59 has many different functions, including preventing complement-dependent cell lysis (<xref ref-type="bibr" rid="bib29">Davies et al., 1989</xref>), facilitating vesicle-dependent signaling (<xref ref-type="bibr" rid="bib44">Golec et al., 2019</xref>; <xref ref-type="bibr" rid="bib68">Krus et al., 2014</xref>), suppressing cell proliferation (<xref ref-type="bibr" rid="bib28">Dashiell et al., 2000</xref>; <xref ref-type="bibr" rid="bib54">Hila et al., 2001</xref>; <xref ref-type="bibr" rid="bib74">Li et al., 2013</xref>; <xref ref-type="bibr" rid="bib76">Longhi et al., 2005</xref>), and orchestrating proximal-distal cell identity (<xref ref-type="bibr" rid="bib33">Echeverri and Tanaka, 2005</xref>). There is little known about Cd59 in the developing nervous system, however.</p><p>To evaluate the function of Cd59 in SC development, we generated <italic>cd59</italic> mutant zebrafish with CRISPR/Cas9 genome editing. Targeting the end of the first coding exon (exon 2; <xref ref-type="fig" rid="fig3">Figure 3A</xref>), we recovered an allele with a 15 bp deletion that occurred across the exon 2–intron 2 splice site, generating a splice mutation (herein referred to as mutant <italic>cd59<sup>uva48</sup></italic>; <xref ref-type="fig" rid="fig3">Figure 3B</xref>). RT-PCR and Sanger sequencing analysis of mutant <italic>cd59<sup>uva48</sup></italic> transcripts revealed that multiple splice variants were produced compared to wildtype <italic>cd59</italic>, which produced a single transcript (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and E</xref>). Analysis of the mutant transcripts indicated that an early stop codon was generated in the N-terminal signal sequence, producing a severely truncated protein (10–48 AA compared to the 119 AA wildtype protein; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E and G</xref>). Furthermore, the predicted proteins lacked the Ly6/uPAR domain and GPI-anchor signal sequence (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E and G</xref>). Therefore, the mutant Cd59 protein was expected to be nonfunctional. We also recovered an additional <italic>cd59</italic> mutant allele, <italic>cd59<sup>uva47</sup></italic>, which was produced with the same single-guide RNA (sgRNA). This mutant had a 6 bp deletion near the end of exon 2 that did not affect the splice site (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B and D</xref>) and therefore produced a single mutant transcript (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). Sequencing of the mutant <italic>cd59<sup>uva47</sup></italic> transcript predicted the absence of two amino acids (AA) in the N-terminal signal sequence, which would yield a slightly smaller protein (117 AA) compared to wildtype Cd59 (119 AA; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E and G</xref>). Though the protein was not severely truncated, we predicted that interfering with the N-terminal signal sequence would prevent protein trafficking to the endoplasmic reticulum and interrupt proper protein function. Collectively, mutant <italic>cd59<sup>uva48</sup></italic> larvae have perturbed RNA splicing that results in premature termination codon (PTC) formation and probable protein truncation, and mutant <italic>cd59<sup>uva47</sup></italic> larvae have a disrupted N-terminal sequence. Considering these results, both mutants were suspected to have impaired Cd59 function.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Generation of <italic>cd59</italic> mutant zebrafish with CRISPR/Cas9 genome editing.</title><p>(<bold>A</bold>) Schematic of zebrafish <italic>cd59</italic> gene. The <italic>cd59</italic> coding sequence (357 bp; CDS) encodes the protein domains with the corresponding colors indicated in (<bold>C</bold>). The non-CDS is indicated in gray. The dashed lines indicate the sgRNA and the target sequence. (<bold>B</bold>) Genomic sequences for wildtype <italic>cd59</italic> and mutant <italic>cd59<sup>uva48</sup></italic> showing a 15 bp deletion at the splice site between exon 2 (blue) and intron 2 (gray) of the <italic>cd59</italic> gene. (<bold>C</bold>) Schematic of Cd59 protein made in wildtype (119 AA; top panel) and <italic>cd59<sup>uva48</sup></italic> mutant fish (10–48 AA; bottom panel). (<bold>D</bold>) Bright-field images of wildtype and <italic>cd59<sup>uva48</sup></italic> mutant larvae at 72 hours post fertilization (hpf) showing no anatomical defects as a result of <italic>cd59</italic> mutation. (<bold>E</bold>) Chromogenic in situ hybridization (CISH) showing <italic>sox10</italic>-positive (gray) oligodendrocytes (OLs) in the spinal cord (filled arrows) and Schwann cells (SCs) on the posterior lateral line nerve (pLLN) (empty arrows) at 72 hpf in transverse sections. (<bold>F</bold>) CISH showing <italic>mbp</italic>-positive (gray) OLs in the spinal cord (filled arrows) and SCs on the pLLN (empty arrows) at 72 hpf in transverse sections. (<bold>G</bold>) CISH showing <italic>krox20</italic>-positive (gray) SCs on the pLLN (empty arrows) and neurons in the brain (filled arrows) at 72 hpf in transverse sections. (<bold>H</bold>) Fluorescent in situ hybridization (FISH) (RNAscope; ACD) showing <italic>cd59</italic> expression (cyan) in <italic>sox10:megfp</italic>-positive SCs (orange) along the pLLN at 72 hpf. Representative images each display a transverse section (z projection of 20 µm) of single SC on the pLLN. (<bold>I</bold>) Imaris renderings show <italic>cd59</italic> puncta that are localized within each SC. (<bold>J</bold>) Scatter plot of the number of <italic>cd59</italic> RNA puncta in pLLN SCs (mean ± SEM: WT: 64.7 ± 7.6, <italic>cd59<sup>uva48</sup></italic>: 14 ± 1.7; p&lt;0.0001; dot = 1 cell; n = 7 fish per group). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. CISH and FISH images were acquired with confocal imaging. Scale bars: (<bold>A</bold>) 0.25 mm; (<bold>E, F</bold>) 25 µm; (<bold>G</bold>) 50 µm. Artwork created by Ashtyn T. Wiltbank with Illustrator (Adobe).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data for the quantification of the number of <italic>cd59</italic> puncta in Schwann cells (SCs) at 72 hours post fertilization (hpf) depicted in <xref ref-type="fig" rid="fig3">Figure 3H</xref>.</title><p>Data contributed to scatter plot of the number of <italic>cd59</italic> RNA puncta in posterior lateral line nerve (pLLN) SCs (mean ± SEM: WT: 64.7 ± 7.6, <italic>cd59<sup>uva48</sup></italic>: 14 ± 1.7; p&lt;0.0001; data point = 1 cell; n = 7 fish per group). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Characterization of <italic>cd59</italic> mutant zebrafish.</title><p>(<bold>A</bold>) Gel electrophoresis showing wildtype (357 bp) and <italic>cd59<sup>uva48</sup></italic> (variable transcript size) RT-PCR products at 72 hours post fertilization (hpf). (<bold>B</bold>) Gel electrophoresis showing wildtype (357 bp) and <italic>cd59<sup>uva47</sup></italic> (351 bp) RT-PCR products at 72 hpf. RT-PCR products were compared to 100 bp DNA ladder for (<bold>A</bold>) and (<bold>B</bold>). (<bold>C</bold>) Bright-field images of wildtype and <italic>cd59<sup>uva47</sup></italic> mutant larvae at 72 hpf showing no anatomical defects as a result of <italic>cd59</italic> mutation. (<bold>D</bold>) Genomic sequences for wildtype <italic>cd59</italic> and mutant <italic>cd59<sup>uva47</sup></italic> showing a 6 bp deletion at the end of exon 2 (blue) in the <italic>cd59</italic> gene. (<bold>E</bold>) Table showing the genome and transcript mutations associated with sequenced RT-PCR products from wildtype (gray) and <italic>cd59</italic> mutant alleles (purple). The resulting transcript and protein length for each allele also included. (<bold>F</bold>) Schematic of Cd59 protein made in wildtypes (119 AA; top panel), <italic>cd59<sup>uva47</sup></italic> mutants (117 AA; middle panel), and <italic>cd59<sup>uva48</sup></italic> mutants (10–48 AA; middle panel). (<bold>G</bold>) Expasy protein translations (<xref ref-type="bibr" rid="bib32">Duvaud et al., 2021</xref>) of sequenced RT-PCR products showing altered amino acid sequences (gray text), early stop codons (black dots), and missing amino acids (blue asterisks) detected in <italic>cd59</italic> mutant alleles (purple). Protein domains colored as described previously. Scale bar: (<bold>A</bold>) 0.25 mm. Artwork created by Ashtyn T. Wiltbank with Illustrator (Adobe).</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Source data from gel electrophoresis of RT-PCR of <italic>cd59<sup>uva48</sup></italic> mutant embryos.</title><p>Unlabeled and labeled images of gel electrophoresis showing wildtype (357 bp) and <italic>cd59<sup>uva48</sup></italic> (variable transcript size) RT-PCR products at 72 hours post fertilization (hpf). RT-PCR products were compared to 100 bp DNA.</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-76640-fig3-figsupp1-data1-v2.pdf"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>Source data from gel electrophoresis of RT-PCR of <italic>cd59<sup>uva47</sup></italic> mutant embryos.</title><p>Unlabeled and labeled images of gel electrophoresis showing wildtype (357 bp) and <italic>cd59<sup>uva47</sup></italic> (351 bp) RT-PCR products at 72 hours post fertilization (hpf). RT-PCR products were compared to 100 bp DNA.</p></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-76640-fig3-figsupp1-data2-v2.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig3-figsupp1-v2.tif"/></fig></fig-group><p>To begin our initial evaluation of these mutants, we sought to compare general developmental characteristics between <italic>cd59</italic> mutant larvae and their wildtype siblings. Both <italic>cd59<sup>uva48</sup></italic> and <italic>cd59<sup>uva47</sup></italic> homozygous adults were viable and produced embryos with no anatomical, behavioral, or reproductive defects (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). Next, we wanted to know if SCs were present in mutant <italic>cd59<sup>uva48</sup></italic> larvae, which were utilized in the majority of our studies. Using CISH, we labeled wildtype and mutant <italic>cd59<sup>uva48</sup></italic> larvae with RNA probes against <italic>sox10</italic>, <italic>krox20</italic> (also known as <italic>early growth response 2b</italic> or <italic>egr2b),</italic> and <italic>mbp</italic> at 72 hpf. Both wildtype and mutant larvae had <italic>sox10</italic>, <italic>mbp,</italic> and <italic>krox20-</italic>positive SCs along the pLLN (<xref ref-type="fig" rid="fig3">Figure 3E–G</xref>), indicating that Cd59 was not necessary for SC genesis or expression of genes necessary for SC maturation and myelination.</p><p>Knowing that SCs were present, we were then curious how <italic>cd59</italic> expression was affected in <italic>cd59<sup>uva48</sup></italic> mutant SCs. According to our RT-PCR analysis, mutant <italic>cd59<sup>uva48</sup></italic> embryos produced RNA transcripts with PTCs (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>). RNA transcripts with PTCs can sometimes undergo nonsense-mediated decay (NMD), a process by which normal and mutant gene expression is controlled through RNA degradation (<xref ref-type="bibr" rid="bib17">Bruno et al., 2011</xref>; <xref ref-type="bibr" rid="bib20">Chang et al., 2007</xref>; <xref ref-type="bibr" rid="bib61">Karam and Wilkinson, 2012</xref>; <xref ref-type="bibr" rid="bib77">Lou et al., 2014</xref>). To determine if mutant <italic>cd59<sup>uva48</sup></italic> RNA transcripts underwent NMD, we used FISH to label wildtype and mutant <italic>cd59<sup>uva48</sup>;sox10:megfp</italic> larvae with a probe against <italic>cd59</italic> (<xref ref-type="fig" rid="fig3">Figure 3H and I</xref>). Quantification of <italic>cd59</italic> RNA puncta showed that <italic>cd59</italic> expression was significantly reduced in mutant SCs compared to wildtype SCs (<xref ref-type="fig" rid="fig3">Figure 3J</xref>), indicating that <italic>cd59<sup>uva48</sup></italic> mutant RNA was being degraded through NMD and therefore could result in a loss of protein. Due to the lack of a zebrafish-specific antibody for Cd59, we were unable to determine if these changes in RNA were reflected at the protein level and therefore cannot confirm if we have produced a null allele for <italic>cd59</italic>. However, our findings indicate that <italic>cd59<sup>uva48</sup></italic> mutants can be used as a loss-of-function model in which to study the role of Cd59 in developing SCs.</p></sec><sec id="s2-3"><title>Cd59 regulates developing SC proliferation</title><p>With our new <italic>cd59</italic> mutants, we began to explore the possible roles Cd59 could play in SC development. Previous studies demonstrate that CD59a can prevent overproliferation of T cells during a viral infection (<xref ref-type="bibr" rid="bib76">Longhi et al., 2005</xref>). Similarly, CD59a is important for limiting deleterious smooth muscle cell proliferation during atherosclerosis (<xref ref-type="bibr" rid="bib74">Li et al., 2013</xref>). Because we observed <italic>cd59</italic> expression during the proliferative phases of SC development, we hypothesized that Cd59 could be involved in developmental SC proliferation. To test our hypothesis, we labeled SCs with a Sox10 antibody and quantified the number of Sox10-positive SCs along the pLLN in wildtype and <italic>cd59<sup>uva48</sup></italic> mutant larvae at various stages during SC development (36 hpf to 7 dpf) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). At all stages we investigated, there were significantly more SCs in mutant embryos and larvae compared to wildtype siblings (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). We observed this excess early in SC development during the SCP stage (36 hpf; <xref ref-type="fig" rid="fig4">Figure 4B</xref>) through the iSC and pmSC stages (~48 hpf, <xref ref-type="fig" rid="fig4">Figure 4C</xref>) and into mature MSC stages (72 hpf, <xref ref-type="fig" rid="fig4">Figure 4D</xref>; 7 dpf, <xref ref-type="fig" rid="fig4">Figure 4E</xref>; <xref ref-type="bibr" rid="bib1">Ackerman and Monk, 2016</xref>). To rule out the possibility of off-target effects from CRISPR/Cas9 genome editing, we evaluated <italic>cd59<sup>uva47</sup></italic> mutants as well. Similarly, we observed the same phenotype in mutant <italic>cd59<sup>uva47</sup></italic> embryos at 48 hpf (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A and B</xref>), demonstrating that mutation of <italic>cd59</italic> was responsible for this phenotype. Together, these data demonstrate that Cd59 functions to limit overproliferation of SCs during development.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>cd59</italic> regulates Schwann cell (SC) proliferation.</title><p>(<bold>A</bold>) Immunofluorescence (IF) showing Sox10-positive SCs (black/gray) along the posterior lateral line nerve (pLLN) from 36 hours post fertilization (hpf) to 7 days post fertilization (dpf). Black dashed lines outline the pLLN. Sox10-positive pigment cells outside of the dashed lines (white asterisks) were not included in the analysis. (<bold>B–E</bold>) Scatter plots of the number of Sox10-positive SCs along the pLLN from 36 hpf to 7 dpf (mean ± SEM: 36 hpf: WT: 5.6 ± 0.2, <italic>cd59<sup>uva48</sup></italic>: 9.1 ± 0.3; 48 hpf: WT: 8.6 ± 0.5, <italic>cd59<sup>uva48</sup></italic>: 15.0 ± 0.7; 72 hpf: WT: 18.0 ± 0.4, <italic>cd59<sup>uva48</sup></italic>: 24.3 ± 0.8; 7 dpf: WT: 27.0 ± 0.6, <italic>cd59<sup>uva48</sup></italic>: 33.9 ± 0.8; p-values: p&lt;0.0001; dot = 1 fish). (<bold>F</bold>) EdU incorporation assay showing <italic>sox10:tagrfp</italic>-positive, pLLN SCs (orange) pulsed with EdU (cyan) from 48 to 55 hpf. (<bold>G</bold>) Scatter plot of the number of EdU-positive SCs along the pLLN at 55 hpf (WT: 6.7 ± 0.5, <italic>cd59<sup>uva48</sup></italic>: 13.6 ± 0.5; p&lt;0.0001; dot = 1 fish). (<bold>H</bold>) Scatter plot of the number of mitotic events observed in SCs from 48 to 55 hpf (mean ± SEM: WT: 0.6 ± 0.1, <italic>cd59<sup>uva48</sup></italic>: 1.7 ± 0.3; p=0.0019; dot = 1 fish). (<bold>I</bold>) Scatter plot of the number of mitotic events observed in SCs from 54 to 75 hpf (mean ± SEM: WT: 4.1 ± 0.3, <italic>cd59<sup>uva48</sup></italic>: 4.1 ± 0.4; dot = 1 fish). (<bold>H</bold>) Scatter plot of the time of final cell division (hpf) observed in SCs from 54 to 75 hpf (mean ± SEM: WT: 69.1 ± 1.1, <italic>cd59<sup>uva48</sup></italic>: 68.4 ± 0.9; dot = 1 fish). All data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm. All images in this figure were acquired with confocal imaging. Each dataset was compared with Student’s <italic>t</italic>-test using GraphPad Prism. Scale bars: (<bold>A, F</bold>) 25 µm.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source data for the quantification of the number of Schwann cells (SCs) on the posterior lateral line nerve (pLLN) at 36 hours post fertilization (hpf).</title><p>Data contributed to scatter plot of the number of Sox10-positive SCs along the pLLN at 36 hpf (mean ± SEM: WT: 5.6 ± 0.2, <italic>cd59<sup>uva48</sup></italic>: 9.1 ± 0.3; p-value: p&lt;0.0001; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Source data for the quantification of the number of Schwann cells (SCs) on the posterior lateral line nerve (pLLN) at 48 hours post fertilization (hpf).</title><p>Data contributed to scatter plot of the number of Sox10-positive SCs along the pLLN at 48 hpf (mean ± SEM: WT: 8.6 ± 0.5, <italic>cd59<sup>uva48</sup></italic>: 15.0 ± 0.7; p-value: p&lt;0.0001; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Source data for the quantification of the number of Schwann cells (SCs) on the posterior lateral line nerve (pLLN) at 72 hours post fertilization (hpf).</title><p>Data contributed to scatter plot of the number of Sox10-positive SCs along the pLLN at 72 hpf (mean ± SEM: WT: 18.0 ± 0.4, <italic>cd59<sup>uva48</sup></italic>: 24.3 ± 0.8; p-value: p&lt;0.0001; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata4"><label>Figure 4—source data 4.</label><caption><title>Source data for the quantification of the number of Schwann cells (SCs) on the posterior lateral line nerve (pLLN) at 7 days post fertilization (dpf).</title><p>Data contributed to scatter plot of the number of Sox10-positive SCs along the pLLN at 7 dpf (mean ± SEM: WT: 27.0 ± 0.6, <italic>cd59<sup>uva48</sup></italic>: 33.9 ± 0.8; p-value: p&lt;0.0001; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-data4-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata5"><label>Figure 4—source data 5.</label><caption><title>Source data for the quantification of the number of EdU-positive Schwann cells (SCs) on the posterior lateral line nerve (pLLN) from 48 to 55 hours post fertilization (hpf) depicted in <xref ref-type="fig" rid="fig4">Figure 4G</xref>.</title><p>Data contributed to scatter plot of the number of EdU-positive SCs along the pLLN at 55 hpf (mean ± SEM: WT: 6.7 ± 0.5, <italic>cd59<sup>uva48</sup></italic>: 13.6 ± 0.5; p&lt;0.0001; dot = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-data5-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata6"><label>Figure 4—source data 6.</label><caption><title>Source data for the quantification of the number of mitotic events from 48 to 55 hours post fertilization (hpf) depicted in <xref ref-type="fig" rid="fig4">Figure 4H</xref>.</title><p>Data contributed to scatter plot of the number of mitotic events observed in Schwann cells (SCs) from 48 to 55 hpf (mean ± SEM: WT: 0.6 ± 0.1, <italic>cd59<sup>uva48</sup></italic>: 1.7 ± 0.3; p=0.0019; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-data6-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata7"><label>Figure 4—source data 7.</label><caption><title>Source data for the quantification of the number of mitotic events from 54 to 75 hours post fertilization (hpf) depicted in <xref ref-type="fig" rid="fig4">Figure 4I</xref>.</title><p>Data contributed to scatter plot of the number of mitotic events observed in Schwann cells (SCs) from 54 to 75 hpf (mean ± SEM: WT: 4.1 ± 0.3, <italic>cd59<sup>uva48</sup></italic>: 4.1 ± 0.4; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-data7-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata8"><label>Figure 4—source data 8.</label><caption><title>Source data for the time of final Schwann cell (SC) division during 54–75 hours post fertilization (hpf) depicted in <xref ref-type="fig" rid="fig4">Figure 4J</xref>.</title><p>Data contributed to scatter plot of the time of final cell division (hpf) observed in SCs from 54 to 75 hpf (mean ± SEM: WT: 69.1 ± 1.1, <italic>cd59<sup>uva48</sup></italic>: 68.4 ± 0.9; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 11–13 (~320 µm).</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-data8-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title><italic>cd59</italic> does not impact proliferation of neurons, neural crest cells (NCCs), motor Schwann cells (SCs), or MEP glia.</title><p>(<bold>A</bold>) Immunofluorescence (IF) showing Sox10-positive SCs (black/gray) along the posterior lateral line nerve (pLLN) at 48 hours post fertilization (hpf). Black dashed lines outline the pLLN. Sox10-positive pigment cells outside of the dashed lines (white asterisks) were not included in the analysis. (<bold>B</bold>) Scatter plot of the number of Sox10-positive SCs along the pLLN at 48 hpf (mean ± SEM: WT: 5.7 ± 0.3, <italic>cd59<sup>uva48</sup></italic>: 8.3 ± 0.5; p=0.0003; dot = 1 fish). Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm. (<bold>C</bold>) IF showing HuC/HuD-positive neurons (cyan) in the spinal cord at 48 hpf (n = 6 fish per group). (<bold>D</bold>) IF showing HuC/HuD-positive neurons (cyan) and Sox10-positive NCCs (orange) in the posterior lateral line ganglia (pLLG) at 24 hpf. White dashed lines outline the pLLG. NCCs outside of the dashed lines were not included in the analysis. (<bold>E</bold>) Scatter plot of the number of HuC/HuD-positive neurons in the pLLG at 24 hpf (mean ± SEM: WT: 20.9 ± 1.0, <italic>cd59<sup>uva48</sup></italic>: 20.3 ± 1.1; dot = 1 fish). (<bold>F</bold>) Scatter plot of the number of Sox10-positive NCCs in the pLLG at 24 hpf (mean ± SEM: WT: 49.2 ± 2.1, <italic>cd59<sup>uva48</sup></italic>: 50.8 ± 1.4; dot = 1 fish). (<bold>G</bold>) IF showing Sox10-positivie NCCs (black/gray) migrating in the trunk at 24 hpf. Black dashed lines outline the migrating NCCs. NCCs outside of the dashed lines were not included in the analysis. Data collected from the 12th somite. (<bold>H</bold>) Scatter plot of the number of Sox10-positive, migrating NCCs in the trunk at 24 hpf (mean ± SEM: WT: 7.1 ± 0.4, <italic>cd59<sup>uva48</sup></italic>: 7.3 ± 0.4; dot = 1 fish). (<bold>I</bold>) Confocal images of <italic>sox10-nls-eos</italic>-positive SCs (orange, filled arrows) along <italic>olig2:dsred</italic>-positive nerves at 72 hpf. SCs along the rostral and caudal branches of the motor nerve were not included in the quantification (one rostral SC indicated with empty arrow). Satellite glia on the dorsal root ganglia (outlined with white dashed line) were not included in the quantification. Data collected from the 12th somite. (<bold>J</bold>) Scatter plot of the number of Sox10-positive SCs and MEP glia on a motor nerve at 72 hpf (mean ± SEM: WT: 6.3 ± 0.4, <italic>cd59<sup>uva48</sup></italic>: 6.4 ± 0.36; dot = 1 fish). (<bold>K</bold>) Scatter plot of the number of Tubulin-positive neuromasts in the trunk at 7 days post fertilization (dpf) (mean ± SEM: WT: 7.4 ± 0.3, <italic>cd59<sup>uva48</sup></italic>: 6.8 ± 0.3; dot = 1 fish). All images in this figure were acquired with confocal imaging. Each dataset was compared with Student’s <italic>t</italic>-test using GraphPad Prism. Scale bars: (<bold>A</bold>) 25 µm; (<bold>C, D, G, I</bold>) 10 µm.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Source data for the quantification of the number of Schwann cells (SCs) on the posterior lateral line nerve (pLLN) at 48 hours post fertilization (hpf) in <italic>cd59<sup>uva47</sup></italic> mutant embryos.</title><p>Data contributed to scatter plot of the number of Sox10-positive SCs along the pLLN at 48 hpf (mean ± SEM: WT: 5.7 ± 0.3, <italic>cd59<sup>uva48</sup></italic>: 8.3 ± 0.5; p=0.0003; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata2"><label>Figure 4—figure supplement 1—source data 2.</label><caption><title>Source data for the quantification of the number of neurons per posterior lateral line ganglia (pLLG) at 24 hours post fertilization (hpf) depicted in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>.</title><p>Data contributed to scatter plot of the number of HuC/HuD-positive neurons in the pLLG at 24 hpf (mean ± SEM: WT: 20.9 ± 1.0, <italic>cd59<sup>uva48</sup></italic>: 20.3 ± 1.1; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-figsupp1-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata3"><label>Figure 4—figure supplement 1—source data 3.</label><caption><title>Source data for the quantification of the number of neural crest cells (NCCs) associated with the posterior lateral line ganglia (pLLG) at 24 hours post fertilization (hpf) depicted in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F</xref>.</title><p>Data contributed to scatter plot of the number of Sox10-positive NCCs in the pLLG at 24 hpf (mean ± SEM: WT: 49.2 ± 2.1, <italic>cd59<sup>uva48</sup></italic>: 50.8 ± 1.4; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-figsupp1-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata4"><label>Figure 4—figure supplement 1—source data 4.</label><caption><title>Source data for the quantification of the number of migrating neural crest cells (NCCs) per stream at 24 hours post fertilization (hpf) depicted in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1H</xref>.</title><p>Data contributed to scatter plot of the number of Sox10-positive, migrating NCCs in the trunk at 24 hpf (mean ± SEM: WT: 7.1 ± 0.4, <italic>cd59<sup>uva48</sup></italic>: 7.3 ± 0.4; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-figsupp1-data4-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata5"><label>Figure 4—figure supplement 1—source data 5.</label><caption><title>Source data for the quantification of the number of Sox10-positive cells (Schwann cells [SCs] and MEP glia) per spinal motor nerve at 72 hours post fertilization (hpf) depicted in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1J</xref>.</title><p>Data contributed to scatter plot of the number of Sox10-positive cell per spinal motor nerves at 72 hpf (mean ± SEM: WT: 6.3 ± 0.4, <italic>cd59<sup>uva48</sup></italic>: 6.4 ± 0.36; dot = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-figsupp1-data5-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata6"><label>Figure 4—figure supplement 1—source data 6.</label><caption><title>Source data for the quantification of the number of trunk neuromasts at 7 days post fertilization (dpf) depicted in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1K</xref>.</title><p>Data contributed to scatter plot of the number of Tubulin-positive neuromasts in the trunk at 7 dpf (mean ± SEM: WT: 7.4 ± 0.3, <italic>cd59<sup>uva48</sup></italic>: 6.8 ± 0.3; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-figsupp1-data6-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Loss of <italic>cd59</italic> does not impact cell death within the peripheral nervous system (PNS) and central nervous system (CNS).</title><p>(<bold>A</bold>) Acridine orange (AO) incorporation assay showing AO-positive (cyan), <italic>sox10:tagrfp</italic>-positive Schwann cells (SCs) (gray) along the posterior lateral line nerve (pLLN) at 48 hours post fertilization (hpf). White dashed lines outline the pLLN. Arrowheads denote proliferative events, which can also be detected by AO. (<bold>B</bold>) Scatter plot of the number of AO-positive SCs along the pLLN at 48 hpf (mean ± SEM: WT: 0.06 ± 0.04, <italic>cd59<sup>uva48</sup></italic>: 0.03 ± 0.03; dot = 1 fish). (<bold>C</bold>) Scatter plot of the number of AO-positive cells ventral to the pLLN at 48 hpf (mean ± SEM: WT: 2.2 ± 0.2, <italic>cd59<sup>uva48</sup></italic>: 2.8 ± 0.3; dot = 1 fish). Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm for (<bold>B</bold>) and (<bold>C</bold>). (<bold>D</bold>) TUNEL assay showing TUNEL-positive (orange) cells in the spinal cord and Sox10-positive SCs along the pLLN at 48 hpf. White dashed lines outline the spinal cord (medial) and the pLLNs (lateral). (<bold>E</bold>) Scatter plot of the number of TUNEL-positive SCs along the pLLN at 48 hpf (mean ± SEM: WT: 0.4 ± 0.2, <italic>cd59<sup>uva48</sup></italic>: 0.6 ± 0.3; dot = 1 fish). (<bold>F</bold>) Scatter plot of the number of TUNEL-positive cells in the spinal cord at 48 hpf (mean ± SEM: WT: 0.4 ± 0.2, <italic>cd59<sup>uva48</sup></italic>: 0.6 ± 0.3; dot = 1 fish). Data were collected from 10 consecutive transverse sections per fish (~200 µm) and normalized to units per 100 µm for (<bold>E</bold>) and (<bold>F</bold>). All images in this figure were acquired with confocal imaging. Each dataset was compared with Student’s <italic>t</italic>-test using GraphPad Prism. Scale bars: (<bold>A, D</bold>) 25 µm.</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Source data for the quantification of the number of acridine orange (AO)-positive Schwann cells (SCs) at 48 hours post fertilization (hpf) depicted in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>.</title><p>Data contributed to scatter plot of the number of AO-positive SCs along the posterior lateral line nerve (pLLN) at 48 hpf (mean ± SEM: WT: 0.06 ± 0.04, <italic>cd59<sup>uva48</sup></italic>: 0.03 ± 0.03; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-figsupp2-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata2"><label>Figure 4—figure supplement 2—source data 2.</label><caption><title>Source data for the quantification of the number of acridine orange (AO)-positive cells ventral to the posterior lateral line nerve (pLLN) at 48 hours post fertilization (hpf) depicted in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C</xref>.</title><p>Data contributed to scatter plot of the number of AO-positive cells ventral to the pLLN at 48 hpf (mean ± SEM: WT: 2.2 ± 0.2, <italic>cd59<sup>uva48</sup></italic>: 2.8 ± 0.3; dot = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-figsupp2-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata3"><label>Figure 4—figure supplement 2—source data 3.</label><caption><title>Source data for the quantification of the number of TUNEL-positive Schwann cells (SCs) at 48 hours post fertilization (hpf) depicted in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2E</xref>.</title><p>Data contributed to scatter plot of the number of TUNEL-positive SCs along the pLLN at 48 hpf (mean ± SEM: WT: 0.4 ± 0.2, <italic>cd59<sup>uva48</sup></italic>: 0.6 ± 0.3; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from 10 consecutive transverse sections per fish (~200 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-figsupp2-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata4"><label>Figure 4—figure supplement 2—source data 4.</label><caption><title>Source data for the quantification of the number of TUNEL-positive central nervous system (CNS) cells at 48 hours post fertilization (hpf) depicted in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2F</xref>.</title><p>Data contributed to scatter plot of the number of TUNEL-positive cells in the spinal cord at 48 hpf (mean ± SEM: WT: 0.4 ± 0.2, <italic>cd59<sup>uva48</sup></italic>: 0.6 ± 0.3; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from 10 consecutive transverse sections per fish (~200 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig4-figsupp2-data4-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig4-figsupp2-v2.tif"/></fig></fig-group><p>To independently confirm this excessive proliferation phenotype seen in SCs, we used EdU to label mitotically active SCs during SC development. Specifically, we incubated <italic>sox10:tagrfp</italic> embryos in EdU from 48 to 55 hpf. The embryos were then fixed and the number of EdU-positive SCs on the pLLN was quantified with confocal imaging. As we hypothesized, the total number of EdU-positive SCs was increased in <italic>cd59<sup>uva48</sup></italic> mutant embryos compared to wildtypes (<xref ref-type="fig" rid="fig4">Figure 4F and G</xref>). From these data, we confirmed that there was more SC proliferation occurring in <italic>cd59<sup>uva48</sup></italic> mutant larvae when compared to wildtype larvae. Consistent with this finding, in vivo, time-lapse imaging of <italic>sox10:tagrfp-</italic>positive SCs along the pLLN showed <italic>cd59<sup>uva48</sup></italic> mutant SCs undergoing significantly more mitotic events than their wildtype siblings, with most of the increased cell divisions occurring between 48 and 55 hpf (<xref ref-type="fig" rid="fig4">Figure 4H</xref>, <xref ref-type="video" rid="video1">Videos 1</xref> and <xref ref-type="video" rid="video2">2</xref>). Between 54 and 75 hpf, however, the number of divisions was similar between wildtype and <italic>cd59<sup>uva48</sup></italic> mutant larvae with no difference in the timing of terminal division (<xref ref-type="fig" rid="fig4">Figure 4I and J</xref>, <xref ref-type="video" rid="video3">Videos 3</xref> and <xref ref-type="video" rid="video4">4</xref>), demonstrating that, although Schwann proliferation is initially amplified in <italic>cd59<sup>uva48</sup></italic> mutant larvae, they are capable of terminating proliferation at the same developmental stage as wildtype larvae.</p><media mimetype="video" mime-subtype="mp4" id="video1" xlink:href="elife-76640-video1.mp4"><label>Video 1.</label><caption><title>Wildtype <italic>sox10:tagrfp</italic>-positive Schwann cells (SCs) along the posterior lateral line nerve (pLLN) migrate and undergo cell division from 48 to 55 hours post fertilization (hpf).</title><p>Images were taken every 10 min, and the movie runs at 3 frames per second (fps). Data were collected from somites 11–13 (~320 µm). Mitotic events indicated with magenta arrows. Quantification of the number of mitotic events is indicated in <xref ref-type="fig" rid="fig4">Figure 4H</xref>. Scale bar: 25 µm.</p></caption></media><media mimetype="video" mime-subtype="mp4" id="video2" xlink:href="elife-76640-video2.mp4"><label>Video 2.</label><caption><title><italic>cd59<sup>uva48</sup></italic> mutant <italic>sox10:tagrfp</italic>-positive Schwann cells (SCs) along the posterior lateral line nerve (pLLN) migrate and undergo cell division from 48 to 55 hours post fertilization (hpf).</title><p>Images were taken every 10 min, and the movie runs at 3 frames per second (fps). Data were collected from somites 11–13 (~320 µm). Mitotic events indicated with magenta arrows. Quantification of the number of mitotic events is indicated in <xref ref-type="fig" rid="fig4">Figure 4H</xref>. Scale bar: 25 µm.</p></caption></media><media mimetype="video" mime-subtype="mp4" id="video3" xlink:href="elife-76640-video3.mp4"><label>Video 3.</label><caption><title>Wildtype <italic>sox10:tagrfp</italic>-positive Schwann cells (SCs) along the posterior lateral line nerve (pLLN) migrate, undergo cell division, and begin to form myelin from 54 to 75 hours post fertilization (hpf).</title><p>Images were taken every 10 min, and the movie runs at 3 frames per second (fps). Data were collected from somites 11–13 (~320 µm). Mitotic events indicated with magenta arrows. Quantification of the number of mitotic events is indicated in <xref ref-type="fig" rid="fig4">Figure 4I</xref>. Time of last final cell division is indicated in <xref ref-type="fig" rid="fig4">Figure 4J</xref>. Scale bar: 25 µm.</p></caption></media><media mimetype="video" mime-subtype="mp4" id="video4" xlink:href="elife-76640-video4.mp4"><label>Video 4.</label><caption><title><italic>cd59<sup>uva48</sup></italic> mutant <italic>sox10:tagrfp</italic>-positive Schwann cells (SCs) along the posterior lateral line nerve (pLLN) migrate, undergo cell division, and begin to form myelin from 54 to 75 hours post fertilization (hpf).</title><p>Images were taken every 10 min, and the movie runs at 3 frames per second (fps). Data were collected from somites 11–13 (~320 µm). Mitotic events indicated with magenta arrows. Quantification of the number of mitotic events is indicated in <xref ref-type="fig" rid="fig4">Figure 4I</xref>. Time of last final cell division is indicated in <xref ref-type="fig" rid="fig4">Figure 4J</xref>. Scale bar: 25 µm.</p></caption></media><p>Taken together, these data demonstrate that Cd59 restricts developmental SC proliferation and that excess SCs generated in <italic>cd59</italic> mutant larvae persist past developmental stages. To rule out changes in cell death as a contributor to SC number, we used acridine orange (AO) incorporation and TUNEL staining to quantify the number of dying SCs at 48 hpf. Co-labeling of <italic>sox10:tagrfp</italic>-positive SCs with AO revealed no changes in SC death between wildtype and mutant <italic>cd59<sup>uva48</sup></italic> embryos (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A, B</xref>). When we assayed death more broadly in the trunk ventral to the pLLN, we also did not observe any increase in AO labeling, indicating that cell death in the embryo did not increase with <italic>cd59</italic> mutation (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A and C</xref>). Similarly, TUNEL staining combined with Sox10 labeling at 48 hpf on sectioned tissue showed that apoptotic SC death on the pLLN was unaltered in mutant <italic>cd59<sup>uva48</sup></italic> embryos (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2D and E</xref>). There was also no difference in the number of TUNEL-positive cells in the spinal cord (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2D and F</xref>). Finally, in agreement with this data, we observed no SC death during in vivo imaging of <italic>sox10:tagrfp</italic>-positive SCs from 48 to 75 hpf in both wildtype and <italic>cd59<sup>uva48</sup></italic> larvae (<xref ref-type="video" rid="video1">Videos 1</xref>–<xref ref-type="video" rid="video4">4</xref>). Overall, these findings show that <italic>cd59</italic> mutation does not perturb SC death.</p><p>Finally, we wanted to determine if <italic>cd59</italic> mutation affected the proliferation of other neural cells in addition to SCs. Looking at CNS neurons labeled with a HuC/HuD antibody, we observed that spinal cord neuron density was indistinguishable between wildtype and mutant <italic>cd59<sup>uva48</sup></italic> embryos at 48 hpf (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>), supporting our observations that cell death does not change in the spinal cord (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2D, F</xref>). To determine if this was also the case in the PNS, we used the same HuC/HuD antibody to label posterior lateral line ganglia (pLLG) neurons and found that the number of HuC/HuD-positive pLLG neurons was the same between wildtype and <italic>cd58<sup>uva48</sup></italic> mutant embryos at 24 hpf (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D, E</xref>). These data indicate the neuronal proliferation is unaffected by <italic>cd59</italic> mutation. We also investigated whether NCC development was affected in our <italic>cd59</italic> mutant embryos. In accordance with the lack of <italic>cd59</italic> expression seen by RNAseq and ISH (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A and B</xref>), we saw no difference in the number of cranial NCCs associated with the pLLG (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D and F</xref>) nor in the number of migrating spinal motor nerve NCCs (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1G and H</xref>). Overall, these data show that Cd59 does not influence NCC proliferation. Furthermore, the increase in SC number during development was not due to an increase in the NCCs that give rise to SCs.</p><p>In addition to neurons and NCCs, we were interested in seeing whether motor nerve-associated SCs or MEP glia, which do not express <italic>cd59</italic> by ISH (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A and B</xref>), also show an overproliferation phenotype in <italic>cd59<sup>uva48</sup></italic> mutants. To investigate this, we labeled 72 hpf <italic>olig2:dsred</italic> larvae with a Sox10 antibody to visualize and quantify motor nerve-associated myelinating glia (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1J</xref>). Accuracy of this quantification was verified with quantification of <italic>sox10:nls-eos</italic>-positive cells along <italic>olig2:dsred</italic>-positive motor nerves (representative images shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1I</xref>). Comparing wildtype and <italic>cd59<sup>uva48</sup></italic> larvae, there was no significant difference between the number of Sox10-positive cells (MEP glia and SCs) along spinal motor nerves (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1I and J</xref>). Collectively, these data show that Cd59 does not regulate proliferation of myelinating glia associated with the motor nerve.</p><p>Another important aspect of the pLLN is that it innervates neuromasts, which are sensory organs that detect water movement (<xref ref-type="bibr" rid="bib43">Ghysen and Dambly-Chaudière, 2007</xref>). Trunk neuromast number and positioning changes as the zebrafish grows in length, initially starting with 5–6 primary neuromasts (deposited from 20 to 40 hpf) that eventually expand into nearly 600 neuromasts in adults (<xref ref-type="bibr" rid="bib43">Ghysen and Dambly-Chaudière, 2007</xref>). Developing SCs can impact the number of neuromasts, as is evident by inappropriate neuromast formation in <italic>erbb</italic> pathway and <italic>sox10</italic> mutants which lack SCs (<xref ref-type="bibr" rid="bib49">Grant et al., 2005</xref>; <xref ref-type="bibr" rid="bib78">Lush and Piotrowski, 2014</xref>; <xref ref-type="bibr" rid="bib102">Perlin et al., 2011</xref>; <xref ref-type="bibr" rid="bib109">Rojas-Muñoz et al., 2009</xref>). To determine if excess SCs also affect neuromast formation, we labeled neuromasts with an acetylated α-Tubulin antibody and quantified the number of truncal neuromasts. Interestingly, there was no change in truncal neuromast number when comparing wildtype and <italic>cd59<sup>uva48</sup></italic> mutant larvae at 7 dpf (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1K</xref>), indicating that an increase in SC number does not alter neuromast formation. Combined, these data demonstrate that Cd59 is playing an early role in SC development by limiting proliferation and that this proliferative effect does not extend to other neural cells in the CNS or PNS.</p></sec><sec id="s2-4"><title><italic>cd59</italic> mutant larvae may have perturbed myelin and node of Ranvier formation in the PNS</title><p>From our observations, we saw that Cd59 functions to prevent overproliferation of developing SCs. Therefore, we next wanted to understand how an increase in SC number would impact myelin and pLLN development. Proliferation is a critical aspect of radial sorting, the process by which iSCs segregate large caliber axons that require myelination, and is necessary for nerve development (<xref ref-type="bibr" rid="bib38">Feltri et al., 2016</xref>). When proliferation is dysregulated, either through insufficient or excessive Schwann cell division, radial sorting can be delayed, arrested, or improperly executed, resulting in myelination that is incomplete or inappropriate, such as instances of polyaxonal myelination of small caliber axons (<xref ref-type="bibr" rid="bib38">Feltri et al., 2016</xref>; <xref ref-type="bibr" rid="bib45">Gomez-Sanchez et al., 2009</xref>). Therefore, we were curious how limiting SC proliferation through Cd59 influences myelinated nerve development. ISH for <italic>mbp</italic> (<xref ref-type="fig" rid="fig3">Figure 3F</xref>), confocal imaging of <italic>mbpa:tagrfp-caax</italic>-positive pLLN SCs (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A and C</xref>), and transmission electron microscopy (TEM) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>) showed that <italic>cd59<sup>uva48</sup></italic> mutant SCs were capable of producing myelin. Additionally, mosaic myelin labeling with <italic>mbpa:tagrfp-caax</italic> or <italic>mbpa:tagrfp-caax</italic> and <italic>mbp:egfp-caax</italic> constructs, injected into one-cell embryos, indicated that the myelin sheath length at 7 dpf did not vary between wildtype and <italic>cd59<sup>uva48</sup></italic> mutant larvae (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A and E</xref>) nor was there any evidence of overlapping sheaths at the same age (data not shown). However, when looking in <italic>mbpa:tagrfp-caax</italic> larvae, we observed that myelinated nerve volume was significantly reduced in 7 dpf <italic>cd59<sup>uva48</sup></italic> mutant larvae (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B and F</xref>). Because axon volume as well as area of axon cross-sections were unaltered, as indicated by acetylated α-Tubulin labeling (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C and G</xref>) and TEM (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1I</xref>), we hypothesized that myelination was affected in <italic>cd59<sup>uva48</sup></italic> mutants. Utilizing TEM, we compared the myelin ultrastructure in pLLNs from wildtype and <italic>cd59<sup>uva48</sup></italic> mutant larvae at 7 dpf. From these data, we observed a nonsignificant decrease in the average number of myelin wraps around each axon relative to the average area of the axon cross-section in <italic>cd59<sup>uva48</sup></italic> mutant larvae compared to wildtype siblings (<xref ref-type="fig" rid="fig5">Figure 5A and D</xref>). Notably, the average axon area did not change between wildtype and mutant nerves (<xref ref-type="fig" rid="fig5">Figure 5A and D</xref>) nor was there a change in the total number of myelinated axons (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1H</xref>). Therefore, although the decrease in myelin wrapping was not statistically significant, it indicates that the decrease in myelinated nerve volume observed in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B and F</xref> could be related to a decrease in the number of myelin wraps on each axon. More work will be needed to determine if there is a direct relationship between myelin development and Cd59 or if this phenotype is due to Cd59-regulated SC proliferation.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Myelin and node of Ranvier development is impaired in <italic>cd59<sup>uva48</sup></italic> mutants.</title><p>(<bold>A</bold>) Transmission electron micrographs showing posterior lateral line nerve (pLLN) axons myelinated by Schwann cells (SCs) at 7 days post fertilization (dpf). Myelin is shaded in blue, and myelinated axons are shaded in orange. (<bold>B</bold>) Immunofluorescence (IF) showing Na<sub>V</sub> channels (cyan) along <italic>mbpa:tagrfp-caax</italic>-positive pLLNs (orange) at 7 dpf. Diffuse Na<sub>V</sub> channel staining along unmyelinated nerves was not quantified. White dashed lines outline the pLLN. White dashed boxes correspond with the insets on the right. (<bold>C</bold>) IF showing NF186 clusters (cyan) along <italic>mbpa:tagrfp-caax</italic>-positive pLLNs (orange) at 7 dpf. White dashed lines outline the pLLN, and the white dashed boxes correspond to the insets on the right. Representative images in (<bold>B</bold>) and (<bold>C</bold>) depict somites 11–13 (~320 µm). (<bold>D</bold>) Average number of myelin wrappings per pLLN axon plotted relative to the average area of axon cross-section at 7 dpf. Data were collected from three sections per fish separated by 100 µm. Significance was determined by comparing the average number of myelin wraps divided by the average axon area for each fish with Student’s <italic>t</italic>-test using GraphPad Prism (average number of myelin wraps per fish mean ± SEM: WT: 3.95 ± 0.19, <italic>cd59<sup>uva48</sup></italic>: 3.27 ± 0.20; average axon area per fish mean ± SEM: WT: 0.51 ± 0.03, <italic>cd59<sup>uva48</sup></italic>: 0.52 ± 0.03; average number of myelin wraps/average axon area per fish mean ± SEM: WT: 0.13 ± 0.01, <italic>cd59<sup>uva48</sup></italic>: 0.16 ± 0.002; p=0.0568; dot = 1 fish). Data quantified in (<bold>D</bold>) were determined from electron micrographs in (<bold>A</bold>). (<bold>E</bold>) Scatter plot of the number of Na<sub>V</sub> channel clusters along <italic>mbpa:tagrfp</italic>-positive pLLN nerves at 7 dpf (mean ± SEM: WT: 17.3 ± 0.7, <italic>cd59<sup>uva48</sup></italic>: 9.9 ± 0.9; p&lt;0.0001; dot = 1 fish). (<bold>F</bold>) Scatter plot of the number of NF186 clusters along <italic>mbpa:tagrfp</italic>-positive pLLN nerves at 7 dpf (mean ± SEM: WT: 24.0 ± 0.7, <italic>cd59<sup>uva48</sup></italic>: 18.2 ± 1.3; p=0.0011; dot = 1 fish). Data were collected from somites 3–13 (~320 µm) and normalized to units per 100 µm for (<bold>E</bold>) and (<bold>F</bold>). Images shown in (<bold>A</bold>) were acquired with transmission electron microscopy. Images shown in (<bold>B</bold>) and (<bold>C</bold>) were acquired with confocal imaging. Each dataset was compared with Student’s <italic>t</italic>-test using GraphPad Prism. Scale bars: (<bold>A</bold>) 1 µm; (<bold>B, C</bold>) 25 µm.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Source data for the quantification of the average number of myelin wraps per fish relative to the average area of axon cross-section per fish at 7 days post fertilization (dpf) depicted in <xref ref-type="fig" rid="fig5">Figure 5D</xref>.</title><p>Data contributed to X-Y plot of the average number of myelin wrappings per fish relative to the average axon area per fish at 7 dpf. Data were collected from three sections per fish separated by 100 µm. Significance was determined by comparing the average number of myelin wraps divided by corresponding the average axon area for each fish with Student’s <italic>t</italic>-test using GraphPad Prism (average number of myelin wraps per fish mean ± SEM: WT: 3.95 ± 0.19, <italic>cd59<sup>uva48</sup></italic>: 3.27 ± 0.20; average axon area per fish mean ± SEM: WT: 0.51 ± 0.03, <italic>cd59<sup>uva48</sup></italic>: 0.52 ± 0.03; average number of myelin wraps/average axon area per fish mean ± SEM: WT: 0.13 ± 0.01, <italic>cd59<sup>uva48</sup></italic>: 0.16 ± 0.002; p=0.0568; dot = 1 fish).</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig5-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Source data for the quantification of the number of Na<sub>V</sub> channel clusters on the posterior lateral line nerve (pLLN) at 7 days post fertilization (dpf) depicted in <xref ref-type="fig" rid="fig5">Figure 5E</xref>.</title><p>Data contributed to scatter plot of the number of Na<sub>V</sub> channel clusters along <italic>mbpa:tagrfp</italic>-positive pLLN nerves at 7 dpf (mean ± SEM: WT: 17.3 ± 0.7, <italic>cd59<sup>uva48</sup></italic>: 9.9 ± 0.9; p&lt;0.0001; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 3–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig5-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata3"><label>Figure 5—source data 3.</label><caption><title>Source data for the quantification of the number of NF186 clusters along the posterior lateral line nerve (pLLN) at 7 days post fertilization (dpf) depicted in <xref ref-type="fig" rid="fig5">Figure 5F</xref>.</title><p>Data contributed to scatter plot of the number of NF186 clusters along <italic>mbpa:tagrfp</italic>-positive pLLN nerves at 7 dpf (mean ± SEM: WT: 24.0 ± 0.7, <italic>cd59<sup>uva48</sup></italic>: 18.2 ± 1.3; p=0.0011; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 3–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig5-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Myelin volume is reduced in <italic>cd59<sup>uva48</sup></italic> mutants.</title><p>(<bold>A</bold>) Mosaic labeling of <italic>mbpa:tagrfp-caax</italic>-positive Schwann cell (SC) myelin sheaths (cyan) along the posterior lateral line nerve (pLLN) at 7 days post fertilization (dpf). (<bold>B</bold>) In vivo imaging of <italic>mbpa:tagrfp-caax</italic>-positive pLLN nerves (cyan; top panel) at 7 dpf. Imaris renderings (white) of nerve volume in bottom panel. (<bold>C</bold>) Immunofluorescence (IF) showing Tubulin-positive pLLN axons (cyan; top panel) at 7 dpf. Imaris renderings (white) of axon volume in bottom panel. Representative images for (<bold>B</bold>) and (<bold>C</bold>) are from somite 12 (~110 µm). (<bold>D</bold>) Imaris renderings (right) of IF (left) showing colocalization of NF186 (magenta) and Na<sub>V</sub> channels (cyan) within <italic>mbpa:tagrfp-caax</italic>-positive nerves (orange). (<bold>E</bold>) Scatter plot of the length of myelin sheaths (µm) along the pLLN at 7 dpf (mean ± SEM: WT: 66.3 ± 2.4, <italic>cd59<sup>uva48</sup></italic>: 63.4 ± 4.6; dot = 1 myelin sheath; n = 6–7 fish per group). (<bold>F</bold>) Scatter plot of the myelinated nerve volumes (µm<sup>3</sup>) along the pLLN at 7 dpf (mean ± SEM: WT: 5.3 ± 0.3, <italic>cd59<sup>uva48</sup></italic>: 3.3 ± 0.2; p&lt;0.0001; dot = 1 fish). (<bold>G</bold>) Scatter plot of axon volumes (µm<sup>3</sup>) along the pLLN at 7 dpf (mean ± SEM: WT: 3.3 ± 0.3, <italic>cd59<sup>uva48</sup></italic>: 3.3 ± 0.5; dot = 1 fish). (<bold>H</bold>) Scatter plot of the number of myelinated axons per pLLN at 7 dpf. Data were collected from three sections per fish separated by 100 µm (mean ± SEM: WT: 16.22 ± 0.6, <italic>cd59<sup>uva48</sup></italic>: 16.67 ± 0.8; dot = 1 section; n = 3 fish per group). Data quantified in (<bold>H</bold>) were determined from electron micrographs in (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). All images in this figure were acquired with confocal imaging. Each dataset was compared with Student’s <italic>t</italic>-test using GraphPad Prism. Scale bars: (<bold>A–C</bold>) 10 µm; (<bold>D</bold>) 5 µm.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Source data for the quantification of myelin sheath measurements depicted in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>.</title><p>Data contributed to scatter plot of the length of myelin sheaths (µm) along the posterior lateral line nerve (pLLN) at 7 days post fertilization (dpf) (mean ± SEM: WT: 66.3 ± 2.4, <italic>cd59<sup>uva48</sup></italic>: 63.4 ± 4.6; data point = 1 myelin sheath; n = 6–7 fish per group). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig5-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata2"><label>Figure 5—figure supplement 1—source data 2.</label><caption><title>Source data for the quantification of myelinated nerve volume measurements depicted in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>.</title><p>Data contributed to scatter plot of the myelinated nerve volumes (µm<sup>3</sup>) along the posterior lateral line nerve (pLLN) at 7 days post fertilization (dpf) (mean ± SEM: WT: 5.3 ± 0.3, <italic>cd59<sup>uva48</sup></italic>: 3.3 ± 0.2; p&lt;0.0001; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somite 12 (~110 µm). All data were normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig5-figsupp1-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata3"><label>Figure 5—figure supplement 1—source data 3.</label><caption><title>Source data for the quantification of axon volume measurements depicted in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F</xref>.</title><p>Data contributed to scatter plot of axon volumes (µm<sup>3</sup>) along the posterior lateral line nerve (pLLN) at 7 days post fertilization (dpf) (mean ± SEM: WT: 3.3 ± 0.3, <italic>cd59<sup>uva48</sup></italic>: 3.3 ± 0.5; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somite 12 (~110 µm). All data were normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig5-figsupp1-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata4"><label>Figure 5—figure supplement 1—source data 4.</label><caption><title>Source data for the quantification of the number of myelinated axons per posterior lateral line nerve (pLLN) at 7 days post fertilization (dpf) depicted in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1G</xref>.</title><p>Data contributed to scatter plot of the number of myelinated axons per pLLN at 7 dpf. Data were collected from three sections per fish separated by 100 µm (mean ± SEM: WT: 16.22 ± 0.6, <italic>cd59<sup>uva48</sup></italic>: 16.67 ± 0.8; data point = 1 section; n = 3 fish per group). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig5-figsupp1-data4-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig5-figsupp1-v2.tif"/></fig></fig-group><p>In addition to producing myelin, myelinating SCs collaborate with axons to construct nodes of Ranvier, which occur between adjacent myelin sheaths and are essential for rapid neurotransmission along myelinated axons (<xref ref-type="bibr" rid="bib106">Rasband and Peles, 2021</xref>). Therefore, we were curious if reduced myelin volume in <italic>cd59<sup>uva48</sup></italic> mutant larvae would also impact nodal development. An important aspect of node construction is the clustering of axonal sodium channels, which assists in the saltatory conduction of action potentials along the nerve and is facilitated by interactions between SC-associated gliomedin and neuronal cell adhesion molecule (NrCAM) and axonal neurofascin 186 (NF186) (<xref ref-type="bibr" rid="bib36">Eshed et al., 2005</xref>; <xref ref-type="bibr" rid="bib37">Feinberg et al., 2010</xref>; <xref ref-type="bibr" rid="bib106">Rasband and Peles, 2021</xref>; <xref ref-type="bibr" rid="bib126">Susuki et al., 2013</xref>). To investigate assembly of the node, we labeled <italic>mbpa:tagrfp-caax</italic> larvae with antibodies to visualize sodium channels and NF186 at 7 dpf. These studies revealed that <italic>cd59<sup>uva48</sup></italic> mutant larvae had fewer discrete sodium channel clusters along the pLLN (<xref ref-type="fig" rid="fig5">Figure 5B and E</xref>). Accordingly, mutant nerves also had fewer clusters of NF186 (<xref ref-type="fig" rid="fig5">Figure 5C and F</xref>). To confirm that our quantification was reliable, we co-labeled NF186 and sodium channels along <italic>mbpa:tagrfp-caax</italic>-positive nerves and observed that NF186 and sodium channels always colocalized along the myelinated nerve in wildtype larvae (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>), indicating that these clusters of NF186 and sodium channels are bona fide nodes of Ranvier. Considered together, these data indicate that <italic>cd59<sup>uva48</sup></italic> mutant larvae do not form nodes of Ranvier normally, though at this time it is unclear if this phenotype is a direct or indirect result of <italic>cd59</italic> mutation, secondary to Cd59-regulated SC proliferation, or a consequence of changes in myelin formation.</p></sec><sec id="s2-5"><title>Developmental inflammation stimulates SC proliferation and is regulated by Cd59</title><p>Cd59 is best known for its ability to inhibit complement-dependent cell lysis, protecting healthy cells from premature death during times of inflammation, such as during an infection or after an injury (<xref ref-type="bibr" rid="bib29">Davies et al., 1989</xref>; <xref ref-type="bibr" rid="bib88">Mead et al., 2004</xref>; <xref ref-type="bibr" rid="bib123">Stahel et al., 2009</xref>; <xref ref-type="bibr" rid="bib145">Yao and Verkman, 2017</xref>). Interestingly, at sublytic levels, complement can stimulate SC and OLC proliferation in vitro without inducing cell death (<xref ref-type="bibr" rid="bib28">Dashiell et al., 2000</xref>; <xref ref-type="bibr" rid="bib54">Hila et al., 2001</xref>; <xref ref-type="bibr" rid="bib112">Rus et al., 1997</xref>; <xref ref-type="bibr" rid="bib111">Rus et al., 1996</xref>; <xref ref-type="bibr" rid="bib130">Tatomir et al., 2020</xref>). Complement is also a potent driver of inflammation, which is also known to drive cell proliferation (<xref ref-type="bibr" rid="bib65">Kiraly et al., 2015</xref>; <xref ref-type="bibr" rid="bib73">Larson et al., 2020</xref>; <xref ref-type="bibr" rid="bib94">Morgan, 2016</xref>; <xref ref-type="bibr" rid="bib93">Morgan and Harris, 2015</xref>; <xref ref-type="bibr" rid="bib118">Silva et al., 2020</xref>). Although complement is present (<xref ref-type="bibr" rid="bib80">Magdalon et al., 2020</xref>; <xref ref-type="bibr" rid="bib148">Zhang and Cui, 2014</xref>), it is unclear if developmental levels of complement or inflammation could impact SC proliferation in vivo and whether this process is Cd59-dependent.</p><p>To determine if complement activity is increased in <italic>cd59<sup>uva48</sup></italic> mutant larvae, we first looked at changes in MAC-binding in developing SCs. MACs are comprised of complement proteins C5b, C6, C7, C8, and C9 and represent the culmination of the three complement pathways (classical, lectin, and alternative) (<xref ref-type="bibr" rid="bib9">Bayly-Jones et al., 2017</xref>). During MAC formation, C9 will polymerize to form pores in the cell membrane, inducing cell proliferation or cell death depending on the concentration of pores (<xref ref-type="bibr" rid="bib9">Bayly-Jones et al., 2017</xref>; <xref ref-type="bibr" rid="bib92">Morgan, 1989</xref>; <xref ref-type="bibr" rid="bib132">Tegla et al., 2011b</xref>). In healthy cells, Cd59 will bind to C8 and C9 and prevent polymerization of C9 as well as subsequent pore formation (<xref ref-type="bibr" rid="bib89">Meri et al., 1990</xref>; <xref ref-type="bibr" rid="bib99">Ninomiya and Sims, 1992</xref>; <xref ref-type="bibr" rid="bib110">Rollins et al., 1991</xref>). Considering these mechanisms, we hypothesized that if Cd59 was dysfunctional, we would see an increase in MAC formation in SC membranes. Using an antibody against C5b8-C5b9, which recognizes assembled MACs, we observed that <italic>cd59</italic><sup>uva48</sup> mutant larvae had more MACs localized to <italic>sox10:megfp</italic>-positive SC membranes compared to wildtype controls at 55 hpf (<xref ref-type="fig" rid="fig6">Figure 6A–C</xref>), indicating that developing SCs are no longer protected from complement in <italic>cd59<sup>uva48</sup></italic> mutants. In the future, these results will require further investigation to confirm that this quantification reflects an increase in MAC formation after <italic>cd59</italic> mutation. However, these data provide preliminary evidence that there is increased MAC binding on SC membranes in <italic>cd59<sup>uva48</sup></italic> mutant embryos.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Membrane attack complex (MAC) formation on Schwann cell (SC) membranes is increased in <italic>cd59<sup>uva48</sup></italic> mutants.</title><p>(<bold>A</bold>) Top panel: immunofluorescence (IF) showing MACs (C5b-9+C5b-8; magenta, indicated with white arrows) embedded in <italic>sox10:megfp-</italic>positive posterior lateral line nerve (pLLN) SC membranes (gray) at 55 hours post fertilization (hpf). White dotted box corresponds with inset of a single z-plane on the right showing that MACs are within SC membranes. (<bold>B</bold>) Imaris renderings showing MACs (C5b-9+C5b-8; orange, indicated with white arrows) embedded in <italic>sox10:megfp-</italic>positive pLLN SC membranes (cyan) at 55 hpf. (<bold>B’</bold>) Enlarged renderings show MAC puncta (orange, indicated with black arrows) embedded in the SC membranes (cyan). (<bold>C</bold>) Scatter plot of the number of MACs in SC membranes at 55 hpf (mean ± SEM: WT: 3.3 ± 0.3, <italic>cd59<sup>uva48</sup></italic>: 11.6 ± 1.9; p&lt;0.0001; dot = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. All data were normalized to units per 100 µm. All images were acquired with confocal imaging. Scale bars: (<bold>A, B</bold>) 10 µm; inset (<bold>A</bold>) and enlarged renderings (<bold>B’</bold>), 5 µm.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Source data for the quantification of membrane attack complexes (MACs)-associated with Schwann cell (SC) membranes at 55 hours post fertilization (hpf) depicted in <xref ref-type="fig" rid="fig6">Figure 6B</xref>.</title><p>Data contributed to scatter plot of the number of MACs in SC membranes at 55 hpf (mean ± SEM: WT: 3.3 ± 0.3, <italic>cd59<sup>uva48</sup></italic>: 11.6 ± 1.9; p&lt;0.0001; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig6-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig6-v2.tif"/></fig><p>Given limited tool availability in zebrafish, we were unable to directly inhibit MAC formation in developing embryos. However, using dexamethasone (Dex), a steroid agonist that inhibits inflammation and associated complement activity (<xref ref-type="bibr" rid="bib34">Engelman et al., 1995</xref>; <xref ref-type="bibr" rid="bib118">Silva et al., 2020</xref>), we sought to investigate the role of developmental inflammation in Cd59-regulated SC proliferation. To do this, wildtype and mutant embryos were incubated in 1% DMSO or 1% DMSO plus 100 μM Dex from 24 to 55 hpf. This treatment method had no notable impacts on anatomical or behavioral development (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). After fixing the embryos, the number of pLLN SCs was quantified using a Sox10 antibody. Excitingly, Dex treatment in <italic>cd59<sup>uva48</sup></italic> mutant embryos restored SC numbers to wildtype levels (<xref ref-type="fig" rid="fig7">Figure 7A and C</xref>). Furthermore, when compared alone, the number of SCs in wildtype larvae was also significantly reduced by Dex treatment (<xref ref-type="fig" rid="fig7">Figure 7A and C</xref>), indicating that developmental inflammation plays a role in homeostatic SC development. In support of these findings, EdU incorporation in <italic>cd59<sup>uva48</sup></italic> mutant SCs from 48 to 55 hpf also returned to wildtype levels with Dex treatment from 24 to 55 hpf (<xref ref-type="fig" rid="fig7">Figure 7B and D</xref>), confirming that Dex treatment does suppress SC proliferation. Interestingly, EdU incorporation in Dex-treated, wildtype SCs was also reduced compared to DMSO-treated, wildtype controls (<xref ref-type="fig" rid="fig7">Figure 7B and D</xref>), showing that Dex can also alter homeostatic SC proliferation. Future investigations will be needed to rule out other effects of glucocorticoid signaling in this process as well as whether or not sublytic MAC formation has a direct effect on SC proliferation in vivo; however, these data indicate that developmental inflammation aids in normal SC proliferation and that this process is amplified when <italic>cd59</italic> is mutated.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Cd59 and inflammation regulate developmental Schwann cell (SC) proliferation.</title><p>(<bold>A</bold>) Immunofluorescence (IF) showing Sox10-positive posterior lateral line nerve (pLLN) SCs (black/gray) at 55 hours post fertilization (hpf) in embryos treated with DMSO or 100 µM dexamethasone (Dex). Black dashed lines outline the pLLN. Sox10-positive pigment cells outside of the dashed lines (white asterisks) were not included in the analysis. (<bold>B</bold>) EdU incorporation assay showing <italic>sox10:nls-eos</italic>-positive, pLLN SCs (orange) pulsed with EdU (cyan) from 48 to 55 hpf in embryos treated with DMSO or 100 µM Dex. White dashed lines outline the pLLN. Magenta dashed lines outline neuromasts. (<bold>C</bold>) Scatter plot of the number of pLLN SCs at 55 hpf. Asterisks (*) indicate significant differences discovered with two-way ANOVA with Tukey’s post-hoc test using GraphPad Prism. Obelisk (†) indicates the significant difference discovered with Student’s <italic>t</italic>-test (GraphPad Prism) comparing WT DMSO and WT Dex alone (mean ± SEM: DMSO: WT: 12.0 ± 0.5, <italic>cd59<sup>uva48</sup></italic>: 18.1 ± 0.6; Dex: WT: 10.4 ± 0.4, <italic>cd59<sup>uva48</sup></italic>: 13.4 ± 0.6; two-way ANOVA p-values: WT DMSO vs. <italic>cd59<sup>uva48</sup></italic> DMSO: p&lt;0.0001, WT Dex vs. <italic>cd59<sup>uva48</sup></italic> DMSO: p&lt;0.0001, WT Dex vs. <italic>cd59<sup>uva48</sup></italic> Dex: p=0.0014, <italic>cd59<sup>uva48</sup></italic> DMSO vs. <italic>cd59<sup>uva48</sup></italic> Dex: p&lt;0.0001; <italic>t</italic>-test p-value (compared WT only): WT DMSO vs. WT Dex: p=0.0206; dot = 1 fish). (<bold>D</bold>) Scatter plot of the number of EdU-positive SCs along the pLLN at 55 hpf in embryos treated with DMSO or 100 µM Dex (mean ± SEM: DMSO: WT: 4.6 ± 0.85, <italic>cd59<sup>uva48</sup></italic>: 9.0 ± 0.68; Dex: WT: 2.7 ± 0.65, <italic>cd59<sup>uva48</sup></italic>: 3.5 ± 0.53; p-values: WT DMSO vs. WT Dex: p=0.0091, WT DMSO vs. <italic>cd59<sup>uva48</sup></italic> DMSO: p=0.0266, WT Dex vs. <italic>cd59<sup>uva48</sup></italic> DMSO: p&lt;0.0001, <italic>cd59<sup>uva48</sup></italic> DMSO vs. <italic>cd59<sup>uva48</sup></italic> Dex: p&lt;0.0001; dot = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. All data were normalized to units per 100 µm. All images were acquired with confocal imaging. Scale bars: (<bold>A, B</bold>) 25 µm.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Source data for the quantification of the number of Schwann cells (SCs) on the posterior lateral line nerve (pLLN) at 55 hours post fertilization (hpf) after dexamethasone (Dex) treatment depicted in <xref ref-type="fig" rid="fig7">Figure 7C</xref>.</title><p>Data contributed to scatter plot of the number of pLLN SCs at 55 hpf (mean ± SEM: DMSO: WT: 12.0 ± 0.5, <italic>cd59<sup>uva48</sup></italic>: 18.1 ± 0.6; Dex: WT: 10.4 ± 0.4, <italic>cd59<sup>uva48</sup></italic>: 13.4 ± 0.6; p-values: WT DMSO vs. <italic>cd59<sup>uva48</sup></italic> DMSO: p&lt;0.0001, WT Dex vs. <italic>cd59<sup>uva48</sup></italic> DMSO: p&lt;0.0001, WT Dex vs. <italic>cd59<sup>uva48</sup></italic> Dex: p=0.0014, <italic>cd59<sup>uva48</sup></italic> DMSO vs. <italic>cd59<sup>uva48</sup></italic> Dex: p&lt;0.0001; <italic>t</italic>-test p-value (compared WT only): WT DMSO vs. WT Dex: p=0.0206; dot = 1 fish). All groups were compared with a two-way ANOVA with Tukey’s post-hoc test using GraphPad Prism. WT DMSO and WT Dex were also compared alone with Student’s <italic>t</italic>-test using GraphPad Prism. Asterisks (*) indicate significant differences discovered with two-way ANOVA with Tukey’s post-hoc test. Obelisk (†) indicates the significant difference discovered with Student’s <italic>t</italic>-test comparing WT DMSO and WT Dex alone. Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig7-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Source data for the quantification of of EdU-positive Schwann cells (SCs) on the posterior lateral line nerve (pLLN) at 55 hours post fertilization (hpf) after dexamethasone (Dex) treatment depicted in <xref ref-type="fig" rid="fig7">Figure 7D</xref>.</title><p>Data contributed to scatter plot of the number of EdU-positive SCs at 55 hpf (mean ± SEM: DMSO: WT: 4.6 ± 0.85, <italic>cd59<sup>uva48</sup></italic>: 9.0 ± 0.68; Dex: WT: 2.7 ± 0.65, <italic>cd59<sup>uva48</sup></italic>: 3.5 ± 0.53; p-values: WT DMSO vs. WT Dex: p=0.0091, WT DMSO vs. <italic>cd59<sup>uva48</sup></italic> DMSO: p=0.0266, WT Dex vs. <italic>cd59<sup>uva48</sup></italic> DMSO: p&lt;0.0001, <italic>cd59<sup>uva48</sup></italic> DMSO vs. <italic>cd59<sup>uva48</sup></italic> Dex: p&lt;0.0001; dot = 1 fish). Data were compared with a two-way ANOVA with Tukey’s post-hoc test using GraphPad Prism. Data were collected from somites 11–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig7-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Controls for dexamethasone (Dex) treatment.</title><p>(<bold>A</bold>) Bright-field images of wildtype and mutant embryos (55 hours post fertilization [hpf]) treated with DMSO or 100 µM Dex from 24 to 55 hpf. Scale bar: (<bold>A</bold>) 0.25 mm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig7-figsupp1-v2.tif"/></fig></fig-group><p>Previously, we showed that mutants with Cd59 dysfunction may have abnormal myelin and node of Ranvier development (<xref ref-type="fig" rid="fig5">Figure 5</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). Though it is still unclear if this phenotype is a direct effect of Cd59 dysfunction or secondary to overproliferation of SCs, we were curious if inhibiting inflammation-induced SC proliferation could rescue these aspects of nerve development. To investigate this hypothesis, we treated <italic>cd59<sup>uva48</sup></italic> mutant embryos with 1% DMSO or 1% DMSO plus 100 μM Dex from 24 to 75 hpf to encompass most developmental SC proliferation. The larvae were then transferred to PTU-egg water and raised until 7 dpf. Labeling with a Sox10 antibody confirmed that this treatment regimen restored SC proliferation similarly to that described in <xref ref-type="fig" rid="fig7">Figure 7A and C</xref> (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1A and B</xref>). We then repeated the same treatment procedure in wildtype and <italic>cd59<sup>uva48</sup></italic> mutant <italic>mbpa:tagrfp-caax</italic> embryos and quantified sodium channel antibody labeling at 7 dpf. Remarkably, we observed that Dex treatment dramatically increased the number of sodium channel clusters in <italic>cd59<sup>uva48</sup></italic> mutant larvae, achieving cluster levels similar to wildtype siblings (<xref ref-type="fig" rid="fig8">Figure 8A and C</xref>). Similarly, when comparing myelinated nerve volume in <italic>mbpa:tagrfp-caax</italic> larvae at 7 dpf, we saw that Dex could also restore <italic>cd59<sup>uva48</sup></italic> mutant nerve volume to wildtype levels (<xref ref-type="fig" rid="fig8">Figure 8B and D</xref>). Collectively, these data indicate that inflammation-induced SC proliferation contributes to perturbed myelin and node of Ranvier development. Although more work will be needed to determine where Cd59 and MACs fit into this process, these experiments provide preliminary evidence that inhibition of developmental inflammation can protect nerve development after <italic>cd59</italic> mutation.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Developmental inflammation influences myelin and node of Ranvier development.</title><p>(<bold>A</bold>) Immunofluorescence (IF) showing Na<sub>V</sub> channels (cyan) along <italic>mbpa:tagrfp-caax</italic>-positive nerves (orange) at 7 days post fertilization (dpf) in larvae treated with DMSO or 100 µM dexamethasone (Dex). Diffuse Na<sub>V</sub> channel staining along unmyelinated nerves was not quantified. White dashed lines outline the posterior lateral line nerve (pLLN). White dashed boxes correspond with the insets below. Representative images are from somite 11–13 (~320 µm). (<bold>B</bold>) In vivo imaging showing the volume of <italic>mbpa:tagrfp-caax-</italic>positive nerves at 7 dpf in larvae treated with DMSO or 100 µM Dex. Bottom panels depict Imaris renderings (white) of myelinated nerve volumes. Representative images are from somite 12 (~110 µm). (<bold>C</bold>) Scatter plot of the number of Na<sub>V</sub> channel clusters along <italic>mbpa:tagrfp-caax</italic>-positive nerves at 7 dpf (mean ± SEM: DMSO: WT: 26.0 ± 0.8, <italic>cd59<sup>uva48</sup></italic>: 18.6 ± 0.6; Dex: WT: 23.9 ± 0.8, <italic>cd59<sup>uva48</sup></italic>: 28.9 ± 0.8; p-values: WT DMSO vs. <italic>cd59<sup>uva48</sup></italic> DMSO: p&lt;0.0001, WT Dex vs. <italic>cd59<sup>uva48</sup></italic> DMSO: p=0.0001, WT Dex vs. <italic>cd59<sup>uva48</sup></italic> Dex: p=0.0001, <italic>cd59<sup>uva48</sup></italic> DMSO vs. <italic>cd59<sup>uva48</sup></italic> Dex: p&lt;0.0001; dot = 1 fish). These data were compared with a two-way ANOVA with Tukey’s post-hoc test using GraphPad Prism. Data were collected from somites 3–13 (~320 µm). (<bold>D</bold>) Scatter plot of myelinated nerve volumes at 7 dpf (mean ± SEM: DMSO: WT: 5.6 ± 0.4, <italic>cd59<sup>uva48</sup></italic>: 4.1 ± 0.2; Dex: WT: 4.9 ± 0.1, <italic>cd59<sup>uva48</sup></italic>: 5.4 ± 0.2; p--values: WT DMSO vs. <italic>cd59<sup>uva48</sup></italic> DMSO: p=0.0009, <italic>cd59<sup>uva48</sup></italic> DMSO vs. <italic>cd59<sup>uva48</sup></italic> Dex: p=0.0006; dot = 1 fish). These data were compared with a two-way ANOVA with Tukey’s post-hoc test using GraphPad Prism. Data were collected from somite 12 (~110 µm). All data were normalized to units per 100 µm. All images were acquired with confocal imaging. Scale bars: (<bold>A</bold>) 25 µm; inset, 25 µm; (<bold>B</bold>) 10 µm.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Source data for the quantification of the number of Na<sub>V</sub> channel clusters with dexamethasone (Dex) treatment depicted in <xref ref-type="fig" rid="fig8">Figure 8C</xref>.</title><p>Data contributed to scatter plot of the number of Na<sub>V</sub> channel clusters along <italic>mbpa:tagrfp-caax</italic>-positive nerves at 7 days post fertilization (dpf) (mean ± SEM: DMSO: WT: 26.0 ± 0.8, <italic>cd59<sup>uva48</sup></italic>: 18.6 ± 0.6; Dex: WT: 23.9 ± 0.8, <italic>cd59<sup>uva48</sup></italic>: 28.9 ± 0.8; p-values: WT DMSO vs. <italic>cd59<sup>uva48</sup></italic> DMSO: p&lt;0.0001, WT Dex vs. <italic>cd59<sup>uva48</sup></italic> DMSO: p=0.0001, WT Dex vs. <italic>cd59<sup>uva48</sup></italic> Dex: p=0.0001, <italic>cd59<sup>uva48</sup></italic> DMSO vs. <italic>cd59<sup>uva48</sup></italic> Dex: p&lt;0.0001; data point = 1 fish). These data were compared with a two-way ANOVA with Tukey’s post-hoc test using GraphPad Prism. Data were collected from somites 3–13 (~320 µm). All data were normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig8-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig8sdata2"><label>Figure 8—source data 2.</label><caption><title>Source data for the quantification of the myelinated nerve volume with dexamethasone (Dex) treatment depicted in <xref ref-type="fig" rid="fig8">Figure 8D</xref>.</title><p>Data contributed to scatter plot of myelinated nerve volumes at 7 days post fertilization (dpf) (mean ± SEM: DMSO: WT: 5.6 ± 0.4, <italic>cd59<sup>uva48</sup></italic>: 4.1 ± 0.2; Dex: WT: 4.9 ± 0.1, <italic>cd59<sup>uva48</sup></italic>: 5.4 ± 0.2; p-values: WT DMSO vs. <italic>cd59<sup>uva48</sup></italic> DMSO: p=0.0009, <italic>cd59<sup>uva48</sup></italic> DMSO vs. <italic>cd59<sup>uva48</sup></italic> Dex: p=0.0006; data point = 1 fish). These data were compared with a two-way ANOVA with Tukey’s post-hoc test using GraphPad Prism. Data were collected from somite 12 (~110 µm). All data were normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig8-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig8-v2.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Extended dexamethasone (Dex) treatment had same impact on Schwann cell (SC) proliferation in <italic>cd59<sup>uva48</sup></italic> mutant larvae.</title><p>(<bold>A</bold>) Immunofluorescence (IF) showing Sox10-positive SCs (black/gray) at 7 days post fertilization (dpf) in <italic>cd59<sup>uva48</sup></italic> mutant larvae treated with DMSO or 100 µM Dex from 24 to 75 hours post fertilization (hpf). Black dashed lines outline the posterior lateral line nerve (pLLN). Sox10-positive pigment cells outside of the dashed lines (white asterisks) were not included in the analysis. Images were acquired with confocal imaging. (<bold>B</bold>) Scatter plot of the number of pLLN SCs at 7 hpf (mean ± SEM: DMSO: 31.9 ± 1.1, Dex: 24.0 ± 0.4; p&lt;0.0001; dot = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 3–13 (~320 µm) and normalized to units per 100 µm. Scale bar: 25 µm.</p><p><supplementary-material id="fig8s1sdata1"><label>Figure 8—figure supplement 1—source data 1.</label><caption><title>Source data for the quantification of the number of Schwann cells (SCs) on the posterior lateral line nerve (pLLN) at 7 days post fertilization (dpf) after extended dexamethasone (Dex) treatment depicted in <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1B</xref>.</title><p>Data contributed to scatter plot of the number of pLLN SCs at 7 hours post fertilization (hpf) (mean ± SEM: DMSO: 31.9 ± 1.1, Dex: 24.0 ± 0.4; p&lt;0.0001; data point = 1 fish). These data were compared with Student’s <italic>t</italic>-test using GraphPad Prism. Data were collected from somites 3–13 (~320 µm) and normalized to units per 100 µm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-76640-fig8-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76640-fig8-figsupp1-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Myelination during nervous system development is essential for neural function, providing trophic and structural support to axons as well as quickening electrical conduction (<xref ref-type="bibr" rid="bib108">Ritchie, 1982</xref>; <xref ref-type="bibr" rid="bib122">Stadelmann et al., 2019</xref>). Consequently, impairment of this process can be devastating to patient quality of life (<xref ref-type="bibr" rid="bib122">Stadelmann et al., 2019</xref>; <xref ref-type="bibr" rid="bib136">van der Knaap and Bugiani, 2017</xref>). For this reason, the genetic mechanisms that orchestrate myelinating glial cell development requires continued exploration. Over the past few decades, we and others have noted expression of <italic>cd59</italic> that is conserved in developing myelinating glial cells across multiple organisms, including zebrafish, rodents, and humans (<xref ref-type="bibr" rid="bib42">Gerber et al., 2021</xref>; <xref ref-type="bibr" rid="bib57">Howard et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Marisca et al., 2020</xref>; <xref ref-type="bibr" rid="bib83">Marques et al., 2018</xref>; <xref ref-type="bibr" rid="bib82">Marques et al., 2016</xref>; <xref ref-type="bibr" rid="bib105">Piller et al., 2021</xref>; <xref ref-type="bibr" rid="bib114">Saunders et al., 2019</xref>; <xref ref-type="bibr" rid="bib117">Siems et al., 2021</xref>; <xref ref-type="bibr" rid="bib125">Sun et al., 2013</xref>; <xref ref-type="bibr" rid="bib144">Wolbert et al., 2020</xref>; <xref ref-type="bibr" rid="bib147">Zajicek et al., 1995</xref>; <xref ref-type="bibr" rid="bib149">Zhu et al., 2019</xref>). Despite these observations, there had been little exploration into the function of Cd59 in the developing nervous system. In this study, we demonstrate that <italic>cd59</italic> is expressed in a subset of developing SCs as well as mature OLs and SCs, revealing transcriptional heterogeneity among myelinating glial cells during development. Focusing on SCs, we demonstrated that Cd59 regulates SC proliferation induced by developmental inflammation. Furthermore, embryos with Cd59 dysfunction may have abnormal myelin and node of Ranvier formation during development. Overall, these findings illuminate the intersection of the innate immune system and glial cells and how they collaborate to establish a functioning nervous system during development.</p><p>Considering the importance of myelination, our investigation revealed some interesting myelin defects in response to <italic>cd59</italic> dysfunction. With the increase in SC proliferation in <italic>cd59</italic> mutant embryos, we hypothesized that the myelin sheath lengths would shorten in order to accommodate the excess SCs and maintain the same amount of myelin on the nerve. Unexpectedly, we noted that with Cd59 dysfunction, the myelin sheath length was unaffected. Additionally, myelin volume was reduced, which may be related to a nonsignificant decrease in the average number myelin wraps around each axon. At this point, it is unclear if the decrease in myelin volume is directly due to Cd59 dysfunction, secondary to SC excess, or simply an indirect consequence of developmental inflammation. That said, from these data we can imagine a couple of potential hypotheses as to why myelin volume is decreased. First, it is possible that Cd59, in addition to regulating SC proliferation, is also necessary for myelinogenesis. Past investigations demonstrate that CD59a helps facilitate vesicle signaling, which is important during insulin release and is implicated in diabetic patients (<xref ref-type="bibr" rid="bib44">Golec et al., 2019</xref>; <xref ref-type="bibr" rid="bib68">Krus et al., 2014</xref>). Within the nervous system, vesicle-dependent signaling is also important for myelin formation as well as trafficking within the myelin sheath (<xref ref-type="bibr" rid="bib8">Baron and Hoekstra, 2010</xref>; <xref ref-type="bibr" rid="bib107">Reiter and Bongarzone, 2020</xref>; <xref ref-type="bibr" rid="bib139">White and Krämer-Albers, 2014</xref>). Electron micrographs show that CD59a is positioned throughout the myelin sheath in oligodendrocytes (<xref ref-type="bibr" rid="bib117">Siems et al., 2021</xref>). Notably, CD59a molecules are observed deep within compacted myelin (<xref ref-type="bibr" rid="bib117">Siems et al., 2021</xref>). Because Cd59 is unlikely to encounter complement when it is so isolated from the extracellular environment, it is possible that Cd59 is playing an additional role in mature myelinating glial cells, possibly by regulating vesicle signaling within the myelin sheath. In future work, it will be interesting to identify if Cd59 has any direct role in SC and/or oligodendrocyte myelinogenesis. That said, it is important to note that <italic>cd59</italic> mutant SCs continue to express molecules necessary for SC development and subsequent myelination, including <italic>sox10</italic>, <italic>mbp</italic>, and <italic>krox20</italic> (<xref ref-type="bibr" rid="bib14">Bremer et al., 2011</xref>; <xref ref-type="bibr" rid="bib47">Gould et al., 1995</xref>; <xref ref-type="bibr" rid="bib59">Jessen and Mirsky, 2005</xref>; <xref ref-type="bibr" rid="bib127">Takada et al., 2010</xref>; <xref ref-type="bibr" rid="bib134">Topilko et al., 1994</xref>), as well as produce myelin at the appropriate developmental stage. Therefore, these SCs are able to make myelin without Cd59. These facts considered, it is also possible that Cd59 is not directly involved in SC myelinogenesis. With this in mind, another possibility is that the excess SCs themselves are responsible for the reduction in myelin through a contact inhibition mechanism. In support of this idea, prior work in vitro demonstrates that SCs produce a glycoprotein called contactinhibin when the cells reach a high density (<xref ref-type="bibr" rid="bib19">Casella et al., 2000</xref>). Contactinhibin and its receptor, contactinhibin receptor, mediate contact-dependent inhibition of growth in SCs and fibroblasts (<xref ref-type="bibr" rid="bib19">Casella et al., 2000</xref>; <xref ref-type="bibr" rid="bib48">Gradl et al., 1995</xref>; <xref ref-type="bibr" rid="bib140">Wieser et al., 1990</xref>), demonstrating that SCs have methods to restrict overgrowth under homeostatic conditions. Interestingly, contactinhibin also interacts with vimentin (<xref ref-type="bibr" rid="bib140">Wieser et al., 1990</xref>), which is known to collaborate with TACE to negatively regulate NRG1 type III expression and subsequent myelin production (<xref ref-type="bibr" rid="bib135">Triolo et al., 2012</xref>). Without vimentin and TACE, SCs hypermyelinate nerves (<xref ref-type="bibr" rid="bib135">Triolo et al., 2012</xref>). Considering these findings, it is possible that overproliferation of SCs in <italic>cd59</italic> mutant larvae leads to activation of these growth-inhibiting molecules, such as contactinhibin, vimentin, and TACE, and consequently decreases NRG1 type III expression and myelinogenesis. Finally, as mentioned previously, it is also possible that Cd59 or Cd59-regulated SC proliferation has nothing to do with changes in myelin development. Dex treatment indicates that developmental inflammation (or possibly other effects of glucocorticoid signaling) contributes to abnormal myelin formation in <italic>cd59</italic> mutant larvae. Therefore, it is possible that this altered myelination is an indirect effect of developmental inflammation and not relevant to Cd59 or Cd59-regulated SC proliferation, indicating that we have more to learn about the role of developmental inflammation in myelinogenesis. Utilizing the <italic>cd59</italic> mutant model established in this article, future studies can investigate these hypotheses to learn more about the molecular mechanisms that regulate myelin development.</p><p>While evaluating myelination, we were also curious about the SCs that were not contributing to myelination. Because the number of myelinated axons as well as myelin sheath length is similar between wildtype and mutant nerves, this indicates that the extra SCs are not producing myelin. It is unclear if this extra population of SCs are NMSCs or undifferentiated iSCs, which is a question worth exploring in a future study. Fortunately, a recent transcriptomic analysis of developing SCs revealed several new markers in which to better differentiate iSCs, NMSCs, and MSCs (<xref ref-type="bibr" rid="bib129">Tasdemir-Yilmaz et al., 2021</xref>), which have historically been difficult to distinguish. Using these new cell-specific markers, future investigations will be able to determine the fate of these extra SCs on <italic>cd59</italic> mutant nerves.</p><p>Beyond changes in myelination, in this study we showed that Cd59-limited proliferation is elicited by developmental inflammation. This finding provokes many interesting questions. First, these data reiterate the idea that the innate immune system and genes traditionally active in immune cells are first used during development to guide nervous system assembly and formation. In the CNS, there is evidence that complement aids in stimulating synaptic pruning of developing dendrites, directing cell polarity in the ventricular zone, guiding cortical neuron migration, and fostering neural progenitor cell proliferation (<xref ref-type="bibr" rid="bib24">Coulthard et al., 2018</xref>; <xref ref-type="bibr" rid="bib23">Coulthard et al., 2017</xref>; <xref ref-type="bibr" rid="bib30">Denny et al., 2013</xref>; <xref ref-type="bibr" rid="bib46">Gorelik et al., 2017</xref>; <xref ref-type="bibr" rid="bib80">Magdalon et al., 2020</xref>; <xref ref-type="bibr" rid="bib100">Paolicelli et al., 2011</xref>; <xref ref-type="bibr" rid="bib124">Stevens et al., 2007</xref>). Similarly, inflammasome signaling was recently shown to be a necessary asset in Purkinje neuron development and mutations in this pathway are associated with increased DNA damage and behavioral deficits (<xref ref-type="bibr" rid="bib72">Lammert et al., 2020</xref>). Finally, microglia, the resident innate immune cell of the CNS, have several roles in CNS development, including phagocytosing cell debris as well as pruning developing synapses and myelin (<xref ref-type="bibr" rid="bib58">Hughes and Appel, 2020</xref>; <xref ref-type="bibr" rid="bib85">Mazaheri et al., 2014</xref>; <xref ref-type="bibr" rid="bib119">Silva et al., 2021</xref>; <xref ref-type="bibr" rid="bib124">Stevens et al., 2007</xref>; <xref ref-type="bibr" rid="bib137">Villani et al., 2019</xref>). To our knowledge, our study is the first examination of the role of inflammation and complement signaling in PNS development beyond the NCC stage (<xref ref-type="bibr" rid="bib18">Carmona-Fontaine et al., 2011</xref>). These data prompt future exploration into this relationship between the nervous and immune systems during PNS formation.</p><p>To further this point, our data indicate that MACs may be involved in enhancing SC proliferation during development. Previous findings in vitro demonstrated that sublytic MACs could stimulate SC proliferation through activation of the MAPK/ERK and PKC pathways (<xref ref-type="bibr" rid="bib28">Dashiell et al., 2000</xref>; <xref ref-type="bibr" rid="bib54">Hila et al., 2001</xref>). These and other mitogenic pathways are also activated in other cells that undergo MAC-stimulated proliferation (<xref ref-type="bibr" rid="bib132">Tegla et al., 2011b</xref>), such as smooth muscle cells, T cells, and oligodendrocytes (<xref ref-type="bibr" rid="bib21">Chauhan and Moore, 2011</xref>; <xref ref-type="bibr" rid="bib112">Rus et al., 1997</xref>; <xref ref-type="bibr" rid="bib111">Rus et al., 1996</xref>; <xref ref-type="bibr" rid="bib132">Tegla et al., 2011b</xref>; <xref ref-type="bibr" rid="bib150">Zwaka et al., 2003</xref>). Collectively, these data have established that MACs induce cell proliferation through activation of Gi protein and Ras/Raf1, which go onto activate MEK1 and ERK1 that then facilitate transcription of cell cycle-related genes, such as CDK4 and CDK2 (<xref ref-type="bibr" rid="bib28">Dashiell et al., 2000</xref>; <xref ref-type="bibr" rid="bib98">Niculescu et al., 1999</xref>; <xref ref-type="bibr" rid="bib97">Niculescu et al., 1997</xref>; <xref ref-type="bibr" rid="bib132">Tegla et al., 2011b</xref>). Simultaneously, PI3K and Akt activate mTOR, P70<sup>S6</sup>, and K<sub>V</sub>1.3 to induce DNA and protein synthesis that aids in cell cycle activation (<xref ref-type="bibr" rid="bib7">Badea et al., 2002</xref>; <xref ref-type="bibr" rid="bib54">Hila et al., 2001</xref>; <xref ref-type="bibr" rid="bib113">Rus et al., 2001</xref>; <xref ref-type="bibr" rid="bib131">Tegla et al., 2011a</xref>; <xref ref-type="bibr" rid="bib132">Tegla et al., 2011b</xref>). At this point, it is unclear whether increased MAC formation in <italic>cd59</italic> mutant SCs leads to activation of these pathways in vivo and whether this mechanism contributes to developmental SC proliferation. Utilizing the tools developed in this study, we look forward to future investigations of these pathways and their role in SC development.</p><p>During our investigation, we also show that <italic>cd59</italic> is expressed in a subset of SCs and OLs and is not expressed in other myelinating glial cells, including MEP glia and SCs that associate with spinal motor nerves. This expression pattern persists at least until 7 dpf in SCs, indicating that developmental heterogeneity lingers in the mature SCs. Furthermore, we show that Cd59 regulates proliferation of sensory SCs on the pLLN but not motor nerve-associated SCs, indicating that these differences in <italic>cd59</italic> expression are associated with functional heterogeneity as well. These findings provoke many topics for further investigation. First, how do <italic>cd59</italic>-positive SCs differ from <italic>cd59</italic>-negative SCs? Does this imply that a subset of SCs is more sensitive to complement activity, or are there other implications for these expression differences? Related, why do motor SCs lack <italic>cd59</italic>? Recent RNAseq analysis of developing satellite glial cells (SGCs) and SCs showed that glial cell precursors, SGCs, and iSCs are heterogenous and that this transcriptional diversity depended on the type of nerve/ganglia they associated with (<xref ref-type="bibr" rid="bib129">Tasdemir-Yilmaz et al., 2021</xref>; <xref ref-type="bibr" rid="bib143">Wiltbank and Kucenas, 2021</xref>). Motor neurons and sensory neurons are transcriptionally and functionally distinct and likely have different demands of the SCs that they are intimately associated with. Therefore, it follows that sensory SC functionality may require Cd59 whereas motor SCs do not. It will be interesting to explore the consequences of this heterogeneity in future investigations.</p><p>We are also curious if Cd59 function is multifaceted in the nervous system. Our findings demonstrated that Cd59 prevents overproliferation of SCs during development by shielding them from developmental inflammation. Similar observations have been noted in T cells and smooth muscle cells (<xref ref-type="bibr" rid="bib74">Li et al., 2013</xref>; <xref ref-type="bibr" rid="bib76">Longhi et al., 2005</xref>). That said, many other functions beyond proliferation control have been documented for CD59. For example, CD59 is required to instruct proximal-distal cell identity, a process that is necessary for proper cell positioning during limb regeneration (<xref ref-type="bibr" rid="bib33">Echeverri and Tanaka, 2005</xref>). In our study, we noted that floor plate and hypochord cells express <italic>cd59</italic>. During neural tube development, floor plate cells play an important role in determining cell fate as well as dorsal-ventral patterning in the spinal cord (<xref ref-type="bibr" rid="bib55">Hirano et al., 1991</xref>; <xref ref-type="bibr" rid="bib146">Yu et al., 2013</xref>), whereas the hypochord orchestrates midline blood vessel pattering (<xref ref-type="bibr" rid="bib22">Cleaver and Krieg, 1998</xref>). Considering the role of CD59 in dictating proximal-distal cell identity during limb regeneration (<xref ref-type="bibr" rid="bib33">Echeverri and Tanaka, 2005</xref>), it would be interesting to see if Cd59 participated in similar signaling pathways in floor plate and hypochord cells. Alternatively, Cd59’s role in dictating proximal-distal cell identity could also be useful during nerve regeneration. Like limb regeneration, there needs to be an appropriate distribution of cells along the proximal-distal axis of the regenerating nerve. With this idea in mind, it would be interesting to examine how Cd59 dysfunction impacts SC distribution after nerve regeneration.</p><p>Finally, our study revealed that Cd59 plays a role in nervous system development. Previous case studies of patients with CD59 dysfunction, such as those with germline PNH and congenital CD59 deficiency, noted early-onset neurological dysfunction in these patients (<xref ref-type="bibr" rid="bib51">Haliloglu et al., 2015</xref>; <xref ref-type="bibr" rid="bib56">Höchsmann and Schrezenmeier, 2015</xref>; <xref ref-type="bibr" rid="bib60">Johnston et al., 2012</xref>; <xref ref-type="bibr" rid="bib62">Karbian et al., 2018</xref>; <xref ref-type="bibr" rid="bib121">Solmaz et al., 2020</xref>). These neurological symptoms were generally attributed to damage from overactivation of complement and excess inflammation (<xref ref-type="bibr" rid="bib56">Höchsmann and Schrezenmeier, 2015</xref>). In support of this idea, eculizumab treatment, which inhibits complement protein 5 (C5) and limits formation of MACs, slowed the progression of severe neurological symptoms, including bulbar symptoms, focal seizures, impaired respiration, and muscular hypotonia. However, eculizumab could not restore full neurological function in these patients (<xref ref-type="bibr" rid="bib56">Höchsmann and Schrezenmeier, 2015</xref>). In light of our recent findings, we propose that CD59 dysfunction could be interfering with nervous system development in these human patients, likely through inflammation-induced overproliferation of SCs and subsequent malformation of myelin and nodes of Ranvier. However, because developmental SC proliferation has completed by the time these patients receive eculizumab (<xref ref-type="bibr" rid="bib25">Cravioto, 1965</xref>; <xref ref-type="bibr" rid="bib56">Höchsmann and Schrezenmeier, 2015</xref>), it is likely too late to restore SC proliferation and preserve nerve development. In future case studies of these patients, it would be interesting to confirm with nerve biopsies whether these patients also have excess SCs and abnormal myelin volume like we have observed in our zebrafish model. In support of this idea, neutrophils isolated from patients with PNH also overproliferate (<xref ref-type="bibr" rid="bib75">Li et al., 2019</xref>), indicating that SCs may do the same. Ultimately, there remain many areas of exploration to fully characterize the role of Cd59 in the developing and mature nervous system.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background<break/>(<italic>Danio rerio</italic>)</td><td align="left" valign="bottom">AB*</td><td align="left" valign="bottom">ZIRC</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:ZFIN_ZDB-GENO-960809-7">ZFIN_ZDB-GENO-960809-7</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. rerio</italic>)</td><td align="left" valign="bottom"><italic>Tg(sox10(4.9):nls-eos)<sup>w18</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib86">McGraw et al., 2012</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:ZFIN_ZDB-ALT-110721-2">ZFIN_ZDB-ALT-110721-2</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. rerio</italic>)</td><td align="left" valign="bottom"><italic>Tg(sox10(4.9):tagrfp)<sup>uva5</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib149">Zhu et al., 2019</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:ZFIN_ZDB-ALT-200513-7">ZFIN_ZDB-ALT-200513-7</ext-link></td><td align="left" valign="bottom">Also referred to as <italic>sox10:tagrfp;</italic> cytoplasmic expression of TagRFP</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. rerio</italic>)</td><td align="left" valign="bottom"><italic>Tg(sox10(7.2):megfp)<sup>sl3</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib66">Kirby et al., 2006</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:ZFIN_ZDB-ALT-150113-6">ZFIN_ZDB-ALT-150113-6</ext-link></td><td align="left" valign="bottom">Also referred to as <italic>sox10:megfp;</italic> membrane-tethered expression of eGFP</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. rerio</italic>)</td><td align="left" valign="bottom"><italic>Tg(mbp(2.0):egfp-caax)<sup>ue2</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib2">Almeida et al., 2011</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:ZFIN_ZDB-ALT-120103-2">ZFIN_ZDB-ALT-120103-2</ext-link></td><td align="left" valign="bottom">Also referred to as <italic>mbp:egfp-caax;</italic> membrane-tethered expression of eGFP</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. rerio</italic>)</td><td align="left" valign="bottom"><italic>gSAIzGFFD37A</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib16">Brown et al., 2022</xref></td><td align="left" valign="bottom"> </td><td align="left" valign="bottom">Also referred to as <italic>Gt(erbb3b:gal4);Tg(uas:egfp</italic>) or <italic>gal4:erbb3b;uas:egfp;</italic> cytoplasmic expression of eGFP</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. rerio</italic>)</td><td align="left" valign="bottom"><italic>Tg(olig2:dsred2)<sup>vu19</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib116">Shin et al., 2003</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:ZFIN_ZDB-FISH-150901">ZFIN_ZDB-FISH-150901</ext-link>-8168</td><td align="left" valign="bottom">Also referred to as <italic>olig2:dsred;</italic> cytoplasmic expression of DsRed2</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. rerio</italic>)</td><td align="left" valign="bottom"><italic>Tg(mbpa(6.6):tagrfp-caax;cry:egfp)<sup>uva53</sup></italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom">Also referred to as <italic>mbpa:tagrfp-caax;</italic> membrane expression of TagRFP; more information found in <italic>‘</italic>Generation of transgenic lines’; available from the Kucenas Lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. rerio</italic>)</td><td align="left" valign="bottom"><italic>Tg(cd59(5.0):tagrfp)<sup>uva52</sup></italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom">Also referred to as <italic>cd59:tagrfp;</italic> cytoplasmic expression of TagRFP; more information found in <italic>‘</italic>Generation of transgenic lines’; available from the Kucenas Lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. rerio</italic>)</td><td align="left" valign="bottom"><italic>cd59<sup>uva48</sup></italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom">15 bp deletion at splice site between exon 2 and intron 2 of <italic>cd59</italic> gene, BX957297.10:g.44_58delTGCTGGGGCTTGGTA; more information found in <italic>‘</italic>Generation of mutant lines<italic>’</italic>; available from the Kucenas Lab</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. rerio</italic>)</td><td align="left" valign="bottom"><italic>cd59<sup>uva47</sup></italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom">6 bp deletion in exon 2 of <italic>cd59</italic> gene, BX957297.10:g.45_50delGCTGGG; more information found in <italic>‘</italic>Generation of mutant lines<italic>’</italic>; available from the Kucenas Lab</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">p5E-cd59(–5.0)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom">More information found in <italic>‘</italic>Generation of transgenic lines<italic>’</italic>; available from the Kucenas Lab</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">p5E-mbpa(–6.6)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom">More information found in ‘Generation of transgenic lines<italic>’</italic>; available from the Kucenas Lab</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pME-tagrfp</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib31">Don et al., 2017</xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pME-tagrfpcaax</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib6">Auer et al., 2015</xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">p3E-polyA</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib69">Kwan et al., 2007</xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pDestTol2pA2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib69">Kwan et al., 2007</xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pDestTol2pA2cryegfp</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib69">Kwan et al., 2007</xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pCS2FA-transposase</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib69">Kwan et al., 2007</xref></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Template for <italic>Tol2</italic> transposase mRNA synthesis</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">MEGAshortscript T7 transcription kit</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# AM1354</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">QIAprep spin miniprep kit</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">Cat# 27106</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">QIAquick PCR purification kit</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">Cat# 28106</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">QIAquick gel extraction kit</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">Cat# 28704</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNeasy mini kit</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">Cat# 74104</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">pENTR 5′-TOPO cloning kit</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# K59120</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">TOPO TA cloning kit</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# K4575J10</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">LR clonase II plus</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# 12538-120</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Click-it EdU cell proliferation kit for imaging. Alexa Fluor 647 dye</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# C11340</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNAscope fluorescent multiplex reagent kit</td><td align="left" valign="bottom">ACD</td><td align="left" valign="bottom">Cat# 320850</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">mMESSAGE mMACHINE sp6 transcription kit</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# AM1340</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ApopTag red in situ apoptosis detection kit</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# S7165</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">High-capacity cDNA reverse transcription kit</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# 4368814</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Glutaraldehyde (electron microscopy grade)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# G7651</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">RNAscope probe diluent</td><td align="left" valign="bottom">ACD</td><td align="left" valign="bottom">Cat# 300041</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">RNAscope probe-Dr-cd59-C2</td><td align="left" valign="bottom">ACD</td><td align="left" valign="bottom">Cat# 561561-C2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DAPI fluoromount-G</td><td align="left" valign="bottom">Southern Biotech</td><td align="left" valign="bottom">Cat# AM1340</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DIG RNA labeling mix</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Cat# 11277073910</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Dexamethasone</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# D1756</td><td align="left" valign="bottom">100 µM, also referred to as Dex</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Instant ocean sea salt</td><td align="left" valign="bottom">ThatFishPlace</td><td align="left" valign="bottom">Cat# 242818</td><td align="left" valign="bottom">0.3 g/L, used to make egg water</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">1-Phenyl-2-thiourea</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# P7629</td><td align="left" valign="bottom">0.004%, also referred to as PTU</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Tricaine-S (MS-222)</td><td align="left" valign="bottom">The Pond Outlet</td><td align="left" valign="bottom">No Cat#</td><td align="left" valign="bottom">Also referred to as tricaine</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Cas9 protein</td><td align="left" valign="bottom">PNA Bio</td><td align="left" valign="bottom">Cat# CP01-50</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Low gelling temperature agarose</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# 9414</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Agar</td><td align="left" valign="bottom">Fisher Scientific</td><td align="left" valign="bottom">Cat# BP1423500</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Sucrose</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# S5016</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">2-Methylbutane</td><td align="left" valign="bottom">Fisher Scientific</td><td align="left" valign="bottom">Cat# 03551-4</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Acridine orange hemi (zinc chloride) salt</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-214488</td><td align="left" valign="bottom">Also referred to as AO</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Diethyl pyrocarbonate</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# D5758</td><td align="left" valign="bottom">1:1000; also referred to as DEPC</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="char" char="." valign="bottom">20× SSC</td><td align="left" valign="bottom">Quality Biological</td><td align="left" valign="bottom">Cat# 351-003-131</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Triton X-100</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# T8787</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">100 bp DNA ladder</td><td align="left" valign="bottom">New England BioLabs Inc.</td><td align="left" valign="bottom">Cat# N3231L</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Sodium cacodylate trihydrate</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# 0250</td><td align="left" valign="bottom">Also referred to as SCT</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Osmium tetroxide (electron microscopy grade)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# 75632</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Uranyl acetate</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib95">Morris et al., 2017</xref></td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">EPON</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib95">Morris et al., 2017</xref></td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Sheep serum</td><td align="left" valign="bottom">Gemini Bioproducts</td><td align="left" valign="bottom">Cat# 100-117</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Goat serum</td><td align="left" valign="bottom">Gemini Bioproducts</td><td align="left" valign="bottom">Cat# 100-109</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Proteinase K</td><td align="left" valign="bottom">Fisher Scientific</td><td align="left" valign="bottom">Cat# BP1700-100</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Bovine serum albumin</td><td align="left" valign="bottom">Fisher Scientific</td><td align="left" valign="bottom">Cat# BP1600-100</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HuC/HuD (mouse monoclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# A-21271</td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-acetylated tubulin (mouse monoclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# T7451</td><td align="left" valign="bottom">(1:10,000); acetylated tubulin; also referred to as tubulin</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Fab fragments anti-digoxigenin-AP (sheep polyclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# 11093274910; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_514497">AB_514497</ext-link></td><td align="char" char="." valign="bottom">(1:5000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-sox10 (rabbit polyclonal)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib12">Binari et al., 2013</xref></td><td align="left" valign="bottom">N/A</td><td align="char" char="." valign="bottom">(1:5000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GFP (chicken polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab13970; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_300798">AB_300798</ext-link></td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-sodium channel, pan (mouse monoclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# S8809</td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TagRFP (rabbit polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# 10367</td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-neurofascin 186 (rabbit polyclonal)</td><td align="left" valign="bottom">Gift from Matthew Rasband</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">(1:200), neurofascin 186; also referred to as NF186</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-C5b-8+C5b-9 (mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab66768</td><td align="left" valign="bottom">(1:500), C5b-8+C5b-9; also referred to membrane attack complex or MAC</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488 anti-chicken IgY (H+L) (goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# A-11039; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534096">AB_2534096</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 647 anti-rabbit IgG (H+L) (goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# A-21244; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535812">AB_2535812</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 647 anti-mouse IgG (H+L) (goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# A-21235; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535804">AB_2535804</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488 anti-mouse IgG (H+L) (goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# A-11001</td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 568 anti-rabbit IgG (H+L) (goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# A-11011</td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">cd59-F (for transgenic construction)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5’-TCAGATCACATCACACCTGA-3'; more information found in ‘Generation of transgenic lines’</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">cd59-R (for transgenic construction)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5’-AATGCCTTCAGTTTACCAGTCT-3'; more information found in ‘Generation of transgenic lines’</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mbpa-F (for transgenic construction)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5’-ATGTCGAGTAATATCGAGCAGC-3'; more information found in <italic>‘</italic>Generation of transgenic lines’</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mbpa-R (for transgenic construction)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib2">Almeida et al., 2011</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5’-GTTGATCTGTTCAGTGGTCTACA-3';</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">cd59-F (for mutant genotyping)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5’-TGGTAAACTGAAGGCATTATGAAA-3'; more information found in <italic>‘</italic>Generation of mutant lines’</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">cd59-R (for mutant genotyping)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5’-GCAGGCATCATCATAGTAGCAG-3'; more information found in <italic>‘</italic>Generation of mutant lines’</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">cd59-F (for RT-PCR analysis)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5'-ATGAAAGCTTCTGTCGGAGTGT-3'; more information found in ‘RT-PCR analysis’</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">cd59-R (for RT-PCR analysis)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5'-TTAGAAAACACCCCACCAGAAG-3'; more information found in ‘RT-PCR analysis’</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">cd59 sgRNA-F (for sgRNA synthesis)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5’-TAATACGACTCACTATAGGGCTGGCTCTGCTGGGGCTGTTTAGAGCTAGAAATAGCAAG-3’; more information found in <italic>‘</italic>Generation of mutant lines’</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Constant oligonucleotide-R (for sgRNA synthesis)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib41">Gagnon et al., 2014</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5’-AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC-3’</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">cd59-F (for CISH RNA probe)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5'-GCCTGCTTGTCTGTCTACGA-3'; more information found in ‘In situ hybridization’</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">cd59-R+T7 (for CISH RNA probe)</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">5'-TAATACGACTCACTATAGAGGTGACGAGATTAGCTGCG-3'; more information found in ‘In situ hybridization’</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ/Fiji</td><td align="left" valign="bottom"/><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism 9.2</td><td align="left" valign="bottom">GraphPad Software</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Metamorph</td><td align="left" valign="bottom">Molecular Devices</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002368">SCR_002368</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Andor iQ 3.6.3</td><td align="left" valign="bottom">Oxford Instruments</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014461">SCR_014461</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Imaris 9.8.0</td><td align="left" valign="bottom">Oxford Instruments</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_007370">SCR_007370</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">RStudio</td><td align="left" valign="bottom">RStudio</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_000432">SCR_000432</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Illustrator</td><td align="left" valign="bottom">Adobe</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_010279">SCR_010279</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">CHOPCHOP</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib71">Labun et al., 2019</xref>; <xref ref-type="bibr" rid="bib70">Labun et al., 2016</xref>; <xref ref-type="bibr" rid="bib41">Gagnon et al., 2014</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://chopchop.cbu.uib.no/">https://chopchop.cbu.uib.no/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">CRISPRscan</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib91">Moreno-Mateos et al., 2015</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.crisprscan.org/">https://www.crisprscan.org/</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Zebrafish husbandry</title><p>All animal studies were approved by the University of Virginia Institutional Animal Care and Use Committee. Adult zebrafish were housed in tanks of 8–10 fish/L in 28.5°C water. Pairwise mating of adult zebrafish generated zebrafish embryos for all experiments. The embryos were raised in egg water (0.3 g instant ocean sea salt per L reverse osmosis water) contained in 10 cm Petri dishes and incubated at 28.5°C. Embryos used for experiments were staged by hpf or dpf (<xref ref-type="bibr" rid="bib64">Kimmel et al., 1995</xref>). To minimize visual obstruction by pigmentation, egg water was exchanged for 0.004% 1-phenyl-2-thiourea (PTU; Sigma) in egg water at 24 hpf. Tricaine-S (MS-222; The Pond Outlet) was utilized as an anesthetic for embryos and larvae used in live imaging and euthanasia. Embryo and larvae sex were undetermined for all experiments because sex cannot be ascertained until ~25 dpf in zebrafish (<xref ref-type="bibr" rid="bib128">Takahashi, 1977</xref>). To maintain genetic diversity, transgenic lines were renewed through outcrossing.</p></sec><sec id="s4-2"><title>Zebrafish transgenic lines</title><p>All transgene descriptions and abbreviations are included in the Key resources table. Transgenic lines produced during this study include <italic>Tg(cd59(5.0):tagrfp)<sup>uva52</sup></italic> and <italic>Tg(mbpa(6.6):tagrfp-caax)<sup>uva53</sup></italic>. The methods used to generate these lines are described in ‘Generation of transgenic lines.’ Previously published strains used in this study include AB*, <italic>Tg(sox10(7.2):megfp)<sup>sl3</sup></italic> (<xref ref-type="bibr" rid="bib66">Kirby et al., 2006</xref>), <italic>Tg(sox10(4.9):tagrfp)<sup>uva5</sup></italic> (<xref ref-type="bibr" rid="bib149">Zhu et al., 2019</xref>), <italic>Gt(erbb3b:gal4);Tg(uas:egfp</italic>) (<xref ref-type="bibr" rid="bib16">Brown et al., 2022</xref>), <italic>Tg(olig2:dsred2)<sup>vu19</sup></italic> (<xref ref-type="bibr" rid="bib116">Shin et al., 2003</xref>), <italic>Tg(sox10(4.9):nls-eos)<sup>w18</sup></italic> (<xref ref-type="bibr" rid="bib86">McGraw et al., 2012</xref>), and <italic>Tg(mbp(2.0):egfp-caax)<sup>ue2</sup></italic> (<xref ref-type="bibr" rid="bib2">Almeida et al., 2011</xref>). All transgenic lines described are stable and incorporated into the germline. In addition to the stable lines, <italic>cd59:tagrfp</italic>, <italic>mbpa:tagrfp-caax</italic> and <italic>mbp:egfp-caax</italic> were also injected into embryos at the one-cell stage to create mosaic labeling (<xref ref-type="bibr" rid="bib63">Kawakami, 2004</xref>).</p></sec><sec id="s4-3"><title>Zebrafish mutant lines</title><p>Mutant lines generated in the course of this study are as follows: <italic>cd59<sup>uva47</sup></italic> (BX957297.10:g.45_50delGCTGGG) and <italic>cd59<sup>uva48</sup></italic> (BX957297.10:g.44_58delTGCTGGGGCTTGGTA). The methods used to generate these lines are described in ‘Generation of mutant lines.’ Mutant and wildtype fish were distinguished with PCR amplification and gel electrophoresis of the mutant allele (see ‘Generation of mutant lines’). Descriptions of all mutant lines and their abbreviations can be found Key resources table.</p></sec><sec id="s4-4"><title>Generation of transgenic lines</title><p>The Tol2kit Gateway-based cloning system was used to produce transgenic constructs (<xref ref-type="bibr" rid="bib69">Kwan et al., 2007</xref>). The following entry and destination vectors were used in the creation of these constructs: <italic>p5E-cd59</italic> (this article)<italic>, p5E-mbpa</italic> (this article), <italic>pME-tagrfp-caax</italic> (<xref ref-type="bibr" rid="bib6">Auer et al., 2015</xref>), <italic>pME-tagrfp</italic> (<xref ref-type="bibr" rid="bib31">Don et al., 2017</xref>), <italic>p3E-polya</italic> (<xref ref-type="bibr" rid="bib69">Kwan et al., 2007</xref>), <italic>pDestTol2pA2</italic> (<xref ref-type="bibr" rid="bib69">Kwan et al., 2007</xref>), and <italic>pDestTol2pA2cryegfp</italic>. These constructs were then used to produce the <italic>Tg(cd59:tagrfp</italic>) and <italic>Tg(mbpa:tagrfp-caax</italic>) zebrafish lines.</p><p>The <italic>Tg(cd59(5.0):tagrfp</italic>) line was generated as follows: PCR amplification of wildtype genomic DNA with forward primer, 5′-<named-content content-type="sequence">TCAGATCACATCACACCTGA</named-content>-3′, and reverse primer, 5′-<named-content content-type="sequence">AATGCCTTCAGTTTACCAGTCT</named-content>-3′, was used to clone 5 kb of the sequence upstream to the <italic>cd59</italic> gene (BX957297.10). The PCR product was purified through with the QIAquick gel extraction kit after gel electrophoresis (QIAGEN). The PCR product was subcloned into a pENTR 5′-TOPO vector (Invitrogen) to create the <italic>p5E-cd59(–5.0</italic>) vector. The resulting p5E-<italic>cd59(5.0</italic>) vector was transformed into chemically competent <italic>Escherichia coli</italic> for amplification, isolated with the QIAprep spin miniprep kit (QIAGEN), and Sanger sequenced to verify accurate assembly. All Sanger sequencing described in the article were conducted through GENEWIZ (Azenta Life Sciences; <ext-link ext-link-type="uri" xlink:href="https://www.genewiz.com/en">https://www.genewiz.com/en</ext-link>). LR reaction (<xref ref-type="bibr" rid="bib5">Ashton et al., 2012</xref>) was used to ligate <italic>p5E-cd59(5.0</italic>) (this article), <italic>pME-tagrfp</italic> (<xref ref-type="bibr" rid="bib31">Don et al., 2017</xref>), <italic>p3E-polya</italic> (<xref ref-type="bibr" rid="bib69">Kwan et al., 2007</xref>), and <italic>pDestTol2pA2</italic> (<xref ref-type="bibr" rid="bib69">Kwan et al., 2007</xref>). The resulting <italic>cd59(5.0):tagrfp</italic> expression vector was transformed into chemically competent <italic>E. coli</italic> for amplification, isolated with the QIAprep spin miniprep kit (QIAGEN), and Sanger sequenced to verify accurate assembly. The stable <italic>Tg(cd59(5.0):tagrfp</italic>) line was established through co-microinjections of <italic>cd59(5.0):tagrfp</italic> expression vector (50 ng/µL) and <italic>Tol2</italic> transposase mRNA (20 ng/µL; mRNA synthesis described in ‘Generation of synthetic mRNA’) in one-cell stage embryos (<xref ref-type="bibr" rid="bib63">Kawakami, 2004</xref>). Founders were screened for germline incorporation of the transgene.</p><p>Similarly, the <italic>Tg(mbpa(6.6):tagrfp-caax</italic>) line was as described for the <italic>Tg(cd59(5.0):tagrfp</italic>) line except: PCR amplification of wildtype genomic DNA with forward primer, 5′-<named-content content-type="sequence">ATGTCGAGTAATATCGAGCAGC</named-content>-3′ (this article), and reverse primer, 5′-<named-content content-type="sequence">GTTGATCTGTTCAGTGGTCTACA</named-content>-3′ (<xref ref-type="bibr" rid="bib2">Almeida et al., 2011</xref>), was used to clone 6.59 kb of the sequence upstream to the <italic>mbpa</italic> gene (CU856623.7). The PCR product was subcloned into a pENTR 5′-TOPO vector (Invitrogen) to create the <italic>p5E-mbpa(–6.6</italic>) vector. LR reaction (<xref ref-type="bibr" rid="bib5">Ashton et al., 2012</xref>) was used to ligate <italic>p5E-mbpa(–6.6</italic>) (this article), <italic>pME-tagrfp-caax</italic> (<xref ref-type="bibr" rid="bib6">Auer et al., 2015</xref>), <italic>p3E-polya</italic> (<xref ref-type="bibr" rid="bib69">Kwan et al., 2007</xref>), and <italic>pDestTol2pA2cryegfp</italic> (<xref ref-type="bibr" rid="bib69">Kwan et al., 2007</xref>). The final <italic>mbpa(6.6):tagrfp-caax</italic> construct and stable zebrafish lines were generated as described for <italic>cd59(5.0):tagrfp</italic>.</p></sec><sec id="s4-5"><title>Generation of mutant lines</title><p><italic>cd59</italic> mutant lines generated during the course of this study were produced using CRISPR/Cas9 genome editing according to the methods described in <xref ref-type="bibr" rid="bib41">Gagnon et al., 2014</xref> except: the sgRNA targeting 5′-<named-content content-type="sequence">GTGCTGGCTCTGCTGGGGCTTGG</named-content>-3′ in the second exon of <italic>cd59</italic> was identified with <italic>CRISPRscan</italic> (<xref ref-type="bibr" rid="bib91">Moreno-Mateos et al., 2015</xref>) and <italic>Chop Chop</italic> (<xref ref-type="bibr" rid="bib70">Labun et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">Labun et al., 2019</xref>; <xref ref-type="bibr" rid="bib41">Gagnon et al., 2014</xref>) and synthesized through PCR amplification with the following primers: forward primer, 5′-<named-content content-type="sequence">taatacgactcactataGGGCTGGCTCTGCTGGGGCTgttttagagctagaaATAGCAAG</named-content>-3′, and constant oligonucleotide reverse primer, 5′-<named-content content-type="sequence">AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC</named-content>-3′ (<xref ref-type="bibr" rid="bib41">Gagnon et al., 2014</xref>). All sgRNA synthesis and cleanup were performed as described in <xref ref-type="bibr" rid="bib41">Gagnon et al., 2014</xref>.</p><p>To generate a mutation in <italic>cd59</italic>, the sgRNA (200 ng/µL) was co-microinjected with Cas9 protein (600 ng/µL; PNA Bio) into embryos at the one-cell stage. Successful insertion and deletion mutation (INDEL) generation was verified according to the <xref ref-type="bibr" rid="bib41">Gagnon et al., 2014</xref> protocol using the following primers: forward primer, 5′-<named-content content-type="sequence">TGGTAAACTGAAGGCATTATGAAA</named-content>-3′, and reverse primer, 5′-<named-content content-type="sequence">GCAGGCATCATCATAGTAGCAG</named-content>-3′.</p><p>To establish stable mutant lines, injected embryos were raised to adulthood and outcrossed with wildtype zebrafish. Founder offspring were screened for germline mutations through PCR amplification of <italic>cd59</italic> with the same genotyping primers listed above. To identify mutant alleles, the resulting PCR product was cloned into pCR4-TOPO TA vector (Invitrogen). Vectors containing <italic>cd59</italic> mutant alleles were amplified in chemically competent <italic>E. coli</italic>, isolated through miniprep (QIAGEN), and sequences were evaluated for INDELs. Founder offspring containing 6 bp (<italic>cd59<sup>uva47</sup></italic>; BX957297.10:g.45_50delGCTGGG) and 15 bp deletions (<italic>cd59<sup>uva48</sup>;</italic> BX957297.10:g.44_58delTGCTGGGGCTTGGTA) in the <italic>cd59</italic> gene were selected for further experimentation and raised to establish stable mutant lines. All subsequent generations were genotyped as described in <xref ref-type="bibr" rid="bib40">Fontenas and Kucenas, 2021</xref> with the same genotyping primers listed above, and the resulting PCR products were screen with gel electrophoresis on a 2.5% agarose gel.</p></sec><sec id="s4-6"><title>Generation of synthetic mRNA</title><p>To aid in transgenic fish creation, <italic>Tol2</italic> transposase mRNA was transcribed from linearized pCS2FA-transposase (<xref ref-type="bibr" rid="bib69">Kwan et al., 2007</xref>) with the mMESSAGE mMACHINE sp6 transcription kit (Invitrogen). The resulting mRNA was co-injected (20 ng/µL) with the transgenic constructs described in ‘Generation of transgenic lines’.</p></sec><sec id="s4-7"><title>RT-PCR analysis</title><p>RNA was extracted with the RNeasy mini kit (QIAGEN) from 72 hpf <italic>cd59<sup>uva48</sup></italic>, cd59<sup>uva47</sup>, and AB* embryos. cDNA libraries were generated from the RNA using the high-capacity cDNA reverse transcription kit (Thermo Fisher). Using the cDNA as a template, PCR amplification was performed with the following primers: forward primer, 5′-<named-content content-type="sequence">ATGAAAGCTTCTGTCGGAGTGT</named-content>-3′, reverse primer, 5′-<named-content content-type="sequence">ATGAAAGCTTCTGTCGGAGTGT</named-content>-3′. The resulting PCR products were visualized with gel electrophoresis on a 2.5% agarose gel.</p><p>To sequence the multiple mutant RNA transcripts found in the <italic>cd59<sup>uva48</sup></italic> mutant, the PCR product was cloned into a pCR4-TOPO TA cloning vector (Invitrogen) as described in ‘Generation of mutant lines.’ The isolated vectors were sequenced and analyzed for INDELs and PTCs with the Expasy protein translation tool (<ext-link ext-link-type="uri" xlink:href="https://web.expasy.org/translate/">https://web.expasy.org/translate/</ext-link>; <xref ref-type="bibr" rid="bib32">Duvaud et al., 2021</xref>). <italic>Cd59<sup>uva48</sup></italic> protein sequences were compared to sequences from <italic>cd59<sup>uva47</sup></italic> and AB* larvae.</p></sec><sec id="s4-8"><title>Confocal imaging</title><p>All embryos were treated with egg water containing PTU (0.004%; Sigma) at 24 hpf to minimize pigmentation obstruction. For in vivo imaging, embryos and larvae (1–7 dpf) were dechorionated manually, if necessary, and anesthetized with 0.01% tricaine-S (MS-222) (The Pond Outlet). Low gelling temperature agarose (0.8%; Sigma) was used to immobilize the anesthetized fish in a 35 mm glass-bottom dish (Greiner). Egg water containing PTU (0.004%; Sigma) and tricaine-S (MS-222) (0.01%; The Pond Outlet) was added to the dish prior to imaging to maintain anesthesia and suppress pigment production. For whole-mount imaging of fixed fish (see ‘Immunofluorescence’), fixed embryos and larvae were immobilized with agarose in a glass-bottom dish prior to imaging. For imaging tissue sections, sections were adhered to microscope slides prior to staining and imaging (see ‘Cryosectioning’ and ‘Immunofluorescence’).</p><p>All fluorescent images were acquired with a ×40 water immersion objective (NA = 1.1) mounted on a motorized Zeiss AxioObserver Z1 microscope equipped with a Quorum WaveFX-XI (Quorum Technologies) or Andor CSU-W (Andor Oxford Instruments plc.) spinning disc confocal system. Time-lapse experiments were imaged every 10 min for 7–24 hr, depending on the experiment. Z stacks were acquired at each time point for time-lapse imaging as well as single-time point imaging for fixed whole-mount and sectioned tissue (see ‘Immunofluorescence,’ ‘In situ hybridization,’ and ‘Cryosectioning’).</p><p>All experiments involving whole embryos and larvae were imaged with the 12th somite at the center of the acquisition window to control for stage of anterior–posterior development. Exceptions include (1) images of mosaic labeling with transgenic constructs, which were acquired regardless of anterior–posterior position, (2) images of Na<sub>V</sub> channels and NF183, which were acquired from the 3rd to the 13th somite to ensure accurate assessment of nodes of Ranvier that are not evenly distributed along nerves, (3) images of the pLLG, which is anterior to the pLLN. All imaging of mosaic labeling as well as myelin volume quantification were obtained in live fish.</p><p>Images and videos were processed with either Metamorph (Molecular Devices) or IQ3 (Oxford Instruments). Fiji (ImageJ; <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/">imageJ.nih.gov</ext-link>), Imaris 9.8 (Oxford Instruments), and Illustrator (Adobe) were used for annotating videos and images, adjusting contrast and brightness, and data analysis.</p></sec><sec id="s4-9"><title>Cryosectioning</title><p>Fixed larvae were mounted in sectioning agar (1.5% agar; Fisher Scientific; 5% sucrose; Sigma; 100 mL ultrapure water) and cryopreserved in 30% sucrose in ultrapure water (Sigma) overnight at 4°C. The agar blocks were frozen by placing them on a small raft floating on 2-methylbutane (Fisher Scientific), the container of which was submerged in a bath of liquid nitrogen. The blocks were sectioned to 20 µm with a cryostat microtome and mounted on microscope slides (VWR). The sections were stored at –20°C until needed for immunofluorescence, ISH, or confocal imaging.</p><p>Prior to sectioning the offspring of heterozygous <italic>cd59</italic> mutant parents, the larvae were anesthetized in egg water with 0.01% tricaine-s (MS-222; The Pond Outlet). The heads were removed with a razor blade. The heads were kept for genotyping, and the trunks were fixed for sectioning.</p></sec><sec id="s4-10"><title>Immunofluorescence</title><p>Larvae (24 hpf to 7 dpf) were fixed in 4% paraformaldehyde (PFA; Sigma) for 1 hr shaking at room temperature (RT) for all experiments except Na<sub>V</sub> channel and NF186 staining, in which samples were fixed for 30 min.</p><p>For whole-mount imaging of embryo and larvae, the samples were prepared as described in <xref ref-type="bibr" rid="bib40">Fontenas and Kucenas, 2021</xref>. The following antibodies were used for whole-mount immunofluorescence staining: mouse anti-acetylated tubulin (1:10,000; Sigma), rabbit anti-sox10 (1:5000) (<xref ref-type="bibr" rid="bib12">Binari et al., 2013</xref>), chicken anti-GFP (1:500; Abcam), mouse anti-sodium channel (1:500; Sigma), rabbit anti-TagRFP (1:500; Invitrogen), rabbit anti-neurofascin 186 (1:200; gift from Dr. Matthew Rasband), mouse anti-C5b-8+C5b-9 (1:500; Abcam), Alexa Fluor 488 goat anti-chicken IgG(H+L) (1:1000; Thermo Fisher), Alexa Fluor 647 goat anti-rabbit IgG(H+L) (1:1000; Thermo Fisher), Alexa Fluor 647 goat anti-mouse IgG(H+L) (1:1000; Thermo Fisher), Alexa Fluor 488 goat anti-mouse IgG(H+L) (1:1000; Thermo Fisher), and Alexa Fluor 568 goat anti-rabbit IgG(H+L) (1:1000; Thermo Fisher). Fish were immobilized and imaged in glass-bottom dishes as described in ‘Confocal imaging’.</p><p>For imaging of tissue sections, the samples were prepared as described in <xref ref-type="bibr" rid="bib40">Fontenas and Kucenas, 2021</xref>. The following antibodies were used for staining tissue sections: mouse anti-HuC/HuD (1:500; Invitrogen), rabbit anti-sox10 (1:5000) (<xref ref-type="bibr" rid="bib12">Binari et al., 2013</xref>), Alexa Fluor 488 goat anti-mouse IgG(H+L) (1:1000; Thermo Fisher), and Alexa Fluor 647 goat anti-rabbit IgG(H+L) (1:1000; Thermo Fisher). After staining, all slides were mounted in DAPI fluoromount-G (Southern Biotech) and were coverslipped (VWR). The slides were stored in the dark until they were imaged as described in ‘Confocal imaging’.</p></sec><sec id="s4-11"><title>In situ hybridization</title><sec id="s4-11-1"><title>Probe synthesis</title><p>The <italic>cd59</italic> RNA probe for CISH was designed and synthesized in our lab. RNA was isolated from 3 dpf larvae with the RNeasy mini kit (QIAGEN). A cDNA library was generated from the 3 dpf RNA using the high-capacity cDNA reverse transcription kit (Thermo Fisher). This cDNA was used as a template for the <italic>cd59</italic> RNA probe. The primers used to generate the <italic>cd59</italic> RNA probe were as follows: forward primer, 5'-<named-content content-type="sequence">GCCTGCTTGTCTGTCTACGA</named-content>-3', and reverse primer plus T7 sequence, 5'-<named-content content-type="sequence">TAATACGACTCACTATAGAGGTGACGAGATTAGCTGCG</named-content>-3'. In addition to the <italic>cd59</italic> RNA probe, we also used previously published probes targeting <italic>sox10</italic> (<xref ref-type="bibr" rid="bib101">Park and Appel, 2003</xref>) and <italic>mbpa</italic> (<xref ref-type="bibr" rid="bib15">Brösamle and Halpern, 2002</xref>). CISH probe synthesis was performed as described in <xref ref-type="bibr" rid="bib40">Fontenas and Kucenas, 2021</xref>. For fluorescent in situ hybridization experiments (FISH), the <italic>cd59</italic> RNA probe (RNAscope probe-Dr-cd59-C2) was purchased from Advanced Cell Diagnostics (ACD).</p></sec><sec id="s4-11-2"><title>Chromogenic in situ hybridization</title><p>Embryos and larvae (1–7 dpf) were dechorionated, if necessary, and fixed in 4% PFA for 1 hr shaking at RT and then transferred to 100% MeOH overnight at –20°C. CISH was performed as described in <xref ref-type="bibr" rid="bib53">Hauptmann and Gerster, 2000</xref>. Images were obtained either using a Zeiss AxioObserver inverted microscope equipped with Zen, using a ×40 oil immersion objective, or a Zeiss AxioObserver Z1 microscope equipped with a Quorum WaveFX-XI (Quorum Technologies) or Andor CSU-W (Andor Oxford Instruments plc.) spinning disc confocal system. Fiji (ImageJ; <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/">imageJ.nih.gov</ext-link>) and Illustrator (Adobe) were used for annotating images, adjusting contrast and brightness, and data analysis.</p></sec><sec id="s4-11-3"><title>Fluorescent in situ hybridization</title><p>Larvae (1–7 dpf) were dechorionated, if necessary, and fixed with 4% PFA (Sigma) for 1 hr shaking at RT, dehydrated in 100% MeOH overnight at –20°C, and cryosectioned (see ‘Cryosectioning’). The agar was gently removed by soaking the slides in 1× DEPC PBS (1:1000 diethyl pyrocarbonate [DEPC; Sigma] in 1× PBS; DEPC inactivated by autoclave).</p><p>To perform FISH, we used the RNAscope fluorescent multiplex reagent kit (ACD) with the following protocol modified from <xref ref-type="bibr" rid="bib50">Gross-Thebing et al., 2014</xref>: for all of subsequent steps, the slides kept in the dark and were coverslipped (VWR) during incubations except for during washes. To permeabilize the tissue, the sections were treated with Protease III (two drops) and incubated at RT for 20 min. The tissue was gently rinsed three times with 1× DEPC PBS and washed with 1× DEPC PBS for 10 min at RT followed by an addition three rinses in 1× DEPC PBS. The sections were then hybridized with <italic>cd59</italic> probe (1:100 RNAscope probe-Dr-cd59-C2 in RNAscope probe diluent; ACD) in a 40°C water bath overnight. The tissue was rinsed three times with 1× DEPC PBS and washed in 0.2× SSCT (0.2× SSC [Quality Biological] and 0.1% Triton X-100 [Sigma] in DEPC water [1:1000 DEPC in ultrapure water; DEPC inactivated by autoclave]) for 10 min and then rinsed again three times with 1× DEPC PBS. This rinse/wash routine was repeated between the following fixation and amplification steps: 4% PFA (5 min at RT), Amp1 (two drops, 30 min at 40°C), Amp2 (two drops, 15 min at 40°C), Amp3 (two drops, 30 min at 40°C), Amp4C (two drops, 15 min at 40°C), and DAPI (two drops, 30 min at RT). After a final rinse/wash, the slides were coverslipped (VWR) with 0.2× SSCT and stored at 4°C until imaged. Sections were imaged as described in ‘Confocal imaging’.</p></sec></sec><sec id="s4-12"><title>Cell death assays</title><sec id="s4-12-1"><title>AO incorporation assay</title><p>To label cell death, 48 hpf embryos were labeled with AO according to the protocol in <xref ref-type="bibr" rid="bib79">Lyons et al., 2005</xref>. Fish were immobilized and imaged in glass-bottom dishes as described in ‘Confocal imaging’.</p></sec><sec id="s4-12-2"><title>TUNEL assay</title><p>To label cell death, 48 hpf embryos were fixed in 4% PFA for 1 hr shaking at RT and then sectioned (see ‘Cryosectioning’). TUNEL staining was performed with the ApopTag red in situ apoptosis detection kit (Sigma) and followed by immunofluorescence for Sox10 (see ‘Immunofluorescence’). Sections were imaged as described in ‘Confocal imaging’.</p></sec></sec><sec id="s4-13"><title>EdU incorporation assay</title><p>To label mitotically active cells, embryos were incubated in EdU (0.4 mM EdU [Invitrogen], 4% DMSO [Sigma], and egg water containing 0.004% PTU [Sigma]) from 48 to 55 hpf. The embryos were then fixed in 4% PFA for 1 hr shaking at RT and permeabilized as described in ‘Immunofluorescence.’ We stained for EdU with the Click-it EdU cell proliferation kit for imaging (Alexa Fluor 647 dye; Invitrogen) as described in the kit protocol. The Click-it reaction was performed for 1 hr shaking at RT. The embryos were washed overnight shaking at 4°C in 1× PBSTx. Additional washes were performed as necessary until the yolk sacs were no longer blue. Fish were immobilized and imaged in glass-bottom dishes as described in ‘Confocal imaging’.</p></sec><sec id="s4-14"><title>Dexamethasone treatment</title><p>To inhibit inflammation, embryos were incubated in 1% DMSO (Sigma) or 1% DMSO plus 100 µM Dex (Sigma) at 28.5°C. Dex concentration was chosen based on a previously published dose–response study in zebrafish larvae (<xref ref-type="bibr" rid="bib142">Wilson et al., 2016</xref>; <xref ref-type="bibr" rid="bib141">Wilson et al., 2013</xref>). For embryos fixed at 55 hpf, the embryos were treated with DMSO or Dex from 24 to 55 hpf. For larvae fixed at 7 dpf, the embryos were treated from 24 to 75 hpf and then transferred to egg water containing PTU (0.004%; Sigma).</p></sec><sec id="s4-15"><title>Transmission electron microscopy</title><p>Headless larvae (7 dpf) were fixed for 3 days at 4<sup>o</sup>C in EM fixation buffer (2% EM-grade glutaraldehyde [Sigma], 2% PFA [Sigma], 0.1 M sodium cacodylate trihydrate, pH 7.3 [SCT; Sigma] in ultrapure water) and washed three times for 10 min each in 0.1 M SCT. The samples were post-fixed in 1% osmium tetroxide (Sigma) in 0.1 M SCT for 1 hr at 4°C and washed three times for 5 min each in ultrapure water at RT. Contrast was initiated with 2% uranyl acetate for 1 hr at RT and washed four times for 5 min each in ultrapure water at RT. The samples were dehydrated as follows: 40% EtOH (2 × 10 min), 60% (2 × 10 min), 80% (2 × 10 min), 100% (2 × 10 min), acetone (2 min), and acetone/EPON (1:1, 15 min). The samples were then incubated in EPON at 4°C overnight with the lid open to allow for gas to escape. Samples were mounted in EPON and polymerized at 60°C for 48 hr. Tissue blocks were sectioned transversely, stained, and imaged according to the methods described in <xref ref-type="bibr" rid="bib95">Morris et al., 2017</xref>. Sections were collected from three parts of the larvae, separated by 100 µm (according to the myelin length data noted in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>, most myelin sheaths are less than 100 µm; separating each section by 100 µm would therefore enable quantification of three separate groups of SCs per pLLN) to enable quantification of three groups of SCs per pLLN.</p></sec><sec id="s4-16"><title>RNAseq analysis</title><p>Published bulk and scRNAseq datasets from zebrafish and rodents were evaluated for <italic>cd59</italic> expression. The chosen datasets included analysis of some or many stages of myelinating glial cell development. Visualization and quantification of <italic>cd59</italic> expression were obtained through the applications included with the publications when possible (publications cited in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) with the following exceptions: (1) TPM quantification of bulk RNAseq of zebrafish myelinating glial cells was acquired from data analyzed in <xref ref-type="bibr" rid="bib105">Piller et al., 2021</xref>; <xref ref-type="bibr" rid="bib149">Zhu et al., 2019</xref>. (2) analysis of NCC lineage scRNAseq in zebrafish from the dataset presented in <xref ref-type="bibr" rid="bib114">Saunders et al., 2019</xref> was performed as follows: tissue collection, FACS, RT-PCR, single-cell collection, library construction, sequencing, read alignment to Ensembl GRCz11, and preliminary data processing were performed as described by <xref ref-type="bibr" rid="bib114">Saunders et al., 2019</xref>, and the data were accessed through GEO via accession <ext-link ext-link-type="uri" xlink:href="https://www-ncbi-nlm-nih-gov.liboff.ohsu.edu/geo/query/acc.cgi?acc=GSE131136">GSE131136</ext-link>. Dimensionality reduction and projection of cells in two dimensions were performed using uniform manifold approximation and projection (UMAP) (<xref ref-type="bibr" rid="bib87">McInnes et al., 2018</xref>) and Louvain clustering (<xref ref-type="bibr" rid="bib13">Blondel et al., 2008</xref>). Cell cluster visualization and analysis were performed using the FindMarkers, FeaturePlot, DimPlot, and VlnPlot functions of Seurat package 4.0.0 (<xref ref-type="bibr" rid="bib52">Hao et al., 2021</xref>).</p></sec><sec id="s4-17"><title>Quantification and statistical analysis</title><sec id="s4-17-1"><title>Nerve volume quantification</title><p>Myelinated nerve and axon volume were quantified by creating a surface rendering of the imaged nerve using Imaris 9.8 (Oxford Instruments). The total volume of each surface rendering was quantified with Imaris 9.8 (Oxford Instruments).</p></sec><sec id="s4-17-2"><title>Myelin length quantification</title><p>Myelin length was measured from images of mosaic <italic>mbpa:tagrfp-caax</italic> labeling using Fiji (ImageJ; <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/">imageJ.nih.gov</ext-link>). Specifically, the length of the myelin sheath was traced with the ‘freehand line’ tool. The length was then quantified with the ‘measure’ tool.</p></sec><sec id="s4-17-3"><title>Axon myelination quantification</title><p>The number of myelin wraps around an axon, as well as the number of myelinated axons per pLLN, was measured in electron micrographs of pLLNs using Fiji (ImageJ; <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/">imageJ.nih.gov</ext-link>). Counting was performed with the ‘multi-point’ and ‘measure’ tools.</p></sec><sec id="s4-17-4"><title>Na<sub>V</sub> channel, NF186, cd59 RNAscope, and MAC quantification</title><p>Puncta quantification (specifically for quantification of Na<sub>V</sub> channels, NF186, <italic>cd59</italic> RNAscope, and MAC quantification) was performed either in Fiji (ImageJ; <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/">imageJ.nih.gov</ext-link>) or Imaris (Oxford Instruments). To ensure only puncta within the pLLN were quantified, each z plane was quantified manually.</p></sec><sec id="s4-17-5"><title>Cell number quantification</title><p>SC, neuron, and NCC images on the pLLN and in the CNS were quantified in Fiji (ImageJ; <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/">imageJ.nih.gov</ext-link>) by creating z projections and counting the number of cells with the ‘multi-point’ and ‘measure’ tools. pLLG neurons and NCCs were counted manually in Imaris 9.8 (Oxford Instruments).</p></sec><sec id="s4-17-6"><title>Mitotic event quantification</title><p>Time-lapse images of developing SCs were evaluated for mitotic events (cell divisions) of <italic>sox10:tagrfp</italic>-positive SCs along the pLLN using Fiji (ImageJ; <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/">imageJ.nih.gov</ext-link>). Mitotic events were defined as follows: SC rounds up, chromatic condenses (darkening of the SC), and division of the daughter cells. The number of mitotic events was quantified with the ‘multi-point’ and ‘measure’ tools. Mitotic events in the representative videos were annotated arrows using the ‘draw arrow in movies’ plugin (<xref ref-type="bibr" rid="bib27">Daetwyler et al., 2020</xref>).</p></sec><sec id="s4-17-7"><title>Statistical analysis</title><p>Student’s <italic>t</italic>-tests, as well as one-way and two-way ANOVAs followed by Tukey’s multiple-comparison tests, were performed using Prism 9.2 (GraphPad Software). The data in plots and the text are presented as means ± SEM.</p></sec><sec id="s4-17-8"><title>Data blinding</title><p>For offspring of heterozygous parents, embryos chosen for experimentation were blindly selected (wildtype and mutant embryos are indistinguishable by eye). Embryo genotype was revealed after imaging and before quantification. For offspring of homozygous parents, embryo genotype was known throughout the entire experiment.</p></sec></sec><sec id="s4-18"><title>Artwork</title><p>All artworks were created in Illustrator (Adobe) by Ashtyn T. Wiltbank. SC and OL development figures (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>) were based on previous schematics and electron micrographs shown in <xref ref-type="bibr" rid="bib1">Ackerman and Monk, 2016</xref>; <xref ref-type="bibr" rid="bib26">Cunningham and Monk, 2018</xref>; <xref ref-type="bibr" rid="bib59">Jessen and Mirsky, 2005</xref>.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Validation</p></fn><fn fn-type="con" id="con3"><p>Methodology</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Funding acquisition, Project administration, Supervision, Validation, Writing – original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal studies were approved by the University of Virginia Institutional Animal Care and Use Committee, protocol #3782.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-76640-transrepform1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated and analyzed during this study are included in the manuscript and supporting source files for Figures 1 to 8. All previously published datasets analyzed, including RNAseq and proteomics, are cited in the manuscript.</p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset1"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>AGA</given-names></name><name><surname>Baker</surname><given-names>PA</given-names></name><name><surname>Ibarra-García-Padilla</surname><given-names>R</given-names></name><name><surname>Moore</surname><given-names>JA</given-names></name><name><surname>Rivas</surname><given-names>LJ</given-names></name><name><surname>Tallman</surname><given-names>JJ</given-names></name><name><surname>Singleton</surname><given-names>EW</given-names></name><name><surname>Westheimer</surname><given-names>JL</given-names></name><name><surname>Corteguera</surname><given-names>JA</given-names></name><name><surname>Uribe</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>An atlas of neural crest lineages along the posterior developing zebrafish at single-cell resolution</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE152906">GSE152906</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Crowley</surname><given-names>SC</given-names></name><name><surname>Latimer</surname><given-names>AJ</given-names></name><name><surname>Lewis</surname><given-names>GM</given-names></name><name><surname>Nash</surname><given-names>R</given-names></name><name><surname>Kucenas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Migratory Neural Crest Cells Phagocytose Dead Cells in the Developing Nervous System</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE135237">GSE135237</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Gerber</surname><given-names>D</given-names></name><name><surname>Pereira</surname><given-names>JA</given-names></name><name><surname>Gerber</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>G</given-names></name><name><surname>Dimitrieva</surname><given-names>S</given-names></name><name><surname>Yángüez</surname><given-names>E</given-names></name><name><surname>Suter</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Transcriptional profiling of mouse peripheral nerves to the single-cell level to build a sciatic nerve ATlas (SNAT)</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE137870">GSE137870</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Marisca</surname><given-names>R</given-names></name><name><surname>Hoche</surname><given-names>T</given-names></name><name><surname>Agirre</surname><given-names>E</given-names></name><name><surname>Hoodless</surname><given-names>LJ</given-names></name><name><surname>Barkey</surname><given-names>W</given-names></name><name><surname>Auer</surname><given-names>F</given-names></name><name><surname>Castelo-Branco</surname><given-names>G</given-names></name><name><surname>Czopka</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Functionally distinct subgroups of oligodendrocyte precursor cells integrate neural activity and execute myelin formation</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE132166">GSE132166</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset5"><person-group person-group-type="author"><name><surname>Marques</surname><given-names>S</given-names></name><name><surname>Zeisel</surname><given-names>A</given-names></name><name><surname>Codeluppi</surname><given-names>S</given-names></name><name><surname>Bruggen</surname><given-names>D</given-names></name><name><surname>Falcão</surname><given-names>AM</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Häring</surname><given-names>M</given-names></name><name><surname>Hochgerner</surname><given-names>H</given-names></name><name><surname>Romanov</surname><given-names>RA</given-names></name><name><surname>Gyllborg</surname><given-names>D</given-names></name><name><surname>Muñoz-Manchado</surname><given-names>AB</given-names></name><name><surname>Manno</surname><given-names>GL</given-names></name><name><surname>Lönnerberg</surname><given-names>P</given-names></name><name><surname>Floriddia</surname><given-names>EM</given-names></name><name><surname>Rezayee</surname><given-names>F</given-names></name><name><surname>Ernfors</surname><given-names>P</given-names></name><name><surname>Arenas</surname><given-names>E</given-names></name><name><surname>Hjerling-Leffler</surname><given-names>J</given-names></name><name><surname>Harkany</surname><given-names>T</given-names></name><name><surname>Richardson</surname><given-names>WD</given-names></name><name><surname>Linnarsson</surname><given-names>S</given-names></name><name><surname>Castelo-Branco</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75330">GSE75330</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset6"><person-group person-group-type="author"><name><surname>Marques</surname><given-names>S</given-names></name><name><surname>Bruggen</surname><given-names>D</given-names></name><name><surname>Vanichkina</surname><given-names>DP</given-names></name><name><surname>Floriddia</surname><given-names>EM</given-names></name><name><surname>Munguba</surname><given-names>H</given-names></name><name><surname>Väremo</surname><given-names>L</given-names></name><name><surname>Giacomello</surname><given-names>S</given-names></name><name><surname>Falcão</surname><given-names>AM</given-names></name><name><surname>Meijer</surname><given-names>M</given-names></name><name><surname>Björklund</surname><given-names>ÅK</given-names></name><name><surname>Hjerling-Leffler</surname><given-names>J</given-names></name><name><surname>Taft</surname><given-names>RJ</given-names></name><name><surname>Castelo-Branco</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Transcriptional Convergence of Oligodendrocyte Lineage Progenitors during Development</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE95194">GSE95194</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset7"><person-group person-group-type="author"><name><surname>Piller</surname><given-names>M</given-names></name><name><surname>Werkman</surname><given-names>IL</given-names></name><name><surname>Brown</surname><given-names>EA</given-names></name><name><surname>Latimer</surname><given-names>AJ</given-names></name><name><surname>Kucenas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Glutamate Signaling via the AMPAR Subunit GluR4 Regulates Oligodendrocyte Progenitor Cell Migration in the Developing Spinal Cord</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE174486">GSE174486</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset8"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>LM</given-names></name><name><surname>Mishra</surname><given-names>AK</given-names></name><name><surname>Aman</surname><given-names>AJ</given-names></name><name><surname>Lewis</surname><given-names>VM</given-names></name><name><surname>Toomey</surname><given-names>MB</given-names></name><name><surname>Packer</surname><given-names>JS</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>McFaline-Figueroa</surname><given-names>JL</given-names></name><name><surname>Corbo</surname><given-names>JC</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Parichy</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Thyroid hormone regulates distinct paths to maturation in pigment cell lineages</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE131136">GSE131136</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset9"><person-group person-group-type="author"><name><surname>Wolbert</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Heming</surname><given-names>M</given-names></name><name><surname>Mausberg</surname><given-names>AK</given-names></name><name><surname>Akkermann</surname><given-names>D</given-names></name><name><surname>Frydrychowicz</surname><given-names>C</given-names></name><name><surname>Fledrich</surname><given-names>R</given-names></name><name><surname>Groeneweg</surname><given-names>L</given-names></name><name><surname>Schulz</surname><given-names>C</given-names></name><name><surname>Stettner</surname><given-names>M</given-names></name><name><surname>Gonzalez</surname><given-names>NA</given-names></name><name><surname>Wiendl</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Redefining the heterogeneity of peripheral nerve cells in health and autoimmunity</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE142541">GSE142541</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset10"><person-group person-group-type="author"><name><surname>Siems</surname><given-names>SB</given-names></name><name><surname>Jahn</surname><given-names>O</given-names></name><name><surname>Hoodless</surname><given-names>LJ</given-names></name><name><surname>Jung</surname><given-names>RB</given-names></name><name><surname>Hesse</surname><given-names>D</given-names></name><name><surname>Möbius</surname><given-names>W</given-names></name><name><surname>Czopka</surname><given-names>T</given-names></name><name><surname>Werner</surname><given-names>HB</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Proteome Profile of Myelin in the Zebrafish Brain</data-title><source>ProteomeXchange</source><pub-id pub-id-type="accession" xlink:href="http://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD023037">PXD023037</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Lori Tocke for zebrafish care and members of the Kucenas Lab for valuable discussions. We thank Drs. Laura Fontenas, Xiaowei Lu, Sarah E Siegrist, John R Lukens, and Scott Zeitlin for helpful suggestions and training. We thank Drs. Laura Fontenas, Alev Erisir, Stacey J Criswell, Natalia Dworak, and the Advanced Microscopy Facility for assistance with EM sample preparation and microscope training. We thank Dr. Matthew N Rasband for the NF186 antibody. We thank Dr. David M Parichy for his advice and for sharing scRNAseq data from (<xref ref-type="bibr" rid="bib114">Saunders et al., 2019</xref>). This work was funded by the NIH/National Institutes of Neurological Disorders and Stroke (NINDS): R01NS107525 (SK) and The Owens Family Foundation (SK).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ackerman</surname><given-names>SD</given-names></name><name><surname>Monk</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The scales and tales of myelination: using zebrafish and mouse to study myelinating glia</article-title><source>Brain Research</source><volume>1641</volume><fpage>79</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2015.10.011</pub-id><pub-id pub-id-type="pmid">26498880</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>RG</given-names></name><name><surname>Czopka</surname><given-names>T</given-names></name><name><surname>Ffrench-Constant</surname><given-names>C</given-names></name><name><surname>Lyons</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Individual axons regulate the myelinating potential of single oligodendrocytes in vivo</article-title><source>Development (Cambridge, England)</source><volume>138</volume><fpage>4443</fpage><lpage>4450</lpage><pub-id pub-id-type="doi">10.1242/dev.071001</pub-id><pub-id pub-id-type="pmid">21880787</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>R.G</given-names></name><name><surname>Lyons</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>On Myelinated Axon Plasticity and Neuronal Circuit Formation and Function</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>10023</fpage><lpage>10034</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3185-16.2017</pub-id><pub-id pub-id-type="pmid">29046438</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>RG</given-names></name><name><surname>Williamson</surname><given-names>JM</given-names></name><name><surname>Madden</surname><given-names>ME</given-names></name><name><surname>Early</surname><given-names>JJ</given-names></name><name><surname>Voas</surname><given-names>MG</given-names></name><name><surname>Talbot</surname><given-names>WS</given-names></name><name><surname>Bianco</surname><given-names>IH</given-names></name><name><surname>Lyons</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Myelination induces axonal hotspots of synaptic vesicle fusion that promote sheath growth</article-title><source>Current Biology</source><volume>31</volume><fpage>3743</fpage><lpage>3754</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2021.06.036</pub-id><pub-id pub-id-type="pmid">34270947</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashton</surname><given-names>RS</given-names></name><name><surname>Conway</surname><given-names>A</given-names></name><name><surname>Pangarkar</surname><given-names>C</given-names></name><name><surname>Bergen</surname><given-names>J</given-names></name><name><surname>Lim</surname><given-names>KI</given-names></name><name><surname>Shah</surname><given-names>P</given-names></name><name><surname>Bissell</surname><given-names>M</given-names></name><name><surname>Schaffer</surname><given-names>DV</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Astrocytes regulate adult hippocampal neurogenesis through ephrin-B signaling</article-title><source>Nature Neuroscience</source><volume>15</volume><fpage>1399</fpage><lpage>1406</lpage><pub-id pub-id-type="doi">10.1038/nn.3212</pub-id><pub-id pub-id-type="pmid">22983209</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auer</surname><given-names>TO</given-names></name><name><surname>Xiao</surname><given-names>T</given-names></name><name><surname>Bercier</surname><given-names>V</given-names></name><name><surname>Gebhardt</surname><given-names>C</given-names></name><name><surname>Duroure</surname><given-names>K</given-names></name><name><surname>Concordet</surname><given-names>JP</given-names></name><name><surname>Wyart</surname><given-names>C</given-names></name><name><surname>Suster</surname><given-names>M</given-names></name><name><surname>Kawakami</surname><given-names>K</given-names></name><name><surname>Wittbrodt</surname><given-names>J</given-names></name><name><surname>Baier</surname><given-names>H</given-names></name><name><surname>Del Bene</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Deletion of a kinesin I motor unmasks a mechanism of homeostatic branching control by neurotrophin-3</article-title><source>eLife</source><volume>4</volume><elocation-id>e05061</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.05061</pub-id><pub-id pub-id-type="pmid">26076409</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badea</surname><given-names>T</given-names></name><name><surname>Niculescu</surname><given-names>F</given-names></name><name><surname>Soane</surname><given-names>L</given-names></name><name><surname>Fosbrink</surname><given-names>M</given-names></name><name><surname>Sorana</surname><given-names>H</given-names></name><name><surname>Rus</surname><given-names>V</given-names></name><name><surname>Shin</surname><given-names>ML</given-names></name><name><surname>Rus</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase</article-title><source>The Journal of Biological Chemistry</source><volume>277</volume><fpage>502</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109354200</pub-id><pub-id pub-id-type="pmid">11687586</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron</surname><given-names>W</given-names></name><name><surname>Hoekstra</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>On the biogenesis of myelin membranes: sorting, trafficking and cell polarity</article-title><source>FEBS Letters</source><volume>584</volume><fpage>1760</fpage><lpage>1770</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2009.10.085</pub-id><pub-id pub-id-type="pmid">19896485</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayly-Jones</surname><given-names>C</given-names></name><name><surname>Bubeck</surname><given-names>D</given-names></name><name><surname>Dunstone</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The mystery behind membrane insertion: a review of the complement membrane attack complex</article-title><source>Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences</source><volume>372</volume><elocation-id>20160221</elocation-id><pub-id pub-id-type="doi">10.1098/rstb.2016.0221</pub-id><pub-id pub-id-type="pmid">28630159</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>BEN GEREN</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1954">1954</year><article-title>The formation from the Schwann cell surface of myelin in the peripheral nerves of chick embryos</article-title><source>Experimental Cell Research</source><volume>7</volume><fpage>558</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1016/s0014-4827(54)80098-x</pub-id><pub-id pub-id-type="pmid">13220597</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>P</given-names></name><name><surname>Niemann</surname><given-names>A</given-names></name><name><surname>Suter</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease)</article-title><source>Glia</source><volume>54</volume><fpage>243</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1002/glia.20386</pub-id><pub-id pub-id-type="pmid">16856148</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binari</surname><given-names>LA</given-names></name><name><surname>Lewis</surname><given-names>GM</given-names></name><name><surname>Kucenas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Perineurial glia require Notch signaling during motor nerve development but not regeneration</article-title><source>The Journal of Neuroscience</source><volume>33</volume><fpage>4241</fpage><lpage>4252</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4893-12.2013</pub-id><pub-id pub-id-type="pmid">23467342</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blondel</surname><given-names>VD</given-names></name><name><surname>Guillaume</surname><given-names>JL</given-names></name><name><surname>Lambiotte</surname><given-names>R</given-names></name><name><surname>Lefebvre</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Fast unfolding of communities in large networks</article-title><source>Journal of Statistical Mechanics</source><volume>2008</volume><elocation-id>10008</elocation-id><pub-id pub-id-type="doi">10.1088/1742-5468/2008/10/P10008</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bremer</surname><given-names>M</given-names></name><name><surname>Fröb</surname><given-names>F</given-names></name><name><surname>Kichko</surname><given-names>T</given-names></name><name><surname>Reeh</surname><given-names>P</given-names></name><name><surname>Tamm</surname><given-names>ER</given-names></name><name><surname>Suter</surname><given-names>U</given-names></name><name><surname>Wegner</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Sox10 is required for Schwann-cell homeostasis and myelin maintenance in the adult peripheral nerve</article-title><source>Glia</source><volume>59</volume><fpage>1022</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.1002/glia.21173</pub-id><pub-id pub-id-type="pmid">21491499</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brösamle</surname><given-names>C</given-names></name><name><surname>Halpern</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Characterization of myelination in the developing zebrafish</article-title><source>Glia</source><volume>39</volume><fpage>47</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1002/glia.10088</pub-id><pub-id pub-id-type="pmid">12112375</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>EA</given-names></name><name><surname>Kawakami</surname><given-names>K</given-names></name><name><surname>Kucenas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A novel gene trap line for visualization and manipulation of erbb3b<sup>+</sup> neural crest and glial cells in zebrafish</article-title><source>Developmental Biology</source><volume>482</volume><fpage>114</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2021.12.007</pub-id><pub-id pub-id-type="pmid">34932993</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruno</surname><given-names>IG</given-names></name><name><surname>Karam</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Bhardwaj</surname><given-names>A</given-names></name><name><surname>Lou</surname><given-names>CH</given-names></name><name><surname>Shum</surname><given-names>EY</given-names></name><name><surname>Song</surname><given-names>HW</given-names></name><name><surname>Corbett</surname><given-names>MA</given-names></name><name><surname>Gifford</surname><given-names>WD</given-names></name><name><surname>Gecz</surname><given-names>J</given-names></name><name><surname>Pfaff</surname><given-names>SL</given-names></name><name><surname>Wilkinson</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay</article-title><source>Molecular Cell</source><volume>42</volume><fpage>500</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2011.04.018</pub-id><pub-id pub-id-type="pmid">21596314</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmona-Fontaine</surname><given-names>C</given-names></name><name><surname>Theveneau</surname><given-names>E</given-names></name><name><surname>Tzekou</surname><given-names>A</given-names></name><name><surname>Tada</surname><given-names>M</given-names></name><name><surname>Woods</surname><given-names>M</given-names></name><name><surname>Page</surname><given-names>KM</given-names></name><name><surname>Parsons</surname><given-names>M</given-names></name><name><surname>Lambris</surname><given-names>JD</given-names></name><name><surname>Mayor</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Complement fragment C3a controls mutual cell attraction during collective cell migration</article-title><source>Developmental Cell</source><volume>21</volume><fpage>1026</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.10.012</pub-id><pub-id pub-id-type="pmid">22118769</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casella</surname><given-names>GT</given-names></name><name><surname>Wieser</surname><given-names>R</given-names></name><name><surname>Bunge</surname><given-names>RP</given-names></name><name><surname>Margitich</surname><given-names>IS</given-names></name><name><surname>Katz</surname><given-names>J</given-names></name><name><surname>Olson</surname><given-names>L</given-names></name><name><surname>Wood</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Density dependent regulation of human Schwann cell proliferation</article-title><source>Glia</source><volume>30</volume><fpage>165</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1002/(sici)1098-1136(200004)30:2&lt;165::aid-glia6&gt;3.0.co;2-l</pub-id><pub-id pub-id-type="pmid">10719358</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>YF</given-names></name><name><surname>Imam</surname><given-names>JS</given-names></name><name><surname>Wilkinson</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The nonsense-mediated decay RNA surveillance pathway</article-title><source>Annual Review of Biochemistry</source><volume>76</volume><fpage>51</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.76.050106.093909</pub-id><pub-id pub-id-type="pmid">17352659</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>AK</given-names></name><name><surname>Moore</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>T cell activation by terminal complex of complement and immune complexes</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>38627</fpage><lpage>38637</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.266809</pub-id><pub-id pub-id-type="pmid">21900254</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleaver</surname><given-names>O</given-names></name><name><surname>Krieg</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>VEGF mediates angioblast migration during development of the dorsal aorta in <italic>Xenopus</italic></article-title><source>Development</source><volume>125</volume><fpage>3905</fpage><lpage>3914</lpage><pub-id pub-id-type="doi">10.1242/dev.125.19.3905</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coulthard</surname><given-names>LG</given-names></name><name><surname>Hawksworth</surname><given-names>OA</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Balachandran</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>JD</given-names></name><name><surname>Sepehrband</surname><given-names>F</given-names></name><name><surname>Kurniawan</surname><given-names>N</given-names></name><name><surname>Jeanes</surname><given-names>A</given-names></name><name><surname>Simmons</surname><given-names>DG</given-names></name><name><surname>Wolvetang</surname><given-names>E</given-names></name><name><surname>Woodruff</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Complement C5aR1 Signaling Promotes Polarization and Proliferation of Embryonic Neural Progenitor Cells through PKCζ</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>5395</fpage><lpage>5407</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0525-17.2017</pub-id><pub-id pub-id-type="pmid">28455369</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coulthard</surname><given-names>LG</given-names></name><name><surname>Hawksworth</surname><given-names>OA</given-names></name><name><surname>Woodruff</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Complement: The Emerging Architect of the Developing Brain</article-title><source>Trends in Neurosciences</source><volume>41</volume><fpage>373</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2018.03.009</pub-id><pub-id pub-id-type="pmid">29606485</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cravioto</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1965">1965</year><article-title>The role of Schwann cells in the development of human peripheral nerves. An electron microscopic study</article-title><source>Journal of Ultrastructure Research</source><volume>12</volume><fpage>634</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1016/s0022-5320(65)80053-3</pub-id><pub-id pub-id-type="pmid">5831054</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>RL</given-names></name><name><surname>Monk</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transmission Electron Microscopy for Zebrafish Larvae and Adult Lateral Line Nerve</article-title><source>Methods in Molecular Biology (Clifton, N.J.)</source><volume>1739</volume><fpage>385</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-7649-2_26</pub-id><pub-id pub-id-type="pmid">29546722</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daetwyler</surname><given-names>S</given-names></name><name><surname>Modes</surname><given-names>CD</given-names></name><name><surname>Fiolka</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Fiji plugin for annotating movies with custom arrows</article-title><source>Biology Open</source><volume>9</volume><elocation-id>bio056200</elocation-id><pub-id pub-id-type="doi">10.1242/bio.056200</pub-id><pub-id pub-id-type="pmid">33168591</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dashiell</surname><given-names>SM</given-names></name><name><surname>Rus</surname><given-names>H</given-names></name><name><surname>Koski</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosis</article-title><source>Glia</source><volume>30</volume><fpage>187</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1002/(sici)1098-1136(200004)30:2&lt;187::aid-glia8&gt;3.0.co;2-7</pub-id><pub-id pub-id-type="pmid">10719360</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>A</given-names></name><name><surname>Simmons</surname><given-names>DL</given-names></name><name><surname>Hale</surname><given-names>G</given-names></name><name><surname>Harrison</surname><given-names>RA</given-names></name><name><surname>Tighe</surname><given-names>H</given-names></name><name><surname>Lachmann</surname><given-names>PJ</given-names></name><name><surname>Waldmann</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells</article-title><source>The Journal of Experimental Medicine</source><volume>170</volume><fpage>637</fpage><lpage>654</lpage><pub-id pub-id-type="doi">10.1084/jem.170.3.637</pub-id><pub-id pub-id-type="pmid">2475570</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denny</surname><given-names>KJ</given-names></name><name><surname>Coulthard</surname><given-names>LG</given-names></name><name><surname>Jeanes</surname><given-names>A</given-names></name><name><surname>Lisgo</surname><given-names>S</given-names></name><name><surname>Simmons</surname><given-names>DG</given-names></name><name><surname>Callaway</surname><given-names>LK</given-names></name><name><surname>Wlodarczyk</surname><given-names>B</given-names></name><name><surname>Finnell</surname><given-names>RH</given-names></name><name><surname>Woodruff</surname><given-names>TM</given-names></name><name><surname>Taylor</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>C5a receptor signaling prevents folate deficiency-induced neural tube defects in mice</article-title><source>Journal of Immunology (Baltimore, Md</source><volume>190</volume><fpage>3493</fpage><lpage>3499</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1203072</pub-id><pub-id pub-id-type="pmid">23420882</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Don</surname><given-names>EK</given-names></name><name><surname>Formella</surname><given-names>I</given-names></name><name><surname>Badrock</surname><given-names>AP</given-names></name><name><surname>Hall</surname><given-names>TE</given-names></name><name><surname>Morsch</surname><given-names>M</given-names></name><name><surname>Hortle</surname><given-names>E</given-names></name><name><surname>Hogan</surname><given-names>A</given-names></name><name><surname>Chow</surname><given-names>S</given-names></name><name><surname>Gwee</surname><given-names>SSL</given-names></name><name><surname>Stoddart</surname><given-names>JJ</given-names></name><name><surname>Nicholson</surname><given-names>G</given-names></name><name><surname>Chung</surname><given-names>R</given-names></name><name><surname>Cole</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A Tol2 Gateway-Compatible Toolbox for the Study of the Nervous System and Neurodegenerative Disease</article-title><source>Zebrafish</source><volume>14</volume><fpage>69</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1089/zeb.2016.1321</pub-id><pub-id pub-id-type="pmid">27631880</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duvaud</surname><given-names>S</given-names></name><name><surname>Gabella</surname><given-names>C</given-names></name><name><surname>Lisacek</surname><given-names>F</given-names></name><name><surname>Stockinger</surname><given-names>H</given-names></name><name><surname>Ioannidis</surname><given-names>V</given-names></name><name><surname>Durinx</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Expasy, the Swiss Bioinformatics Resource Portal, as designed by its users</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>W216</fpage><lpage>W227</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab225</pub-id><pub-id pub-id-type="pmid">33849055</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Echeverri</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Proximodistal patterning during limb regeneration</article-title><source>Developmental Biology</source><volume>279</volume><fpage>391</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2004.12.029</pub-id><pub-id pub-id-type="pmid">15733667</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelman</surname><given-names>RM</given-names></name><name><surname>Rousou</surname><given-names>JA</given-names></name><name><surname>Flack</surname><given-names>JE</given-names></name><name><surname>Deaton</surname><given-names>DW</given-names></name><name><surname>Kalfin</surname><given-names>R</given-names></name><name><surname>Das</surname><given-names>DK</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Influence of steroids on complement and cytokine generation after cardiopulmonary bypass</article-title><source>The Annals of Thoracic Surgery</source><volume>60</volume><fpage>801</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1016/0003-4975(95)00211-3</pub-id><pub-id pub-id-type="pmid">7677537</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erne</surname><given-names>B</given-names></name><name><surname>Sansano</surname><given-names>S</given-names></name><name><surname>Frank</surname><given-names>M</given-names></name><name><surname>Schaeren-Wiemers</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Rafts in adult peripheral nerve myelin contain major structural myelin proteins and myelin and lymphocyte protein (MAL) and CD59 as specific markers</article-title><source>Journal of Neurochemistry</source><volume>82</volume><fpage>550</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.2002.00987.x</pub-id><pub-id pub-id-type="pmid">12153479</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eshed</surname><given-names>Y</given-names></name><name><surname>Feinberg</surname><given-names>K</given-names></name><name><surname>Poliak</surname><given-names>S</given-names></name><name><surname>Sabanay</surname><given-names>H</given-names></name><name><surname>Sarig-Nadir</surname><given-names>O</given-names></name><name><surname>Spiegel</surname><given-names>I</given-names></name><name><surname>Bermingham</surname><given-names>JR</given-names><suffix>Jr</suffix></name><name><surname>Peles</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier</article-title><source>Neuron</source><volume>47</volume><fpage>215</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2005.06.026</pub-id><pub-id pub-id-type="pmid">16039564</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feinberg</surname><given-names>K</given-names></name><name><surname>Eshed-Eisenbach</surname><given-names>Y</given-names></name><name><surname>Frechter</surname><given-names>S</given-names></name><name><surname>Amor</surname><given-names>V</given-names></name><name><surname>Salomon</surname><given-names>D</given-names></name><name><surname>Sabanay</surname><given-names>H</given-names></name><name><surname>Dupree</surname><given-names>JL</given-names></name><name><surname>Grumet</surname><given-names>M</given-names></name><name><surname>Brophy</surname><given-names>PJ</given-names></name><name><surname>Shrager</surname><given-names>P</given-names></name><name><surname>Peles</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A glial signal consisting of gliomedin and NrCAM clusters axonal Na+ channels during the formation of nodes of Ranvier</article-title><source>Neuron</source><volume>65</volume><fpage>490</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.02.004</pub-id><pub-id pub-id-type="pmid">20188654</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feltri</surname><given-names>ML</given-names></name><name><surname>Poitelon</surname><given-names>Y</given-names></name><name><surname>Previtali</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>How Schwann Cells Sort Axons: New Concepts</article-title><source>The Neuroscientist</source><volume>22</volume><fpage>252</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1177/1073858415572361</pub-id><pub-id pub-id-type="pmid">25686621</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontenas</surname><given-names>L</given-names></name><name><surname>Kucenas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Motor Exit Point (MEP) Glia: Novel Myelinating Glia That Bridge CNS and PNS Myelin</article-title><source>Frontiers in Cellular Neuroscience</source><volume>12</volume><elocation-id>333</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2018.00333</pub-id><pub-id pub-id-type="pmid">30356886</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontenas</surname><given-names>L</given-names></name><name><surname>Kucenas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Spinal cord precursors utilize neural crest cell mechanisms to generate hybrid peripheral myelinating glia</article-title><source>eLife</source><volume>10</volume><elocation-id>e64267</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.64267</pub-id><pub-id pub-id-type="pmid">33554855</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagnon</surname><given-names>JA</given-names></name><name><surname>Valen</surname><given-names>E</given-names></name><name><surname>Thyme</surname><given-names>SB</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Akhmetova</surname><given-names>L</given-names></name><name><surname>Ahkmetova</surname><given-names>L</given-names></name><name><surname>Pauli</surname><given-names>A</given-names></name><name><surname>Montague</surname><given-names>TG</given-names></name><name><surname>Zimmerman</surname><given-names>S</given-names></name><name><surname>Richter</surname><given-names>C</given-names></name><name><surname>Schier</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion and large-scale assessment of single-guide RNAs</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e98186</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0098186</pub-id><pub-id pub-id-type="pmid">24873830</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerber</surname><given-names>D</given-names></name><name><surname>Pereira</surname><given-names>JA</given-names></name><name><surname>Gerber</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>G</given-names></name><name><surname>Dimitrieva</surname><given-names>S</given-names></name><name><surname>Yángüez</surname><given-names>E</given-names></name><name><surname>Suter</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Transcriptional profiling of mouse peripheral nerves to the single-cell level to build a sciatic nerve ATlas (SNAT)</article-title><source>eLife</source><volume>10</volume><elocation-id>e58591</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.58591</pub-id><pub-id pub-id-type="pmid">33890853</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghysen</surname><given-names>A</given-names></name><name><surname>Dambly-Chaudière</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The lateral line microcosmos</article-title><source>Genes &amp; Development</source><volume>21</volume><fpage>2118</fpage><lpage>2130</lpage><pub-id pub-id-type="doi">10.1101/gad.1568407</pub-id><pub-id pub-id-type="pmid">17785522</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golec</surname><given-names>E</given-names></name><name><surname>Rosberg</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>E</given-names></name><name><surname>Renström</surname><given-names>E</given-names></name><name><surname>Blom</surname><given-names>AM</given-names></name><name><surname>King</surname><given-names>BC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A cryptic non-GPI-anchored cytosolic isoform of CD59 controls insulin exocytosis in pancreatic β-cells by interaction with SNARE proteins</article-title><source>FASEB Journal</source><volume>33</volume><fpage>12425</fpage><lpage>12434</lpage><pub-id pub-id-type="doi">10.1096/fj.201901007R</pub-id><pub-id pub-id-type="pmid">31412214</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Sanchez</surname><given-names>JA</given-names></name><name><surname>Lopez de Armentia</surname><given-names>M</given-names></name><name><surname>Lujan</surname><given-names>R</given-names></name><name><surname>Kessaris</surname><given-names>N</given-names></name><name><surname>Richardson</surname><given-names>WD</given-names></name><name><surname>Cabedo</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Sustained axon-glial signaling induces Schwann cell hyperproliferation, Remak bundle myelination, and tumorigenesis</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>11304</fpage><lpage>11315</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1753-09.2009</pub-id><pub-id pub-id-type="pmid">19741137</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorelik</surname><given-names>A</given-names></name><name><surname>Sapir</surname><given-names>T</given-names></name><name><surname>Haffner-Krausz</surname><given-names>R</given-names></name><name><surname>Olender</surname><given-names>T</given-names></name><name><surname>Woodruff</surname><given-names>TM</given-names></name><name><surname>Reiner</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Developmental activities of the complement pathway in migrating neurons</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15096</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15096</pub-id><pub-id pub-id-type="pmid">28462915</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>RM</given-names></name><name><surname>Byrd</surname><given-names>AL</given-names></name><name><surname>Barbarese</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>The number of Schmidt-Lanterman incisures is more than doubled in shiverer PNS myelin sheaths</article-title><source>Journal of Neurocytology</source><volume>24</volume><fpage>85</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1007/BF01181552</pub-id><pub-id pub-id-type="pmid">7745445</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gradl</surname><given-names>G</given-names></name><name><surname>Faust</surname><given-names>D</given-names></name><name><surname>Oesch</surname><given-names>F</given-names></name><name><surname>Wieser</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Density-dependent regulation of cell growth by contactinhibin and the contactinhibin receptor</article-title><source>Current Biology</source><volume>5</volume><fpage>526</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(95)00105-9</pub-id><pub-id pub-id-type="pmid">7583102</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>KA</given-names></name><name><surname>Raible</surname><given-names>DW</given-names></name><name><surname>Piotrowski</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Regulation of latent sensory hair cell precursors by glia in the zebrafish lateral line</article-title><source>Neuron</source><volume>45</volume><fpage>69</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2004.12.020</pub-id><pub-id pub-id-type="pmid">15629703</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross-Thebing</surname><given-names>T</given-names></name><name><surname>Paksa</surname><given-names>A</given-names></name><name><surname>Raz</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Simultaneous high-resolution detection of multiple transcripts combined with localization of proteins in whole-mount embryos</article-title><source>BMC Biology</source><volume>12</volume><elocation-id>55</elocation-id><pub-id pub-id-type="doi">10.1186/s12915-014-0055-7</pub-id><pub-id pub-id-type="pmid">25124741</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haliloglu</surname><given-names>G</given-names></name><name><surname>Maluenda</surname><given-names>J</given-names></name><name><surname>Sayinbatur</surname><given-names>B</given-names></name><name><surname>Aumont</surname><given-names>C</given-names></name><name><surname>Temucin</surname><given-names>C</given-names></name><name><surname>Tavil</surname><given-names>B</given-names></name><name><surname>Cetin</surname><given-names>M</given-names></name><name><surname>Oguz</surname><given-names>KK</given-names></name><name><surname>Gut</surname><given-names>I</given-names></name><name><surname>Picard</surname><given-names>V</given-names></name><name><surname>Melki</surname><given-names>J</given-names></name><name><surname>Topaloglu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Early-onset chronic axonal neuropathy, strokes, and hemolysis: inherited CD59 deficiency</article-title><source>Neurology</source><volume>84</volume><fpage>1220</fpage><lpage>1224</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000001391</pub-id><pub-id pub-id-type="pmid">25716358</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Wilk</surname><given-names>AJ</given-names></name><name><surname>Darby</surname><given-names>C</given-names></name><name><surname>Zager</surname><given-names>M</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mimitou</surname><given-names>EP</given-names></name><name><surname>Jain</surname><given-names>J</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Fleming</surname><given-names>LM</given-names></name><name><surname>Yeung</surname><given-names>B</given-names></name><name><surname>Rogers</surname><given-names>AJ</given-names></name><name><surname>McElrath</surname><given-names>JM</given-names></name><name><surname>Blish</surname><given-names>CA</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrated analysis of multimodal single-cell data</article-title><source>Cell</source><volume>184</volume><fpage>3573</fpage><lpage>3587</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id><pub-id pub-id-type="pmid">34062119</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hauptmann</surname><given-names>G</given-names></name><name><surname>Gerster</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Multicolor whole-mount in situ hybridization</article-title><source>Methods in Molecular Biology (Clifton, N.J.)</source><volume>137</volume><fpage>139</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1385/1-59259-066-7:139</pub-id><pub-id pub-id-type="pmid">10948532</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hila</surname><given-names>S</given-names></name><name><surname>Soane</surname><given-names>L</given-names></name><name><surname>Koski</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Sublytic C5b-9-stimulated Schwann cell survival through PI 3-kinase-mediated phosphorylation of BAD</article-title><source>Glia</source><volume>36</volume><fpage>58</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1002/glia.1095</pub-id><pub-id pub-id-type="pmid">11571784</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirano</surname><given-names>S</given-names></name><name><surname>Fuse</surname><given-names>S</given-names></name><name><surname>Sohal</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>The effect of the floor plate on pattern and polarity in the developing central nervous system</article-title><source>Science (New York, N.Y.)</source><volume>251</volume><fpage>310</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1126/science.1987648</pub-id><pub-id pub-id-type="pmid">1987648</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Höchsmann</surname><given-names>B</given-names></name><name><surname>Schrezenmeier</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Congenital CD59 Deficiency</article-title><source>Hematology/Oncology Clinics of North America</source><volume>29</volume><fpage>495</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1016/j.hoc.2015.01.006</pub-id><pub-id pub-id-type="pmid">26043388</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>AG</given-names></name><name><surname>Baker</surname><given-names>PA</given-names></name><name><surname>Ibarra-García-Padilla</surname><given-names>R</given-names></name><name><surname>Moore</surname><given-names>JA</given-names></name><name><surname>Rivas</surname><given-names>LJ</given-names></name><name><surname>Tallman</surname><given-names>JJ</given-names></name><name><surname>Singleton</surname><given-names>EW</given-names></name><name><surname>Westheimer</surname><given-names>JL</given-names></name><name><surname>Corteguera</surname><given-names>JA</given-names></name><name><surname>Uribe</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>An atlas of neural crest lineages along the posterior developing zebrafish at single-cell resolution</article-title><source>eLife</source><volume>10</volume><elocation-id>e60005</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.60005</pub-id><pub-id pub-id-type="pmid">33591267</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>AN</given-names></name><name><surname>Appel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Microglia phagocytose myelin sheaths to modify developmental myelination</article-title><source>Nature Neuroscience</source><volume>23</volume><fpage>1055</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-0654-2</pub-id><pub-id pub-id-type="pmid">32632287</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jessen</surname><given-names>KR</given-names></name><name><surname>Mirsky</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The origin and development of glial cells in peripheral nerves</article-title><source>Nature Reviews. Neuroscience</source><volume>6</volume><fpage>671</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nrn1746</pub-id><pub-id pub-id-type="pmid">16136171</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>JJ</given-names></name><name><surname>Gropman</surname><given-names>AL</given-names></name><name><surname>Sapp</surname><given-names>JC</given-names></name><name><surname>Teer</surname><given-names>JK</given-names></name><name><surname>Martin</surname><given-names>JM</given-names></name><name><surname>Liu</surname><given-names>CF</given-names></name><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Ye</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Brodsky</surname><given-names>RA</given-names></name><name><surname>Biesecker</surname><given-names>LG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria</article-title><source>American Journal of Human Genetics</source><volume>90</volume><fpage>295</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2011.11.031</pub-id><pub-id pub-id-type="pmid">22305531</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karam</surname><given-names>R</given-names></name><name><surname>Wilkinson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A conserved microRNA/NMD regulatory circuit controls gene expression</article-title><source>RNA Biology</source><volume>9</volume><fpage>22</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.4161/rna.9.1.18010</pub-id><pub-id pub-id-type="pmid">22258150</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karbian</surname><given-names>N</given-names></name><name><surname>Eshed-Eisenbach</surname><given-names>Y</given-names></name><name><surname>Tabib</surname><given-names>A</given-names></name><name><surname>Hoizman</surname><given-names>H</given-names></name><name><surname>Morgan</surname><given-names>BP</given-names></name><name><surname>Schueler-Furman</surname><given-names>O</given-names></name><name><surname>Peles</surname><given-names>E</given-names></name><name><surname>Mevorach</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Molecular pathogenesis of human CD59 deficiency</article-title><source>Neurology. Genetics</source><volume>4</volume><elocation-id>e280</elocation-id><pub-id pub-id-type="doi">10.1212/NXG.0000000000000280</pub-id><pub-id pub-id-type="pmid">30533526</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Transgenesis and gene trap methods in zebrafish by using the Tol2 transposable element</article-title><source>Methods in Cell Biology</source><volume>77</volume><fpage>201</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/s0091-679x(04)77011-9</pub-id><pub-id pub-id-type="pmid">15602913</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimmel</surname><given-names>CB</given-names></name><name><surname>Ballard</surname><given-names>WW</given-names></name><name><surname>Kimmel</surname><given-names>SR</given-names></name><name><surname>Ullmann</surname><given-names>B</given-names></name><name><surname>Schilling</surname><given-names>TF</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Stages of embryonic development of the zebrafish</article-title><source>Developmental Dynamics</source><volume>203</volume><fpage>253</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1002/aja.1002030302</pub-id><pub-id pub-id-type="pmid">8589427</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiraly</surname><given-names>O</given-names></name><name><surname>Gong</surname><given-names>G</given-names></name><name><surname>Olipitz</surname><given-names>W</given-names></name><name><surname>Muthupalani</surname><given-names>S</given-names></name><name><surname>Engelward</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1004901</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004901</pub-id><pub-id pub-id-type="pmid">25647331</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirby</surname><given-names>BB</given-names></name><name><surname>Takada</surname><given-names>N</given-names></name><name><surname>Latimer</surname><given-names>AJ</given-names></name><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Carney</surname><given-names>TJ</given-names></name><name><surname>Kelsh</surname><given-names>RN</given-names></name><name><surname>Appel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development</article-title><source>Nature Neuroscience</source><volume>9</volume><fpage>1506</fpage><lpage>1511</lpage><pub-id pub-id-type="doi">10.1038/nn1803</pub-id><pub-id pub-id-type="pmid">17099706</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koski</surname><given-names>CL</given-names></name><name><surname>Estep</surname><given-names>AE</given-names></name><name><surname>Sawant-Mane</surname><given-names>S</given-names></name><name><surname>Shin</surname><given-names>ML</given-names></name><name><surname>Highbarger</surname><given-names>L</given-names></name><name><surname>Hansch</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Complement Regulatory Molecules on Human Myelin and Glial Cells: Differential Expression Affects the Deposition of Activated Complement Proteins</article-title><source>Journal of Neurochemistry</source><volume>66</volume><fpage>303</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.1996.66010303.x</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krus</surname><given-names>U</given-names></name><name><surname>King</surname><given-names>BC</given-names></name><name><surname>Nagaraj</surname><given-names>V</given-names></name><name><surname>Gandasi</surname><given-names>NR</given-names></name><name><surname>Sjölander</surname><given-names>J</given-names></name><name><surname>Buda</surname><given-names>P</given-names></name><name><surname>Garcia-Vaz</surname><given-names>E</given-names></name><name><surname>Gomez</surname><given-names>MF</given-names></name><name><surname>Ottosson-Laakso</surname><given-names>E</given-names></name><name><surname>Storm</surname><given-names>P</given-names></name><name><surname>Fex</surname><given-names>M</given-names></name><name><surname>Vikman</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>E</given-names></name><name><surname>Barg</surname><given-names>S</given-names></name><name><surname>Blom</surname><given-names>AM</given-names></name><name><surname>Renström</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The complement inhibitor CD59 regulates insulin secretion by modulating exocytotic events</article-title><source>Cell Metabolism</source><volume>19</volume><fpage>883</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.03.001</pub-id><pub-id pub-id-type="pmid">24726385</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname><given-names>KM</given-names></name><name><surname>Fujimoto</surname><given-names>E</given-names></name><name><surname>Grabher</surname><given-names>C</given-names></name><name><surname>Mangum</surname><given-names>BD</given-names></name><name><surname>Hardy</surname><given-names>ME</given-names></name><name><surname>Campbell</surname><given-names>DS</given-names></name><name><surname>Parant</surname><given-names>JM</given-names></name><name><surname>Yost</surname><given-names>HJ</given-names></name><name><surname>Kanki</surname><given-names>JP</given-names></name><name><surname>Chien</surname><given-names>CB</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The Tol2kit: A multisite gateway-based construction kit for Tol2 transposon transgenesis constructs</article-title><source>Developmental Dynamics</source><volume>236</volume><fpage>3088</fpage><lpage>3099</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21343</pub-id><pub-id pub-id-type="pmid">17937395</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labun</surname><given-names>K</given-names></name><name><surname>Montague</surname><given-names>TG</given-names></name><name><surname>Gagnon</surname><given-names>JA</given-names></name><name><surname>Thyme</surname><given-names>SB</given-names></name><name><surname>Valen</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>W272</fpage><lpage>W276</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw398</pub-id><pub-id pub-id-type="pmid">27185894</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labun</surname><given-names>K</given-names></name><name><surname>Montague</surname><given-names>TG</given-names></name><name><surname>Krause</surname><given-names>M</given-names></name><name><surname>Torres Cleuren</surname><given-names>YN</given-names></name><name><surname>Tjeldnes</surname><given-names>H</given-names></name><name><surname>Valen</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>W171</fpage><lpage>W174</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz365</pub-id><pub-id pub-id-type="pmid">31106371</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lammert</surname><given-names>CR</given-names></name><name><surname>Frost</surname><given-names>EL</given-names></name><name><surname>Bellinger</surname><given-names>CE</given-names></name><name><surname>Bolte</surname><given-names>AC</given-names></name><name><surname>McKee</surname><given-names>CA</given-names></name><name><surname>Hurt</surname><given-names>ME</given-names></name><name><surname>Paysour</surname><given-names>MJ</given-names></name><name><surname>Ennerfelt</surname><given-names>HE</given-names></name><name><surname>Lukens</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>AIM2 inflammasome surveillance of DNA damage shapes neurodevelopment</article-title><source>Nature</source><volume>580</volume><fpage>647</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2174-3</pub-id><pub-id pub-id-type="pmid">32350463</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>TA</given-names></name><name><surname>Tokareva</surname><given-names>Y</given-names></name><name><surname>Cole</surname><given-names>MM</given-names></name><name><surname>Brenowitz</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Inflammation Induced by Natural Neuronal Death and LPS Regulates Neural Progenitor Cell Proliferation in the Healthy Adult Brain</article-title><source>ENeuro</source><volume>7</volume><elocation-id>ENEURO.0023-20.2020</elocation-id><pub-id pub-id-type="doi">10.1523/ENEURO.0023-20.2020</pub-id><pub-id pub-id-type="pmid">32424053</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>YJ</given-names></name><name><surname>Chu</surname><given-names>XM</given-names></name><name><surname>Gao</surname><given-names>MH</given-names></name><name><surname>Wang</surname><given-names>XH</given-names></name><name><surname>Nie</surname><given-names>SM</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Lv</surname><given-names>CY</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Molecular mechanism of inhibitory effects of CD59 gene on atherosclerosis in ApoE (-/-) mice</article-title><source>Immunology Letters</source><volume>156</volume><fpage>68</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.imlet.2013.09.025</pub-id><pub-id pub-id-type="pmid">24084445</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Fu</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Abnormal expression and mutation of the RBPJ gene may be involved in CD59<sup>-</sup> clonal proliferation in paroxysmal nocturnal hemoglobinuria</article-title><source>Experimental and Therapeutic Medicine</source><volume>17</volume><fpage>4536</fpage><lpage>4546</lpage><pub-id pub-id-type="doi">10.3892/etm.2019.7475</pub-id><pub-id pub-id-type="pmid">31086586</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longhi</surname><given-names>MP</given-names></name><name><surname>Sivasankar</surname><given-names>B</given-names></name><name><surname>Omidvar</surname><given-names>N</given-names></name><name><surname>Morgan</surname><given-names>BP</given-names></name><name><surname>Gallimore</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner</article-title><source>Journal of Immunology (Baltimore, Md</source><volume>175</volume><fpage>7098</fpage><lpage>7102</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.175.11.7098</pub-id><pub-id pub-id-type="pmid">16301611</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lou</surname><given-names>CH</given-names></name><name><surname>Shao</surname><given-names>A</given-names></name><name><surname>Shum</surname><given-names>EY</given-names></name><name><surname>Espinoza</surname><given-names>JL</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Karam</surname><given-names>R</given-names></name><name><surname>Wilkinson</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Posttranscriptional control of the stem cell and neurogenic programs by the nonsense-mediated RNA decay pathway</article-title><source>Cell Reports</source><volume>6</volume><fpage>748</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.01.028</pub-id><pub-id pub-id-type="pmid">24529710</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lush</surname><given-names>ME</given-names></name><name><surname>Piotrowski</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>ErbB expressing Schwann cells control lateral line progenitor cells via non-cell-autonomous regulation of Wnt/β-catenin</article-title><source>eLife</source><volume>3</volume><elocation-id>e01832</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.01832</pub-id><pub-id pub-id-type="pmid">24642408</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>DA</given-names></name><name><surname>Pogoda</surname><given-names>HM</given-names></name><name><surname>Voas</surname><given-names>MG</given-names></name><name><surname>Woods</surname><given-names>IG</given-names></name><name><surname>Diamond</surname><given-names>B</given-names></name><name><surname>Nix</surname><given-names>R</given-names></name><name><surname>Arana</surname><given-names>N</given-names></name><name><surname>Jacobs</surname><given-names>J</given-names></name><name><surname>Talbot</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>erbb3 and erbb2 are essential for schwann cell migration and myelination in zebrafish</article-title><source>Current Biology</source><volume>15</volume><fpage>513</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2005.02.030</pub-id><pub-id pub-id-type="pmid">15797019</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magdalon</surname><given-names>J</given-names></name><name><surname>Mansur</surname><given-names>F</given-names></name><name><surname>Teles E Silva</surname><given-names>AL</given-names></name><name><surname>de Goes</surname><given-names>VA</given-names></name><name><surname>Reiner</surname><given-names>O</given-names></name><name><surname>Sertié</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Complement System in Brain Architecture and Neurodevelopmental Disorders</article-title><source>Frontiers in Neuroscience</source><volume>14</volume><elocation-id>23</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2020.00023</pub-id><pub-id pub-id-type="pmid">32116493</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marisca</surname><given-names>R</given-names></name><name><surname>Hoche</surname><given-names>T</given-names></name><name><surname>Agirre</surname><given-names>E</given-names></name><name><surname>Hoodless</surname><given-names>LJ</given-names></name><name><surname>Barkey</surname><given-names>W</given-names></name><name><surname>Auer</surname><given-names>F</given-names></name><name><surname>Castelo-Branco</surname><given-names>G</given-names></name><name><surname>Czopka</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Functionally distinct subgroups of oligodendrocyte precursor cells integrate neural activity and execute myelin formation</article-title><source>Nature Neuroscience</source><volume>23</volume><fpage>363</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1038/s41593-019-0581-2</pub-id><pub-id pub-id-type="pmid">32066987</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marques</surname><given-names>S</given-names></name><name><surname>Zeisel</surname><given-names>A</given-names></name><name><surname>Codeluppi</surname><given-names>S</given-names></name><name><surname>van Bruggen</surname><given-names>D</given-names></name><name><surname>Mendanha Falcão</surname><given-names>A</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Häring</surname><given-names>M</given-names></name><name><surname>Hochgerner</surname><given-names>H</given-names></name><name><surname>Romanov</surname><given-names>RA</given-names></name><name><surname>Gyllborg</surname><given-names>D</given-names></name><name><surname>Muñoz Manchado</surname><given-names>A</given-names></name><name><surname>La Manno</surname><given-names>G</given-names></name><name><surname>Lönnerberg</surname><given-names>P</given-names></name><name><surname>Floriddia</surname><given-names>EM</given-names></name><name><surname>Rezayee</surname><given-names>F</given-names></name><name><surname>Ernfors</surname><given-names>P</given-names></name><name><surname>Arenas</surname><given-names>E</given-names></name><name><surname>Hjerling-Leffler</surname><given-names>J</given-names></name><name><surname>Harkany</surname><given-names>T</given-names></name><name><surname>Richardson</surname><given-names>WD</given-names></name><name><surname>Linnarsson</surname><given-names>S</given-names></name><name><surname>Castelo-Branco</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system</article-title><source>Science (New York, N.Y.)</source><volume>352</volume><fpage>1326</fpage><lpage>1329</lpage><pub-id pub-id-type="doi">10.1126/science.aaf6463</pub-id><pub-id pub-id-type="pmid">27284195</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marques</surname><given-names>S</given-names></name><name><surname>van Bruggen</surname><given-names>D</given-names></name><name><surname>Vanichkina</surname><given-names>DP</given-names></name><name><surname>Floriddia</surname><given-names>EM</given-names></name><name><surname>Munguba</surname><given-names>H</given-names></name><name><surname>Väremo</surname><given-names>L</given-names></name><name><surname>Giacomello</surname><given-names>S</given-names></name><name><surname>Falcão</surname><given-names>AM</given-names></name><name><surname>Meijer</surname><given-names>M</given-names></name><name><surname>Björklund</surname><given-names>ÅK</given-names></name><name><surname>Hjerling-Leffler</surname><given-names>J</given-names></name><name><surname>Taft</surname><given-names>RJ</given-names></name><name><surname>Castelo-Branco</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transcriptional Convergence of Oligodendrocyte Lineage Progenitors during Development</article-title><source>Developmental Cell</source><volume>46</volume><fpage>504</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2018.07.005</pub-id><pub-id pub-id-type="pmid">30078729</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maturana</surname><given-names>HR</given-names></name></person-group><year iso-8601-date="1960">1960</year><article-title>The fine anatomy of the optic nerve of anurans--an electron microscope study</article-title><source>The Journal of Biophysical and Biochemical Cytology</source><volume>7</volume><fpage>107</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1083/jcb.7.1.107</pub-id><pub-id pub-id-type="pmid">13853859</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazaheri</surname><given-names>F</given-names></name><name><surname>Breus</surname><given-names>O</given-names></name><name><surname>Durdu</surname><given-names>S</given-names></name><name><surname>Haas</surname><given-names>P</given-names></name><name><surname>Wittbrodt</surname><given-names>J</given-names></name><name><surname>Gilmour</surname><given-names>D</given-names></name><name><surname>Peri</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Distinct roles for BAI1 and TIM-4 in the engulfment of dying neurons by microglia</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>4046</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms5046</pub-id><pub-id pub-id-type="pmid">24898390</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGraw</surname><given-names>HF</given-names></name><name><surname>Snelson</surname><given-names>CD</given-names></name><name><surname>Prendergast</surname><given-names>A</given-names></name><name><surname>Suli</surname><given-names>A</given-names></name><name><surname>Raible</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Postembryonic neuronal addition in zebrafish dorsal root ganglia is regulated by Notch signaling</article-title><source>Neural Development</source><volume>7</volume><elocation-id>23</elocation-id><pub-id pub-id-type="doi">10.1186/1749-8104-7-23</pub-id><pub-id pub-id-type="pmid">22738203</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McInnes</surname><given-names>L</given-names></name><name><surname>Healy</surname><given-names>J</given-names></name><name><surname>Saul</surname><given-names>N</given-names></name><name><surname>Großberger</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>UMAP: Uniform Manifold Approximation and Projection</article-title><source>Journal of Open Source Software</source><volume>3</volume><elocation-id>861</elocation-id><pub-id pub-id-type="doi">10.21105/joss.00861</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mead</surname><given-names>RJ</given-names></name><name><surname>Neal</surname><given-names>JW</given-names></name><name><surname>Griffiths</surname><given-names>MR</given-names></name><name><surname>Linington</surname><given-names>C</given-names></name><name><surname>Botto</surname><given-names>M</given-names></name><name><surname>Lassmann</surname><given-names>H</given-names></name><name><surname>Morgan</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis</article-title><source>Laboratory Investigation; a Journal of Technical Methods and Pathology</source><volume>84</volume><fpage>21</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1038/labinvest.3700015</pub-id><pub-id pub-id-type="pmid">14631387</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meri</surname><given-names>S</given-names></name><name><surname>Morgan</surname><given-names>BP</given-names></name><name><surname>Davies</surname><given-names>A</given-names></name><name><surname>Daniels</surname><given-names>RH</given-names></name><name><surname>Olavesen</surname><given-names>MG</given-names></name><name><surname>Waldmann</surname><given-names>H</given-names></name><name><surname>Lachmann</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers</article-title><source>Immunology</source><volume>71</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">1698710</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merle</surname><given-names>NS</given-names></name><name><surname>Noe</surname><given-names>R</given-names></name><name><surname>Halbwachs-Mecarelli</surname><given-names>L</given-names></name><name><surname>Fremeaux-Bacchi</surname><given-names>V</given-names></name><name><surname>Roumenina</surname><given-names>LT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Complement System Part II: Role in Immunity</article-title><source>Frontiers in Immunology</source><volume>6</volume><elocation-id>257</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2015.00257</pub-id><pub-id pub-id-type="pmid">26074922</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno-Mateos</surname><given-names>MA</given-names></name><name><surname>Vejnar</surname><given-names>CE</given-names></name><name><surname>Beaudoin</surname><given-names>JD</given-names></name><name><surname>Fernandez</surname><given-names>JP</given-names></name><name><surname>Mis</surname><given-names>EK</given-names></name><name><surname>Khokha</surname><given-names>MK</given-names></name><name><surname>Giraldez</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo</article-title><source>Nature Methods</source><volume>12</volume><fpage>982</fpage><lpage>988</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3543</pub-id><pub-id pub-id-type="pmid">26322839</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects</article-title><source>The Biochemical Journal</source><volume>264</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1042/bj2640001</pub-id><pub-id pub-id-type="pmid">2690818</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>BP</given-names></name><name><surname>Harris</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Complement, a target for therapy in inflammatory and degenerative diseases</article-title><source>Nature Reviews. Drug Discovery</source><volume>14</volume><fpage>857</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1038/nrd4657</pub-id><pub-id pub-id-type="pmid">26493766</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The membrane attack complex as an inflammatory trigger</article-title><source>Immunobiology</source><volume>221</volume><fpage>747</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1016/j.imbio.2015.04.006</pub-id><pub-id pub-id-type="pmid">25956457</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>AD</given-names></name><name><surname>Erisir</surname><given-names>A</given-names></name><name><surname>Criswell</surname><given-names>SJ</given-names></name><name><surname>Kucenas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transmission electron microscopy of zebrafish spinal motor nerve roots</article-title><source>Developmental Dynamics</source><volume>246</volume><fpage>956</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.1002/dvdy.24529</pub-id><pub-id pub-id-type="pmid">28598521</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nave</surname><given-names>KA</given-names></name><name><surname>Werner</surname><given-names>HB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Myelination of the nervous system: mechanisms and functions</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>30</volume><fpage>503</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100913-013101</pub-id><pub-id pub-id-type="pmid">25288117</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niculescu</surname><given-names>F</given-names></name><name><surname>Rus</surname><given-names>H</given-names></name><name><surname>van Biesen</surname><given-names>T</given-names></name><name><surname>Shin</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent</article-title><source>Journal of Immunology (Baltimore, Md</source><volume>158</volume><fpage>4405</fpage><lpage>4412</lpage><pub-id pub-id-type="pmid">9127005</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niculescu</surname><given-names>F</given-names></name><name><surname>Badea</surname><given-names>T</given-names></name><name><surname>Rus</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase</article-title><source>Atherosclerosis</source><volume>142</volume><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/s0021-9150(98)00185-3</pub-id><pub-id pub-id-type="pmid">9920505</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ninomiya</surname><given-names>H</given-names></name><name><surname>Sims</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the “b”domain of C9</article-title><source>The Journal of Biological Chemistry</source><volume>267</volume><fpage>13675</fpage><lpage>13680</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)42266-1</pub-id><pub-id pub-id-type="pmid">1377690</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolicelli</surname><given-names>RC</given-names></name><name><surname>Bolasco</surname><given-names>G</given-names></name><name><surname>Pagani</surname><given-names>F</given-names></name><name><surname>Maggi</surname><given-names>L</given-names></name><name><surname>Scianni</surname><given-names>M</given-names></name><name><surname>Panzanelli</surname><given-names>P</given-names></name><name><surname>Giustetto</surname><given-names>M</given-names></name><name><surname>Ferreira</surname><given-names>TA</given-names></name><name><surname>Guiducci</surname><given-names>E</given-names></name><name><surname>Dumas</surname><given-names>L</given-names></name><name><surname>Ragozzino</surname><given-names>D</given-names></name><name><surname>Gross</surname><given-names>CT</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Synaptic pruning by microglia is necessary for normal brain development</article-title><source>Science (New York, N.Y.)</source><volume>333</volume><fpage>1456</fpage><lpage>1458</lpage><pub-id pub-id-type="doi">10.1126/science.1202529</pub-id><pub-id pub-id-type="pmid">21778362</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HC</given-names></name><name><surname>Appel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Delta-Notch signaling regulates oligodendrocyte specification</article-title><source>Development (Cambridge, England)</source><volume>130</volume><fpage>3747</fpage><lpage>3755</lpage><pub-id pub-id-type="doi">10.1242/dev.00576</pub-id><pub-id pub-id-type="pmid">12835391</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlin</surname><given-names>JR</given-names></name><name><surname>Lush</surname><given-names>ME</given-names></name><name><surname>Stephens</surname><given-names>WZ</given-names></name><name><surname>Piotrowski</surname><given-names>T</given-names></name><name><surname>Talbot</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neuronal Neuregulin 1 type III directs Schwann cell migration</article-title><source>Development (Cambridge, England)</source><volume>138</volume><fpage>4639</fpage><lpage>4648</lpage><pub-id pub-id-type="doi">10.1242/dev.068072</pub-id><pub-id pub-id-type="pmid">21965611</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1960">1960a</year><article-title>The formation and structure of myelin sheaths in the central nervous system</article-title><source>The Journal of Biophysical and Biochemical Cytology</source><volume>8</volume><fpage>431</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1083/jcb.8.2.431</pub-id><pub-id pub-id-type="pmid">13734758</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1960">1960b</year><article-title>The structure of myelin sheaths in the central nervous system of <italic>Xenopus laevis</italic> (Daudin)</article-title><source>The Journal of Biophysical and Biochemical Cytology</source><volume>7</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1083/jcb.7.1.121</pub-id><pub-id pub-id-type="pmid">14432183</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piller</surname><given-names>M</given-names></name><name><surname>Werkman</surname><given-names>IL</given-names></name><name><surname>Brown</surname><given-names>EA</given-names></name><name><surname>Latimer</surname><given-names>AJ</given-names></name><name><surname>Kucenas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Glutamate Signaling via the AMPAR Subunit GluR4 Regulates Oligodendrocyte Progenitor Cell Migration in the Developing Spinal Cord</article-title><source>The Journal of Neuroscience</source><volume>41</volume><fpage>5353</fpage><lpage>5371</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2562-20.2021</pub-id><pub-id pub-id-type="pmid">33975920</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasband</surname><given-names>MN</given-names></name><name><surname>Peles</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mechanisms of node of Ranvier assembly</article-title><source>Nature Reviews. Neuroscience</source><volume>22</volume><fpage>7</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1038/s41583-020-00406-8</pub-id><pub-id pub-id-type="pmid">33239761</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiter</surname><given-names>CR</given-names></name><name><surname>Bongarzone</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The Role of Vesicle Trafficking and Release in Oligodendrocyte Biology</article-title><source>Neurochemical Research</source><volume>45</volume><fpage>620</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1007/s11064-019-02913-2</pub-id><pub-id pub-id-type="pmid">31782103</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>On the relation between fibre diameter and conduction velocity in myelinated nerve fibres</article-title><source>Proceedings of the Royal Society of London. Series B, Biological Sciences</source><volume>217</volume><fpage>29</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1098/rspb.1982.0092</pub-id><pub-id pub-id-type="pmid">6131421</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas-Muñoz</surname><given-names>A</given-names></name><name><surname>Rajadhyksha</surname><given-names>S</given-names></name><name><surname>Gilmour</surname><given-names>D</given-names></name><name><surname>van Bebber</surname><given-names>F</given-names></name><name><surname>Antos</surname><given-names>C</given-names></name><name><surname>Rodríguez Esteban</surname><given-names>C</given-names></name><name><surname>Nüsslein-Volhard</surname><given-names>C</given-names></name><name><surname>Izpisúa Belmonte</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>ErbB2 and ErbB3 regulate amputation-induced proliferation and migration during vertebrate regeneration</article-title><source>Developmental Biology</source><volume>327</volume><fpage>177</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2008.12.012</pub-id><pub-id pub-id-type="pmid">19133254</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rollins</surname><given-names>SA</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Ninomiya</surname><given-names>H</given-names></name><name><surname>Sims</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9</article-title><source>Journal of Immunology (Baltimore, Md)</source><volume>146</volume><fpage>2345</fpage><lpage>2351</lpage><pub-id pub-id-type="pmid">1706395</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rus</surname><given-names>HG</given-names></name><name><surname>Niculescu</surname><given-names>F</given-names></name><name><surname>Shin</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Sublytic complement attack induces cell cycle in oligodendrocytes</article-title><source>Journal of Immunology (Baltimore, Md)</source><volume>156</volume><fpage>4892</fpage><lpage>4900</lpage><pub-id pub-id-type="pmid">8648139</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rus</surname><given-names>H</given-names></name><name><surname>Niculescu</surname><given-names>F</given-names></name><name><surname>Badea</surname><given-names>T</given-names></name><name><surname>Shin</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Terminal complement complexes induce cell cycle entry in oligodendrocytes through mitogen activated protein kinase pathway</article-title><source>Immunopharmacology</source><volume>38</volume><fpage>177</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1016/s0162-3109(97)00063-5</pub-id><pub-id pub-id-type="pmid">9476129</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rus</surname><given-names>HG</given-names></name><name><surname>Niculescu</surname><given-names>FI</given-names></name><name><surname>Shin</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Role of the C5b-9 complement complex in cell cycle and apoptosis</article-title><source>Immunological Reviews</source><volume>180</volume><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1034/j.1600-065x.2001.1800104.x</pub-id><pub-id pub-id-type="pmid">11414362</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>LM</given-names></name><name><surname>Mishra</surname><given-names>AK</given-names></name><name><surname>Aman</surname><given-names>AJ</given-names></name><name><surname>Lewis</surname><given-names>VM</given-names></name><name><surname>Toomey</surname><given-names>MB</given-names></name><name><surname>Packer</surname><given-names>JS</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>McFaline-Figueroa</surname><given-names>JL</given-names></name><name><surname>Corbo</surname><given-names>JC</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Parichy</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Thyroid hormone regulates distinct paths to maturation in pigment cell lineages</article-title><source>eLife</source><volume>8</volume><elocation-id>e45181</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.45181</pub-id><pub-id pub-id-type="pmid">31140974</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scolding</surname><given-names>NJ</given-names></name><name><surname>Morgan</surname><given-names>BP</given-names></name><name><surname>Compston</surname><given-names>DAS</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The expression of complement regulatory proteins by adult human oligodendrocytes</article-title><source>Journal of Neuroimmunology</source><volume>84</volume><fpage>69</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/s0165-5728(97)00241-5</pub-id><pub-id pub-id-type="pmid">9600710</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>HC</given-names></name><name><surname>Topczewska</surname><given-names>JM</given-names></name><name><surname>Mawdsley</surname><given-names>DJ</given-names></name><name><surname>Appel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Neural cell fate analysis in zebrafish using olig2 BAC transgenics</article-title><source>Methods in Cell Science</source><volume>25</volume><fpage>7</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1023/B:MICS.0000006847.09037.3a</pub-id><pub-id pub-id-type="pmid">14739582</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siems</surname><given-names>SB</given-names></name><name><surname>Jahn</surname><given-names>O</given-names></name><name><surname>Hoodless</surname><given-names>LJ</given-names></name><name><surname>Jung</surname><given-names>RB</given-names></name><name><surname>Hesse</surname><given-names>D</given-names></name><name><surname>Möbius</surname><given-names>W</given-names></name><name><surname>Czopka</surname><given-names>T</given-names></name><name><surname>Werner</surname><given-names>HB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Proteome Profile of Myelin in the Zebrafish Brain</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>9</volume><elocation-id>640169</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.640169</pub-id><pub-id pub-id-type="pmid">33898427</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>NJ</given-names></name><name><surname>Nagashima</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Kakuk-Atkins</surname><given-names>L</given-names></name><name><surname>Ashrafzadeh</surname><given-names>M</given-names></name><name><surname>Hyde</surname><given-names>DR</given-names></name><name><surname>Hitchcock</surname><given-names>PF</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Inflammation and matrix metalloproteinase 9 (Mmp-9) regulate photoreceptor regeneration in adult zebrafish</article-title><source>Glia</source><volume>68</volume><fpage>1445</fpage><lpage>1465</lpage><pub-id pub-id-type="doi">10.1002/glia.23792</pub-id><pub-id pub-id-type="pmid">32034934</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>NJ</given-names></name><name><surname>Dorman</surname><given-names>LC</given-names></name><name><surname>Vainchtein</surname><given-names>ID</given-names></name><name><surname>Horneck</surname><given-names>NC</given-names></name><name><surname>Molofsky</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>In situ and transcriptomic identification of microglia in synapse-rich regions of the developing zebrafish brain</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>5916</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-26206-x</pub-id><pub-id pub-id-type="pmid">34625548</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>CJ</given-names></name><name><surname>Morris</surname><given-names>AD</given-names></name><name><surname>Welsh</surname><given-names>TG</given-names></name><name><surname>Kucenas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Contact-mediated inhibition between oligodendrocyte progenitor cells and motor exit point glia establishes the spinal cord transition zone</article-title><source>PLOS Biology</source><volume>12</volume><elocation-id>e1001961</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001961</pub-id><pub-id pub-id-type="pmid">25268888</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solmaz</surname><given-names>I</given-names></name><name><surname>Aytekin</surname><given-names>ES</given-names></name><name><surname>Çağdaş</surname><given-names>D</given-names></name><name><surname>Tan</surname><given-names>C</given-names></name><name><surname>Tezcan</surname><given-names>I</given-names></name><name><surname>Gocmen</surname><given-names>R</given-names></name><name><surname>Haliloglu</surname><given-names>G</given-names></name><name><surname>Anlar</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Recurrent Demyelinating Episodes as Sole Manifestation of Inherited CD59 Deficiency</article-title><source>Neuropediatrics</source><volume>51</volume><fpage>206</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1055/s-0039-3399583</pub-id><pub-id pub-id-type="pmid">31752029</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stadelmann</surname><given-names>C</given-names></name><name><surname>Timmler</surname><given-names>S</given-names></name><name><surname>Barrantes-Freer</surname><given-names>A</given-names></name><name><surname>Simons</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Myelin in the Central Nervous System: Structure, Function, and Pathology</article-title><source>Physiological Reviews</source><volume>99</volume><fpage>1381</fpage><lpage>1431</lpage><pub-id pub-id-type="doi">10.1152/physrev.00031.2018</pub-id><pub-id pub-id-type="pmid">31066630</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stahel</surname><given-names>PF</given-names></name><name><surname>Flierl</surname><given-names>MA</given-names></name><name><surname>Morgan</surname><given-names>BP</given-names></name><name><surname>Persigehl</surname><given-names>I</given-names></name><name><surname>Stoll</surname><given-names>C</given-names></name><name><surname>Conrad</surname><given-names>C</given-names></name><name><surname>Touban</surname><given-names>BM</given-names></name><name><surname>Smith</surname><given-names>WR</given-names></name><name><surname>Beauchamp</surname><given-names>K</given-names></name><name><surname>Schmidt</surname><given-names>OI</given-names></name><name><surname>Ertel</surname><given-names>W</given-names></name><name><surname>Leinhase</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice</article-title><source>Journal of Neuroinflammation</source><volume>6</volume><elocation-id>2</elocation-id><pub-id pub-id-type="doi">10.1186/1742-2094-6-2</pub-id><pub-id pub-id-type="pmid">19133139</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>B</given-names></name><name><surname>Allen</surname><given-names>NJ</given-names></name><name><surname>Vazquez</surname><given-names>LE</given-names></name><name><surname>Howell</surname><given-names>GR</given-names></name><name><surname>Christopherson</surname><given-names>KS</given-names></name><name><surname>Nouri</surname><given-names>N</given-names></name><name><surname>Micheva</surname><given-names>KD</given-names></name><name><surname>Mehalow</surname><given-names>AK</given-names></name><name><surname>Huberman</surname><given-names>AD</given-names></name><name><surname>Stafford</surname><given-names>B</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name><name><surname>Litke</surname><given-names>AM</given-names></name><name><surname>Lambris</surname><given-names>JD</given-names></name><name><surname>Smith</surname><given-names>SJ</given-names></name><name><surname>John</surname><given-names>SWM</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The classical complement cascade mediates CNS synapse elimination</article-title><source>Cell</source><volume>131</volume><fpage>1164</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.10.036</pub-id><pub-id pub-id-type="pmid">18083105</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Zebrafish CD59 has both bacterial-binding and inhibiting activities</article-title><source>Developmental and Comparative Immunology</source><volume>41</volume><fpage>178</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2013.05.008</pub-id><pub-id pub-id-type="pmid">23707788</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Susuki</surname><given-names>K</given-names></name><name><surname>Chang</surname><given-names>KJ</given-names></name><name><surname>Zollinger</surname><given-names>DR</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Ogawa</surname><given-names>Y</given-names></name><name><surname>Eshed-Eisenbach</surname><given-names>Y</given-names></name><name><surname>Dours-Zimmermann</surname><given-names>MT</given-names></name><name><surname>Oses-Prieto</surname><given-names>JA</given-names></name><name><surname>Burlingame</surname><given-names>AL</given-names></name><name><surname>Seidenbecher</surname><given-names>CI</given-names></name><name><surname>Zimmermann</surname><given-names>DR</given-names></name><name><surname>Oohashi</surname><given-names>T</given-names></name><name><surname>Peles</surname><given-names>E</given-names></name><name><surname>Rasband</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Three mechanisms assemble central nervous system nodes of Ranvier</article-title><source>Neuron</source><volume>78</volume><fpage>469</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.03.005</pub-id><pub-id pub-id-type="pmid">23664614</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname><given-names>N</given-names></name><name><surname>Kucenas</surname><given-names>S</given-names></name><name><surname>Appel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Sox10 is necessary for oligodendrocyte survival following axon wrapping</article-title><source>Glia</source><volume>58</volume><fpage>996</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1002/glia.20981</pub-id><pub-id pub-id-type="pmid">20229602</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>H.</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Juvenile Hermaphroditism in the Zebrafish, <italic>Brachydanio rerio</italic></article-title><source>北海道大學水産學部研究彙報</source><volume>28</volume><fpage>57</fpage><lpage>65</lpage></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tasdemir-Yilmaz</surname><given-names>OE</given-names></name><name><surname>Druckenbrod</surname><given-names>NR</given-names></name><name><surname>Olukoya</surname><given-names>OO</given-names></name><name><surname>Dong</surname><given-names>W</given-names></name><name><surname>Yung</surname><given-names>AR</given-names></name><name><surname>Bastille</surname><given-names>I</given-names></name><name><surname>Pazyra-Murphy</surname><given-names>MF</given-names></name><name><surname>Sitko</surname><given-names>AA</given-names></name><name><surname>Hale</surname><given-names>EB</given-names></name><name><surname>Vigneau</surname><given-names>S</given-names></name><name><surname>Gimelbrant</surname><given-names>AA</given-names></name><name><surname>Kharchenko</surname><given-names>PV</given-names></name><name><surname>Goodrich</surname><given-names>LV</given-names></name><name><surname>Segal</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Diversity of developing peripheral glia revealed by single-cell RNA sequencing</article-title><source>Developmental Cell</source><volume>56</volume><fpage>2516</fpage><lpage>2535</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2021.08.005</pub-id><pub-id pub-id-type="pmid">34469751</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatomir</surname><given-names>A</given-names></name><name><surname>Rao</surname><given-names>G</given-names></name><name><surname>Boodhoo</surname><given-names>D</given-names></name><name><surname>Vlaicu</surname><given-names>SI</given-names></name><name><surname>Beltrand</surname><given-names>A</given-names></name><name><surname>Anselmo</surname><given-names>F</given-names></name><name><surname>Rus</surname><given-names>V</given-names></name><name><surname>Rus</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Histone Deacetylase SIRT1 Mediates C5b-9-Induced Cell Cycle in Oligodendrocytes</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>619</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.00619</pub-id><pub-id pub-id-type="pmid">32328069</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tegla</surname><given-names>CA</given-names></name><name><surname>Cudrici</surname><given-names>C</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Trippe</surname><given-names>R</given-names></name><name><surname>Rus</surname><given-names>V</given-names></name><name><surname>Niculescu</surname><given-names>F</given-names></name><name><surname>Rus</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011a</year><article-title>Membrane attack by complement: the assembly and biology of terminal complement complexes</article-title><source>Immunologic Research</source><volume>51</volume><fpage>45</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1007/s12026-011-8239-5</pub-id><pub-id pub-id-type="pmid">21850539</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tegla</surname><given-names>CA</given-names></name><name><surname>Cudrici</surname><given-names>C</given-names></name><name><surname>Rozycka</surname><given-names>M</given-names></name><name><surname>Soloviova</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>Azimzadeh</surname><given-names>P</given-names></name><name><surname>Andrian-Albescu</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>Niculescu</surname><given-names>F</given-names></name><name><surname>Rus</surname><given-names>V</given-names></name><name><surname>Judge</surname><given-names>SIV</given-names></name><name><surname>Rus</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011b</year><article-title>C5b-9-activated, K(v)1.3 channels mediate oligodendrocyte cell cycle activation and dedifferentiation</article-title><source>Experimental and Molecular Pathology</source><volume>91</volume><fpage>335</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.yexmp.2011.04.006</pub-id><pub-id pub-id-type="pmid">21540025</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tone</surname><given-names>M</given-names></name><name><surname>Diamond</surname><given-names>LE</given-names></name><name><surname>Walsh</surname><given-names>LA</given-names></name><name><surname>Tone</surname><given-names>Y</given-names></name><name><surname>Thompson</surname><given-names>SAJ</given-names></name><name><surname>Shanahan</surname><given-names>EM</given-names></name><name><surname>Logan</surname><given-names>JS</given-names></name><name><surname>Waldmann</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>High level transcription of the complement regulatory protein CD59 requires an enhancer located in intron 1</article-title><source>The Journal of Biological Chemistry</source><volume>274</volume><fpage>710</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.2.710</pub-id><pub-id pub-id-type="pmid">9873006</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Topilko</surname><given-names>P</given-names></name><name><surname>Schneider-Maunoury</surname><given-names>S</given-names></name><name><surname>Levi</surname><given-names>G</given-names></name><name><surname>Baron-Van Evercooren</surname><given-names>A</given-names></name><name><surname>Chennoufi</surname><given-names>ABY</given-names></name><name><surname>Seitanidou</surname><given-names>T</given-names></name><name><surname>Babinet</surname><given-names>C</given-names></name><name><surname>Charnay</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Krox-20 controls myelination in the peripheral nervous system</article-title><source>Nature</source><volume>371</volume><fpage>796</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1038/371796a0</pub-id><pub-id pub-id-type="pmid">7935840</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Triolo</surname><given-names>D</given-names></name><name><surname>Dina</surname><given-names>G</given-names></name><name><surname>Taveggia</surname><given-names>C</given-names></name><name><surname>Vaccari</surname><given-names>I</given-names></name><name><surname>Porrello</surname><given-names>E</given-names></name><name><surname>Rivellini</surname><given-names>C</given-names></name><name><surname>Domi</surname><given-names>T</given-names></name><name><surname>La Marca</surname><given-names>R</given-names></name><name><surname>Cerri</surname><given-names>F</given-names></name><name><surname>Bolino</surname><given-names>A</given-names></name><name><surname>Quattrini</surname><given-names>A</given-names></name><name><surname>Previtali</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Vimentin regulates peripheral nerve myelination</article-title><source>Development (Cambridge, England)</source><volume>139</volume><fpage>1359</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1242/dev.072371</pub-id><pub-id pub-id-type="pmid">22357929</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Knaap</surname><given-names>MS</given-names></name><name><surname>Bugiani</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms</article-title><source>Acta Neuropathologica</source><volume>134</volume><fpage>351</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1007/s00401-017-1739-1</pub-id><pub-id pub-id-type="pmid">28638987</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villani</surname><given-names>A</given-names></name><name><surname>Benjaminsen</surname><given-names>J</given-names></name><name><surname>Moritz</surname><given-names>C</given-names></name><name><surname>Henke</surname><given-names>K</given-names></name><name><surname>Hartmann</surname><given-names>J</given-names></name><name><surname>Norlin</surname><given-names>N</given-names></name><name><surname>Richter</surname><given-names>K</given-names></name><name><surname>Schieber</surname><given-names>NL</given-names></name><name><surname>Franke</surname><given-names>T</given-names></name><name><surname>Schwab</surname><given-names>Y</given-names></name><name><surname>Peri</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Clearance by Microglia Depends on Packaging of Phagosomes into a Unique Cellular Compartment</article-title><source>Developmental Cell</source><volume>49</volume><fpage>77</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.02.014</pub-id><pub-id pub-id-type="pmid">30880002</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Z</given-names></name><name><surname>Fei</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Emerging Role of Schwann Cells in Neuropathic Pain: Receptors, Glial Mediators and Myelination</article-title><source>Frontiers in Cellular Neuroscience</source><volume>13</volume><elocation-id>116</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2019.00116</pub-id><pub-id pub-id-type="pmid">30971897</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>R</given-names></name><name><surname>Krämer-Albers</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Axon-glia interaction and membrane traffic in myelin formation</article-title><source>Frontiers in Cellular Neuroscience</source><volume>7</volume><elocation-id>284</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2013.00284</pub-id><pub-id pub-id-type="pmid">24431989</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieser</surname><given-names>RJ</given-names></name><name><surname>Schütz</surname><given-names>S</given-names></name><name><surname>Tschank</surname><given-names>G</given-names></name><name><surname>Thomas</surname><given-names>H</given-names></name><name><surname>Dienes</surname><given-names>HP</given-names></name><name><surname>Oesch</surname><given-names>F</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Isolation and characterization of a 60-70-kD plasma membrane glycoprotein involved in the contact-dependent inhibition of growth</article-title><source>The Journal of Cell Biology</source><volume>111</volume><fpage>2681</fpage><lpage>2692</lpage><pub-id pub-id-type="doi">10.1083/jcb.111.6.2681</pub-id><pub-id pub-id-type="pmid">2277080</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>KS</given-names></name><name><surname>Matrone</surname><given-names>G</given-names></name><name><surname>Livingstone</surname><given-names>DEW</given-names></name><name><surname>Al-Dujaili</surname><given-names>EAS</given-names></name><name><surname>Mullins</surname><given-names>JJ</given-names></name><name><surname>Tucker</surname><given-names>CS</given-names></name><name><surname>Hadoke</surname><given-names>PWF</given-names></name><name><surname>Kenyon</surname><given-names>CJ</given-names></name><name><surname>Denvir</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Physiological roles of glucocorticoids during early embryonic development of the zebrafish (<italic>Danio rerio</italic>): Glucocorticoid physiology in the developing zebrafish embryo</article-title><source>J Physiol</source><volume>591</volume><fpage>6209</fpage><lpage>6220</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2013.256826</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>KS</given-names></name><name><surname>Tucker</surname><given-names>CS</given-names></name><name><surname>Al-Dujaili</surname><given-names>EAS</given-names></name><name><surname>Holmes</surname><given-names>MC</given-names></name><name><surname>Hadoke</surname><given-names>PWF</given-names></name><name><surname>Kenyon</surname><given-names>CJ</given-names></name><name><surname>Denvir</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Early-life glucocorticoids programme behaviour and metabolism in adulthood in zebrafish</article-title><source>The Journal of Endocrinology</source><volume>230</volume><fpage>125</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1530/JOE-15-0376</pub-id><pub-id pub-id-type="pmid">27390302</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiltbank</surname><given-names>AT</given-names></name><name><surname>Kucenas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Diversity and convergence within peripheral glia development</article-title><source>Trends in Neurosciences</source><volume>44</volume><fpage>930</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2021.10.004</pub-id><pub-id pub-id-type="pmid">34689995</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolbert</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Heming</surname><given-names>M</given-names></name><name><surname>Mausberg</surname><given-names>AK</given-names></name><name><surname>Akkermann</surname><given-names>D</given-names></name><name><surname>Frydrychowicz</surname><given-names>C</given-names></name><name><surname>Fledrich</surname><given-names>R</given-names></name><name><surname>Groeneweg</surname><given-names>L</given-names></name><name><surname>Schulz</surname><given-names>C</given-names></name><name><surname>Stettner</surname><given-names>M</given-names></name><name><surname>Alonso Gonzalez</surname><given-names>N</given-names></name><name><surname>Wiendl</surname><given-names>H</given-names></name><name><surname>Stassart</surname><given-names>R</given-names></name><name><surname>Meyer Zu Hörste</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Redefining the heterogeneity of peripheral nerve cells in health and autoimmunity</article-title><source>PNAS</source><volume>117</volume><fpage>9466</fpage><lpage>9476</lpage><pub-id pub-id-type="doi">10.1073/pnas.1912139117</pub-id><pub-id pub-id-type="pmid">32295886</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Verkman</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G</article-title><source>Acta Neuropathologica Communications</source><volume>5</volume><elocation-id>15</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-017-0417-9</pub-id><pub-id pub-id-type="pmid">28212662</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>McGlynn</surname><given-names>S</given-names></name><name><surname>Matise</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Floor plate-derived sonic hedgehog regulates glial and ependymal cell fates in the developing spinal cord</article-title><source>Development (Cambridge, England)</source><volume>140</volume><fpage>1594</fpage><lpage>1604</lpage><pub-id pub-id-type="doi">10.1242/dev.090845</pub-id><pub-id pub-id-type="pmid">23482494</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zajicek</surname><given-names>J</given-names></name><name><surname>Wing</surname><given-names>M</given-names></name><name><surname>Skepper</surname><given-names>J</given-names></name><name><surname>Compston</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Human oligodendrocytes are not sensitive to complement. A study of CD59 expression in the human central nervous system</article-title><source>Laboratory Investigation; a Journal of Technical Methods and Pathology</source><volume>73</volume><fpage>128</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">7541492</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Cui</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Complement system in zebrafish</article-title><source>Developmental and Comparative Immunology</source><volume>46</volume><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2014.01.010</pub-id><pub-id pub-id-type="pmid">24462834</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Crowley</surname><given-names>SC</given-names></name><name><surname>Latimer</surname><given-names>AJ</given-names></name><name><surname>Lewis</surname><given-names>GM</given-names></name><name><surname>Nash</surname><given-names>R</given-names></name><name><surname>Kucenas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Migratory Neural Crest Cells Phagocytose Dead Cells in the Developing Nervous System</article-title><source>Cell</source><volume>179</volume><fpage>74</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.08.001</pub-id><pub-id pub-id-type="pmid">31495570</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zwaka</surname><given-names>TP</given-names></name><name><surname>Torzewski</surname><given-names>J</given-names></name><name><surname>Hoeflich</surname><given-names>A</given-names></name><name><surname>Déjosez</surname><given-names>M</given-names></name><name><surname>Kaiser</surname><given-names>S</given-names></name><name><surname>Hombach</surname><given-names>V</given-names></name><name><surname>Jehle</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The terminal complement complex inhibits apoptosis in vascular smooth muscle cells by activating an autocrine IGF-1 loop</article-title><source>FASEB Journal</source><volume>17</volume><fpage>1346</fpage><lpage>1348</lpage><pub-id pub-id-type="doi">10.1096/fj.02-0814fje</pub-id><pub-id pub-id-type="pmid">12759337</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76640.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Feltri</surname><given-names>M Laura</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01q1z8k08</institution-id><institution>SUNY Buffalo</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2022.01.11.475853" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2022.01.11.475853"/></front-stub><body><p>This work investigates the function of the small GPI-anchored protein Cd59, a protein known to suppress complement-mediated inflammation, in Schwann cell development and myelination, using zebrafish as a model system. This article will be of interest to developmental biologists, glial biologists, and immunologists as it suggests the interesting and novel findings that Cd59 regulates Schwann cell development, mainly by modulating Schwann cell proliferation.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76640.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Feltri</surname><given-names>M Laura</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01q1z8k08</institution-id><institution>SUNY Buffalo</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.01.11.475853">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.01.11.475853v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Cd59 and inflammation orchestrate Schwann cell development&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Didier Stainier as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>There is strong consensus by all three reviewers on the potential interest and novelty of the paper. However, reviewers 1 and 3 felt that more experiments are needed to support the major conclusions of the paper. I do agree with these reviewers that the data in figure 2, 3 and 5 should be significantly improved to be more convincing. I also agree that, while the rescue is impressive, desametazone has very broad action and more data are needed to corroborate that excessive proliferation and myelination were actually rescued after desametazone treatment. Although the suggestion of reviewer 1 to confirm the rescue using available drugs with a more restricted complement effect is valuable, I think that it would be sufficient to discuss the shortcoming of desametazone and tune down the claims about the effect of inflammation in the text and title. Reviewers 1 and 3 also had questions about the mechanisms, that relate to explanation regarding the large effect of Cd59 deletion, given the small percentage of cells expressing CD59, and also on how to explain the relationship between Schwann cell proliferation and impaired myelination or formation of nodes of Ranvier. I would add to this that it is very surprising that increased proliferation in Schwann cell precursors does not lead to increased apoptosis, as it is well known that Schwann cell precursors depend on axonal contact for survival.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1. What could impair myelination if Schwann cells are not overproliferating anymore at the time of myelination? Analysis of the Schwann cell cycle at the time of myelination could provide some explanation. We need at least expression data of the inducers and inhibitors of myelination. There is also no functional analyses. The impaired myelination and node of Ranvier formation must lead to functional impairment.</p><p>2. Figure 2—figure supplement 1, panel C: even with a lot of effort, I cannot see co-localization of cd59 (cyan) with Sox10:megfp (orange) at any time-point. It could be that some of the Sox10:megfp-labeled cells are cd59-positive, but arrows are missing on the orange channel and it is not clear whether those are confocal images or not. Whether cd59 is expressed in Sox10-expressing cells is an essential point for the study, so it is important to show convincing images. Co-localization is also not convincing in Figure 2B. In addition, the arrows seem to indicate cd59-positive cells and not Sox10:megfp SCs or OLs, as stated in the figure legend. Co-IF showing cd59:tagrfp expression in Sox10-positive SCs is more convincing. Please, add co-IF images at 3 or 4 dpf to illustrate quantification shown in Figure 2E. According to the Material and methods section, the IF images seem to have been taken by confocal microscopy. Please, add this information in the figure legend.</p><p>3. Figure 2¬—figure supplement 2: in panel A, co-localization is again not obvious at all. In panels B-D, what are we looking at? IF or in vivo labeling? Could the authors quickly clarify the expected subcellular localization of the different egfp reporters used here to avoid the need to look for this information in the referenced articles?</p><p>4. Figure 3G: same comment as above, not convincing. I really do not understand what we are looking at. In Figure 3H, the authors show a graph representing the number of puncta per cell. Does it mean that what is shown in Figure 3G is a single cell? To me, this does not look like a single cell. How do the authors define the limits of single cells? They need to show images with several cells so that we have an idea of how straightforward it is to detect the limits of each cell. In the figure legend of Figure 3G, it is not written that the images presented show single cells.</p><p>5. Figure 5A: THE EM images of the mutant and the control look very different in quality. Could the authors show images of comparable quality/resolution? Looking at these images, I wonder how easy it is to count individual wraps in a reliable manner. In Figure 5D, it seems that the total number of axons has been used as n for statistics and not the average of all axons per fish with a n of 3, as stated in the figure legend. For statistical analyses, the n should be the number of fish, n=3. If the n is too high, there is a risk of finding a significant difference where there is no real difference. Please, re-calculate in case the n used was indeed the number of axons and not the number of fish.</p><p>6. Figure 5C: The NF186 staining is not convincing at all. This needs to be improved. At the moment, it appears very unspecific. Co-localization with another nodal component or another antibody with a less non-specific signal could help. In addition, the resolution of the images shown in Figure 5B is not good enough and should also be improved. The mbpa:tagrfp-caax does not help much either. It would be better to use an antibody to detect MBP or Neurofilament, for example.</p><p>7. Figure 6A: Again, the staining here for C5b-9/C5b-8 is not convincing. First, the signal is very low and we don't see much. Second, it is not clear whether the authors permeabilized the tissues or not (this information does not seem to be given in the Material and methods section). C5b-9/C5b-8 should be localized at the cell surface, so a cross-view should be added to the longitudinal view to demonstrate the membrane localization.</p><p>8. Discussion: This part does not really discuss in depth the main claimed findings of the study and does not discuss the potential implication of the new findings in relation to the CD59 human deficiency and neurological dysfunctions resistant to treatment by complement inhibitors. This part thus appears incomplete.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>This is an interesting and relevant manuscript and nice work, and everyone in the field should benefit from reading it. My congratulations! I have just a few observations that the authors may want to consider for their revision</p><p>-As CD59 is only one out of several factors affecting Schwann cell development (GPCRs, ECM, transcription factors,.…), I feel phrasing that CD59 'orchestrates' SC development (in the title) may be a little too strong. 'Regulates', maybe?</p><p>-Some letters and numbers are too small to be deciphered in Figure 1 Suppl 1 A, C1, C2 and D</p><p>-Image quality is comparatively poor in Figure 1 Sup1 A, B1, B2, B3. This may be just in my PDF copy, but if not the authors may want to search for ways to improve them.</p><p>-In Figure 1 Sup1 D legend, I suppose the authors mean 'myelinating OLCs', not 'mouse OLCs'</p><p>-Page 26, Line 226-227, I suppose the authors mean 117 AA, not 177 AA</p><p>- In case suitable samples and antibodies are available, Figure 3 would benefit from Western blot validation of the lack of CD59 in the zebrafish line.</p><p>-Figure 4 F, the authors may want to consider if these are truly representative images. The difference is not easily spotted.</p><p>-Why not switch Figure 4 S2 and Figure 4 S1? It may possibly fit better with the line of arguments. Not essential, just a suggestion.</p><p>-Figure 5 A, can the authors please double-check if these are truly representative images? I am asking because the axon diameters seem to differ in the mutants as judged by the example images. Are there enough suitable samples to quantify axonal diameters? Is it possible to say if axons are normally sorted out of bundles, i.e. to quantify the numbers and diameters of axons in bundles? Sorting defects are common pathology in the PNS, at least in mammals.</p><p>- In case suitable samples and antibodies are available, Fig6 would benefit from a Western blot for the complement. Not an essential revision</p><p>-Related to Fig7, in case suitable samples are available it would be interesting to see TEM of myelinated axons and nodes after Dexamethasone treatment. Not an essential revision, just interesting</p><p>- In case the required samples are available, it would be interesting to see some examination of adult WT vs mutant zebrafish. Not an essential revision, again.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76640.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>There is strong consensus by all three reviewers on the potential interest and novelty of the paper. However, reviewers 1 and 3 felt that more experiments are needed to support the major conclusions of the paper. I do agree with these reviewers that the data in figure 2, 3 and 5 should be significantly improved to be more convincing. I also agree that, while the rescue is impressive, desametazone has very broad action and more data are needed to corroborate that excessive proliferation and myelination were actually rescued after desametazone treatment. Although the suggestion of reviewer 1 to confirm the rescue using available drugs with a more restricted complement effect is valuable, I think that it would be sufficient to discuss the shortcoming of desametazone and tune down the claims about the effect of inflammation in the text and title. Reviewers 1 and 3 also had questions about the mechanisms, that relate to explanation regarding the large effect of Cd59 deletion, given the small percentage of cells expressing CD59, and also on how to explain the relationship between Schwann cell proliferation and impaired myelination or formation of nodes of Ranvier. I would add to this that it is very surprising that increased proliferation in Schwann cell precursors does not lead to increased apoptosis, as it is well known that Schwann cell precursors depend on axonal contact for survival.</p></disp-quote><p>Thank you for your comments. We have added data to improve figures 2, 3, and 5 as well as expanded our discussion to speculate on some of the potential mechanisms at play and other interesting questions elicited by the results of this study. We have also adjusted our claims to reflect the shortcomings of dexamethasone. We have addressed the rest of the reviewer comments below.</p><p>With regards to the SCPs, it appears that there is enough room on the nerve to accommodate the extra cells. From our time-lapse imaging, we observe that all SCPs have contact with the nerve, which we speculate must be sufficient to maintain their survival.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>1. What could impair myelination if Schwann cells are not overproliferating anymore at the time of myelination? Analysis of the Schwann cell cycle at the time of myelination could provide some explanation. We need at least expression data of the inducers and inhibitors of myelination. There is also no functional analyses. The impaired myelination and node of Ranvier formation must lead to functional impairment.</p></disp-quote><p>Thank you for your comment. We added discussion around potential mechanisms for impaired myelination in our text.</p><p>In addition to the <italic>sox10</italic> and <italic>mbp</italic> expression we show in Figure 3E and F, we have added analysis of <italic>krox20</italic> expression. These data indicate that the <italic>cd59</italic> mutant SCs are expressing genes that are necessary for SC development and myelination. In addition to these data, the <italic>cd59</italic> mutant SCs also produce myelin at the correct developmental stage, indicating that these cells are capable of myelination.</p><p>Given these data, we propose two possible hypotheses in our discussion as to why myelin formation is reduced in the cd59 mutants.</p><p>With regards to functional impairment, we agree that this will be interesting to look at in future studies. At the developmental stages we are looking at, it is not typical to see functional issues and therefore, we are not surprised that there is no obvious phenotype. However, in a future study, we would love to look closer at the consequences of these myelin and node of Ranvier defects in our adult mutants, which do appear to have neurological dysfunction.</p><disp-quote content-type="editor-comment"><p>2. Figure 2—figure supplement 1, panel C: even with a lot of effort, I cannot see co-localization of cd59 (cyan) with Sox10:megfp (orange) at any time-point. It could be that some of the Sox10:megfp-labeled cells are cd59-positive, but arrows are missing on the orange channel and it is not clear whether those are confocal images or not. Whether cd59 is expressed in Sox10-expressing cells is an essential point for the study, so it is important to show convincing images. Co-localization is also not convincing in Figure 2B. In addition, the arrows seem to indicate cd59-positive cells and not Sox10:megfp SCs or OLs, as stated in the figure legend. Co-IF showing cd59:tagrfp expression in Sox10-positive SCs is more convincing. Please, add co-IF images at 3 or 4 dpf to illustrate quantification shown in Figure 2E. According to the Material and methods section, the IF images seem to have been taken by confocal microscopy. Please, add this information in the figure legend.</p></disp-quote><p>Thank you for pointing this out. In these studies, we are using a membrane-tethered transgenic line to label SCs. Therefore, we don’t expect precise co-localization of <italic>cd59</italic> with this transgene. Instead, we expect to see <italic>cd59</italic> expression within <italic>sox10</italic>-positive cells. We have added the missing arrows to the orange channel (Figure 2 —figure supplement 1C) and clarified that these are confocal images.</p><p>In addition, we have also added Imaris renderings to highlight the <italic>cd59</italic> puncta that are localized within the SCs and OLs (see Figure 2C, Figure 2 —figure supplement 1D, Figure 2 —figure supplement 2B, and Figure 3I).</p><p>We have adjusted the figure legend to make it clear that the arrows are pointing to <italic>cd59</italic>-postive SCs and OLs.</p><p>We have added the 3 dpf time point to the figure as well (see Figure 2E).</p><disp-quote content-type="editor-comment"><p>3. Figure 2¬—figure supplement 2: in panel A, co-localization is again not obvious at all. In panels B-D, what are we looking at? IF or in vivo labeling? Could the authors quickly clarify the expected subcellular localization of the different egfp reporters used here to avoid the need to look for this information in the referenced articles?</p></disp-quote><p>Thank you for your comment. We have clarified in the figure legend that these are in vivo images as well as described the expected subcellular localizations.</p><disp-quote content-type="editor-comment"><p>4. Figure 3G: same comment as above, not convincing. I really do not understand what we are looking at. In Figure 3H, the authors show a graph representing the number of puncta per cell. Does it mean that what is shown in Figure 3G is a single cell? To me, this does not look like a single cell. How do the authors define the limits of single cells? They need to show images with several cells so that we have an idea of how straightforward it is to detect the limits of each cell. In the figure legend of Figure 3G, it is not written that the images presented show single cells.</p></disp-quote><p>Thank you for your comment. The images do depict single cells labeled with a membrane-tethered transgene. We have added Imaris renderings to make this more clear (see Figure 2C, Figure 2 —figure supplement 1D, Figure 2 —figure supplement 2B, and Figure 3I). We have updated the figure legend to reflect this information.</p><disp-quote content-type="editor-comment"><p>5. Figure 5A: THE EM images of the mutant and the control look very different in quality. Could the authors show images of comparable quality/resolution? Looking at these images, I wonder how easy it is to count individual wraps in a reliable manner. In Figure 5D, it seems that the total number of axons has been used as n for statistics and not the average of all axons per fish with a n of 3, as stated in the figure legend. For statistical analyses, the n should be the number of fish, n=3. If the n is too high, there is a risk of finding a significant difference where there is no real difference. Please, re-calculate in case the n used was indeed the number of axons and not the number of fish.</p></disp-quote><p>Thank you for your comment. We have added a different representative image for the mutant (see Figure 5A). We used the total number of axons for statistics because with TEM it is difficult to section exactly at the same position along the anterior-posterior axis of the larvae. By analyzing all of the axons rather than the average, we can account for anterior-posterior differences as well as visualize the distribution the data, which would be lost by averaging per fish. We have also updated our figure legend to better clarify our statistics.</p><disp-quote content-type="editor-comment"><p>6. Figure 5C: The NF186 staining is not convincing at all. This needs to be improved. At the moment, it appears very unspecific. Co-localization with another nodal component or another antibody with a less non-specific signal could help. In addition, the resolution of the images shown in Figure 5B is not good enough and should also be improved. The mbpa:tagrfp-caax does not help much either. It would be better to use an antibody to detect MBP or Neurofilament, for example.</p></disp-quote><p>Thank you for your comment. Please see our previous responses to these comments.</p><disp-quote content-type="editor-comment"><p>7. Figure 6A: Again, the staining here for C5b-9/C5b-8 is not convincing. First, the signal is very low and we don't see much. Second, it is not clear whether the authors permeabilized the tissues or not (this information does not seem to be given in the Material and methods section). C5b-9/C5b-8 should be localized at the cell surface, so a cross-view should be added to the longitudinal view to demonstrate the membrane localization.</p></disp-quote><p>Thank you for your comment. We have added our antibody controls to the supplemental figures (please see Figure 6 —figure supplement 1A) demonstrating that we can increase MAC deposition by inducing complement activation (either through heat-related damage or DNase-elicited DNA damage). We also do not observe signal when the primary antibody is not present. Based on our controls, we do not think the extra MAC labeling is background. Rather, we believe that MAC deposition has increased globally in the <italic>cd59</italic> mutant embryos. This is not surprising given that complement activation leads to a positive feedback loop of more complement and immune activation, which is likely occurring in the <italic>cd59</italic> mutants.</p><p>To help clarify the MAC data, we have also added Imaris renderings of the MACs that are bound to the SC membranes, demonstrating that there are more MACs embedded in the <italic>cd59</italic> mutant SC membranes compared to wildtype SCs (see Figure 6B).</p><p>Also, in regards our methods, we did permeabilize the tissue according to the protocol we cited in the methods (Fontenas and Kucenas 2021).</p><disp-quote content-type="editor-comment"><p>8. Discussion: This part does not really discuss in depth the main claimed findings of the study and does not discuss the potential implication of the new findings in relation to the CD59 human deficiency and neurological dysfunctions resistant to treatment by complement inhibitors. This part thus appears incomplete.</p></disp-quote><p>Thank you for your comment. We have expanded our discussion and added our thoughts about these findings in relation to human CD59 dysfunction (please see line 642).</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>This is an interesting and relevant manuscript and nice work, and everyone in the field should benefit from reading it. My congratulations! I have just a few observations that the authors may want to consider for their revision</p><p>-As CD59 is only one out of several factors affecting Schwann cell development (GPCRs, ECM, transcription factors,.…), I feel phrasing that CD59 'orchestrates' SC development (in the title) may be a little too strong. 'Regulates', maybe?</p></disp-quote><p>Thank you for your comment. We have incorporated your suggestion into the title.</p><disp-quote content-type="editor-comment"><p>-Some letters and numbers are too small to be deciphered in Figure 1 Suppl 1 A, C1, C2 and D</p></disp-quote><p>Thank you for pointing this out. We have adjusted the text to be more easily viewed.</p><disp-quote content-type="editor-comment"><p>-Image quality is comparatively poor in Figure 1 Sup1 A, B1, B2, B3. This may be just in my PDF copy, but if not the authors may want to search for ways to improve them.</p></disp-quote><p>Thank you for letting us know. Our PDF copies and printed copies have good image quality, but we will ensure that if our manuscript is accepted for publication, this figure is quality checked.</p><disp-quote content-type="editor-comment"><p>-In Figure 1 Sup1 D legend, I suppose the authors mean 'myelinating OLCs', not 'mouse OLCs'</p></disp-quote><p>Thank you for noticing this! We have corrected the typo.</p><disp-quote content-type="editor-comment"><p>-Page 26, Line 226-227, I suppose the authors mean 117 AA, not 177 AA</p></disp-quote><p>Thank you for noticing this! We have corrected the typo.</p><disp-quote content-type="editor-comment"><p>- In case suitable samples and antibodies are available, Figure 3 would benefit from Western blot validation of the lack of CD59 in the zebrafish line.</p></disp-quote><p>Thank you for the suggestion. Alas, we tried seven different antibodies and none were suitable for Western blot or IF. This is a common issue in the zebrafish field with many antibodies.</p><disp-quote content-type="editor-comment"><p>-Figure 4 F, the authors may want to consider if these are truly representative images. The difference is not easily spotted.</p></disp-quote><p>Thank you for the suggestion. We have selected a different representative image to better illustrate the difference between groups (please see Figure 4F).</p><disp-quote content-type="editor-comment"><p>-Why not switch Figure 4 S2 and Figure 4 S1? It may possibly fit better with the line of arguments. Not essential, just a suggestion.</p></disp-quote><p>Thank you for this suggestion. We have reread our paper and prefer keeping the figures as they were originally cited in the text.</p><disp-quote content-type="editor-comment"><p>-Figure 5 A, can the authors please double-check if these are truly representative images? I am asking because the axon diameters seem to differ in the mutants as judged by the example images. Are there enough suitable samples to quantify axonal diameters? Is it possible to say if axons are normally sorted out of bundles, i.e. to quantify the numbers and diameters of axons in bundles? Sorting defects are common pathology in the PNS, at least in mammals.</p></disp-quote><p>Thank you for the suggestion. We quantified the area of each axon cross section (in lieu of axon diameter since these axons are not quite circular) and saw no significant differences in the size of the axons in wildtypes and mutants (see Figure 5 —figure supplement 1I). We have also added a different representative image (see Figure 5A).</p><disp-quote content-type="editor-comment"><p>- In case suitable samples and antibodies are available, Fig6 would benefit from a Western blot for the complement. Not an essential revision</p></disp-quote><p>Thank you for the suggestion. Given that the embryos are so small, it would be extremely difficult to isolate enough SCs for a Western blot. We would love to see future studies, perhaps in mammals, that could follow up on this suggestion.</p><disp-quote content-type="editor-comment"><p>-Related to Fig7, in case suitable samples are available it would be interesting to see TEM of myelinated axons and nodes after Dexamethasone treatment. Not an essential revision, just interesting</p></disp-quote><p>Thank you for the suggestion. While this would be interesting, the TEM staff that ran the electron microscopy cores have recently left their positions, and the University of Virginia has yet to replace them. Also, we do not have samples prepared that would allow us to deliver this data in a reasonable time frame. That said, this would be a great suggestion to follow up on in future studies.</p><disp-quote content-type="editor-comment"><p>- In case the required samples are available, it would be interesting to see some examination of adult WT vs mutant zebrafish. Not an essential revision, again.</p></disp-quote><p>Thank you for the suggestion. This is definitely an interesting idea that we would like to focus on in a future study. However, we would like the current manuscript to focus on the developmental side of this story.</p></body></sub-article></article>